ĐẠI HỌC QUỐC GIA THÀNH PHỐ HỒ CHÍ MINH
Transcription
ĐẠI HỌC QUỐC GIA THÀNH PHỐ HỒ CHÍ MINH
VIETNAM NATIONAL UNIVERSITY - HO CHI MINH CITY UNIVERSITY OF SCIENCE HUYNH BUI LINH CHI STUDY ON CHEMICAL CONSTITUENTS AND BIOLOGICAL ACTIVITIES OF THE LICHEN PARMOTREMA PRAESOREDIOSUM (NYL.) HALE (PARMELIACEAE) DOCTORAL THESIS IN CHEMISTRY Ho Chi Minh City, 2014 VIETNAM NATIONAL UNIVERSITY - HO CHI MINH CITY UNIVERSITY OF SCIENCE HUYNH BUI LINH CHI STUDY ON CHEMICAL CONSTITUENTS AND BIOLOGICAL ACTIVITIES OF THE LICHEN PARMOTREMA PRAESOREDIOSUM (NYL.) HALE (PARMELIACEAE) Subject: Organic Chemistry Code number: 62 44 27 01 Examination Board: Prof. Dr. Nguyen Minh Duc (1st Reviewer) Assoc. Prof. Dr. Tran Cong Luan (2nd Reviewer) Assoc. Prof. Dr. Pham Dinh Hung (3rd Reviewer) Assoc. Prof. Dr. Le Thi Hong Nhan (1st Independent Reviewer) Dr. Le Tien Dung (2nd Independent Reviewer) SUPERVISORS: PROF. DR. NGUYEN KIM PHI PHUNG PROF. DR. TAKAO TANAHASHI Ho Chi Minh City, 2014 i SOCIALIST REPUBLIC OF VIETNAM INDEPENDENCE-FREEDOM-HAPPINESS DECLARATION The work presented in this thesis was completed in the period of November 2009 to November 2013 under the co-supervision of Professor Nguyen Kim Phi Phung of the University of Science, Vietnam National University, Ho Chi Minh City, Vietnam and Professor Takao Tanahashi of the Kobe Pharmaceutical University, Japan. In compliance with the university regulations, I declare that: 1. Except where due acknowledgement has been made, the work is that of the author alone; 2. The work has not been submitted previously, in whole or in part, to qualify for any other academic award; 3. The content of the thesis is the result of the work which has been carried out since the official commencement date of the approved doctoral research program; 4. Ethics procedures and guidelines have been followed. Ho Chi Minh City, Sept 30, 2014 PhD student HUYNH BUI LINH CHI ii ACKNOWLEDGEMENTS There are many individuals without whom the work described in this thesis might not have been possible, and to whom I am greatly indebted. Firstly, I wish to thank my supervisor, Prof. Dr. Nguyen Kim Phi Phung for her knowledge, support, and guidance, hundreds of meetings/emails and for always keeping me on my toes, from the very beginning to the very end of my PhD. I would also like to acknowledge my second supervisor, Prof. Dr. Takao Tanahashi for his guidance, patience and who has taught me the true spirit of research. I am deeply indebted to Dr. Yukiko Takenaka at Kobe Pharmaceutical University, Japan for her teachings, kindness, helpful suggestion and valuable advice in this research. I would also like to express my sincere thanks to PhD Vo Thi Phi Giao at University of Science, Vietnam National University, Ho Chi Minh City and Dr. Harrie J. M. Sipman, Botanic Garden and Botany Museum Berlin-Dahlem, Freie University, Berlin, Germany for his expertise in the identification of lichen. I am very grateful to thank Prof. Dr. Shigeki Yamamoto, Prof. Dr. Hitoshi Watarai at Osaka University, Japan and PhD. Do Thi My Lien for giving up their precious time to help me with CD spectra, sample preparation and proof reading of some isolated compounds of the thesis. A special thanks to Dr. Le Hoang Duy for his helpful assistance and friendship during my work at Kobe Pharmaceutical University, Japan. I would like to acknowledge the encouragement, insightful comments of the rest of examination board: Prof. Dr. Nguyen Cong Hao, Prof. Dr. Nguyen Minh Duc, Assoc. Prof. Dr. Tran Cong Luan, Assoc. Prof. Dr. Pham Dinh Hung, Assoc. Prof. Dr. Nguyen Trung Nhan, Dr. Pham Nguyen Kim Tuyen and Dr. Le Tien Dung. iii Similarly, I would also like to thank my teachers, friends and students in the Department of Organic Chemistry, Faculty of Chemistry, University of Science, Vietnam National University-Ho Chi Minh City. Most importantly, I would like to thank my husband, for being the most patient and supportive witness to my academic journey over the past four years. Without his support, love and encouragement, this study would not have been possible. Finally, I would like to thank my parents for believing in me and for being proud of me. Their unconditional love and support has given me the strength and courage while I am far from home. THANK YOU iv TABLE OF CONTENTS DECLARATION ....................................................................................................... i ACKNOWLEDGEMENTS ...................................................................................... ii TABLE OF CONTENTS ......................................................................................... iv LIST OF ABBREVIATIONS.................................................................................. vi LIST OF TABLES ................................................................................................... xi LIST OF FIGURES ............................................................................................... xiii LIST OF APPENDICES......................................................................................... xv INTRODUCTION ..................................................................................................... 1 CHAPTER 1: LITERATURE REVIEW ................................................................ 3 1.1. GENERIC DESCRIPTION ............................................................................... 3 1.1.1. The lichen .......................................................................................................... 3 1.1.2. Parmotrema praesorediosum (Nyl.) Hale ......................................................... 4 1.2. CHEMICAL STUDIES ON THE LICHEN GENUS PARMOTREMA ........... 6 1.2.1. Lichen secondary metabolites ........................................................................... 6 1.2.2. Chemical studies on the lichen genus Parmotrema .......................................... 8 1.3. BIOLOGICAL ACTIVITIES ......................................................................... 14 1.3.1. The biological significance of lichen metabolites ........................................... 14 1.3.2. The biological significance of the lichen Parmotrema ................................... 15 CHAPTER 2: EXPERIMENTAL ......................................................................... 20 2.1. MATERIALS AND ANALYSIS METHODS ............................................... 20 2.2. LICHEN MATERIALS .................................................................................. 22 v 2.3. EXTRACTION AND ISOLATION PROCEDURES .................................... 22 2.3.1. Isolating compounds from the methanol precipitate ....................................... 22 2.3.2. Isolating compounds from the petroleum ether E1 extract ............................ 23 2.3.3. Isolating compounds from the petroleum ether E2 extract ............................ 23 2.3.4. Isolating compounds from the chloroform extract ......................................... 24 2.4. PREPARATION OF SOME DERIVATIVES ................................................ 28 2.4.1. Esterification of PRAES-C2 ............................................................................ 28 2.4.2. Methylation of PRAES-C25 ............................................................................ 29 2.5. BIOLOGICAL ASSAY .................................................................................. 29 2.5.1. Cytotoxicity ..................................................................................................... 29 2.5.2. In vitro acetylcholinesterase (AChE) inhibition assay .................................... 30 CHAPTER 3: RESULTS AND DISSCUSSION .................................................. 32 3.1. CHEMICAL STRUCTURE ELUCIDATION .............................................. 32 3.1.1. Chemical structure of aliphatic acids .............................................................. 33 3.1.1.1. Structure elucidation of compound PRAES-C1........................................... 33 3.1.1.2. Structure elucidation of compound PRAES-E14 ......................................... 34 3.1.1.3. Structure elucidation of compound PRAES-C10 ........................................ 35 3.1.1.4. Structure elucidation of compound PRAES-C11 ........................................ 39 3.1.1.5. Structure elucidation of compound PRAES-E19 ......................................... 40 3.1.1.6. Structure elucidation of compound PRAES-C2........................................... 41 3.1.2. Chemical structure of mononuclear phenolic compounds .............................. 45 3.1.2.1. Structure elucidation of compound PRAES-T1 ........................................... 45 3.1.2.2. Structure elucidation of compound PRAES-E1 ........................................... 46 vi 3.1.2.3. Structure elucidation of compound PRAES-T2 ........................................... 48 3.1.2.4. Structure elucidation of compound PRAES-E11 ......................................... 49 3.1.2.5. Structure elucidation of compound PRAES-T4 ........................................... 50 3.1.2.6. Structure elucidation of compound PRAES-T6 ........................................... 50 3.1.2.7. Structure elucidation of compound PRAES-E2 ........................................... 51 3.1.2.8. Structure elucidation of compound PRAES-C22 ........................................ 53 3.1.2.9. Structure elucidation of compound PRAES-C23 ........................................ 55 3.1.2.10. Structure elucidation of compound PRAES-C24 ...................................... 56 3.1.2.11. Structure elucidation of compound PRAES-C25 ...................................... 59 3.1.2.12. Structure elucidation of compound PRAES-C26 ...................................... 63 3.1.3. Chemical structure of depsides ....................................................................... 66 3.1.3.1. Structure elucidation of compound PRAES-T3 ........................................... 66 3.1.3.2. Structure elucidation of compound PRAES-C7........................................... 67 3.1.3.3. Structure elucidation of compound PRAES-E18 ......................................... 69 3.1.4. Chemical structure of depsidones ................................................................... 70 3.1.4.1. Structure elucidation of compound PRAES-C14 ........................................ 70 3.1.4.2. Structure elucidation of compound PRAES-C12 ........................................ 73 3.1.5. Chemical structure of diphenyl ethers ............................................................ 74 3.1.5.1. Structure elucidation of compound PRAES-C5........................................... 74 3.1.5.2. Structure elucidation of compound PRAES-C15 ........................................ 77 3.1.5.3. Structure elucidation of compound PRAES-C16 ........................................ 79 3.1.5.4. Structure elucidation of compound PRAES-C20 ........................................ 84 3.1.5.5. Structure elucidation of compound PRAES-C18 ........................................ 86 vii 3.1.5.6. Structure elucidation of compound PRAES-C3........................................... 89 3.1.5.7. Structure elucidation of compound PRAES-C4........................................... 91 3.1.5.8. Structure elucidation of compound PRAES-C21 ........................................ 93 3.1.6. Chemical structure of dibenzofurans .............................................................. 97 3.1.6.1. Structure elucidation of compound PRAES-E5 ........................................... 97 3.1.6.2. Structure elucidation of compound PRAES-E3 ........................................... 99 3.1.6.3. Structure elucidation of compound PRAES-C8......................................... 100 3.1.7. Chemical structure of xanthones ................................................................... 103 3.1.7.1. Structure elucidation of compound PRAES-C27 ...................................... 103 3.1.7.2. Structure elucidation of compound PRAES-C28 ...................................... 108 3.1.8. Chemical structure of triterpenoids ............................................................... 111 3.1.8.1. Structure elucidation of compound PRAES-E17 ....................................... 111 3.1.8.2. Structure elucidation of compound PRAES-E6 ......................................... 112 3.1.8.3. Structure elucidation of compound PRAES-E13 ....................................... 113 3.1.9. Chemical structure of a macrocylic compound............................................. 117 3.1.9.1. Structure elucidation of compound PRAES-E15 ....................................... 117 3.2. BIOLOGICAL ASSAY ................................................................................ 120 3.2.1. Cytotoxicity activitivy................................................................................... 120 3.2.2. Acetylcholinesterase inhibitory activity ....................................................... 121 CHAPTER 4: CONCLUSION ............................................................................. 124 4.1. CONSTITUENTS OF PARMOTREMA PRAESOREDIOSUM ................... 124 4.2. BIOLOGICAL ASSAY ................................................................................ 132 FUTURE OUTLOOK ........................................................................................... 133 viii LIST OF PUBLICATIONS .................................................................................. 134 REFERENCES ...................................................................................................... 135 APPENDICES ....................................................................................................... 145 ix LIST OF ABBREVIATIONS 1D One dimensional 2D Two dimensional Ac Acetone AcOH Acetic acid br Broad C Chloroform calcd Calculated CC Column chromatography CD Circular dichroism COSY Homonuclear shift correlation spectroscopy CPCM Conductor-like polarized continuum model d Doublet dd Doublet of doublets DEPT Distortionless enhancement by polarisation transfer DMSO Dimethyl sulfoxide EA Ethyl acetate EI-MS Electron-impact ionization mass spectrum EtOH Ethanol H n-Hexane HMBC Heteronuclear multiple bond correlation spectroscopy HPLC High performance liquid chromatography HR-EIMS High resolution electron-impact ionization mass spectrum HR-ESIMS High resolution electrospray ionization mass spectrum x HSQC Heteronuclear single quantum correlation spectroscopy IR Infrared spectrophotometry m Multiplet M Methanol MeOH Methanol min Minutes MS Mass spectrum NMR Nuclear magnetic resonance NOESY Nuclear overhauser enhancement spectroscopy P Petroleum ether ppm Parts per million (chemical shift value) pre TLC Preparative thin-layer chromatography q Quartet quint Quintet ROESY Rotating-frame overhauser enhancement spectroscopy s Singlet sext Sextet t Triplet TD-DFT Time dependent density functional theory TLC Thin-layer chromatography TMS Tetramethylsilane UV Ultraviolet xi LIST OF TABLES Table 1.1. In vitro biological activities of the lichen genus Parmotrema 17 Table 3.1. Isolated compounds from Parmotrema praesorediosum 32 Table 3.2. 1 38 Table 3.3. 13 Table 3.4. NMR data of PRAES-T1, PRAES-E1, PRAES-T2 47 Table 3.5. NMR data of PRAES-E11, PRAES-T4, PRAES-T6, PRAES-E2 52 Table 3.6. NMR data of PRAES-C22, PRAES-C23, PRAES-C24 58 Table 3.7. NMR data of PRAES-C25, PRAES-C25M, PRAES-C26 65 Table 3.8. NMR data of PRAES-T3, PRAES-C7, PRAES-C9, PRAES-E18 68 Table 3.9. NMR data of PRAES-C14 and PRAES-C12 72 Table 3.10. 1 H NMR data of PRAES-C5 and Lecanorol 76 Table 3.11. 1 H NMR data of PRAES-C15, PRAES-C16, PRAES-C20, H NMR of aliphatic compounds C NMR of aliphatic compounds PRAES-C18, PRAES-C3 and PRAES-C4 Table 3.12 13 39 82 C NMR data of PRAES-C15, PRAES-C16, PRAES-C20, PRAES-C18, PRAES-C3 and PRAES-C4 83 Table 3.13. NMR data of PRAES-C21 96 Table 3.14. NMR data of PRAES-E5 and PRAES-E3 (CDCl3) 98 Table 3.15. NMR data of PRAES-C8, PRAES-E5 and Usimine A 102 Table 3.16. NMR data of PRAES-C27, Blennolide G, Blennolide B and Chromone lactone (CDCl3) Table 3.17. NMR data of PRAES-C27 and PRAES-C28 (CDCl3) 106 110 xii Table 3.18. NMR data of PRAES-E17, PRAES-E6, PRAES-E13 and 1β,3βDiacetoxyhopan-22-ol Table 3.19. NMR data of PRAES-E15 115 120 Table 3.20. % Inhibition of cytotoxic activity against three cancer cell lines of isolated compounds 122 Table 3.21. IC50 value of cytotoxic activity against three cancer cell lines of isolated compounds 122 Table 3.22. Acetylcholinesterase inhibition of some extracts and isolated compounds 123 xiii LIST OF FIGURES Figure 1.1. Types of the lichen 3 Figure 1.2. Parmotrema praesorediosum (Nyl.) Hale (Parmeliaceae) 5 Figure 1.3. Biosynthetic pathways of the major groups of lichen substances 7 Figure 2.1: Isolation of compounds from the prepicitate and petroleum ether extracts of Parmotrema praesorediosum (Nyl.) Hale 26 Figure 2.2: Isolation of compounds from the chloroform extract of Parmotrema praesorediosum (Nyl.) Hale 27 Figure 3.1. HMBC correlations of PRAES-C1 and PRAES-E14 36 Figure 3.2. HMBC correlations of PRAES-C10 37 Figure 3.3. HMBC correlations of PRAES-E19 41 Figure 3.4. HMBC correlations of PRAES-C2 42 Figure 3.5. Comparison of experimental CD spectrum of PRAES-C2Me and theoretical calculated one. 44 Figure 3.6. CD spectra of isolated aliphatic compounds 45 Figure 3.7. HMBC correlations of PRAES-E1 and PRAES-T2 48 Figure 3.8. HMBC correlations of PRAES-E11, PRAES-T4 and PRAES-E2 52 Figure 3.9. HMBC and NOESY correlations of PRAES-C22 54 Figure 3.10. HMBC and NOESY correlations of PRAES-C23 56 Figure 3.11. HMBC and NOESY correlations of PRAES-C24 57 Figure 3.12. COSY, HMBC and NOESY correlations of PRAES-C25M 61 Figure 3.13. Mechanism for the methylation of PRAES-C25 62 Figure 3.14. HMBC and NOESY correlations of PRAES-C25 and PRAES-C26 63 xiv Figure 3.15. HMBC correlations of PRAES-C9 and PRAES-C7 67 Figure 3.16. COSY and HMBC correlations of PRAES-E18 70 Figure 3.17. HMBC correlations of PRAES-C12 73 Figure 3.18. HMBC correlations of PRAES-C5 75 Figure 3.19. HMBC and NOESY correlations of PRAES-C15 78 Figure 3.20. HMBC and ROESY correlations of PRAES-C16 80 Figure 3.21. HMBC and ROESY correlations of PRAES-C20 85 Figure 3.22. 1H NMR data of PRAES-C18 and diphenyl ether 87 Figure 3.23. HMBC and ROESY correlations of PRAES-C18 88 Figure 3.24. HMBC correlations of PRAES-C3 90 Figure 3.25. HMBC correlations of PRAES-C4 93 Figure 3.26. HMBC correlations of PRAES-C21 94 Figure 3.27. ROESY correlations of PRAES-C21 95 Figure 3.28. HMBC correlations of PRAES-E5 97 Figure 3.29. HMBC correlations of PRAES-E3 99 Figure 3.30. HMBC correlations of PRAES-C8 101 Figure 3.31. The structure of Usimine A 102 Figure 3.32. COSY, HMBC and ROESY correlations of PRAES-C27 104 Figure 3.33. ROESY correlations of PRAES-C28 109 Figure 3.34. COSY and HMBC correlations of PRAES-C28 111 Figure 3.35. HMBC correlations of PRAES-E17 112 Figure 3.36. HMBC correlations of PRAES-E13 114 Figure 3.37. COSY and HMBC correlations of PRAES-E15 118 xv LIST OF APPENDICES Appendices 1-7: IR, MS and NMR spectra of PRAES-C1 146 Appendices 8-15: IR, MS and NMR spectra of PRAES-E14 149 Appendices 16-21: MS and NMR spectra of PRAES-C10 153 Appendices 22-26: MS and NMR spectra of PRAES-C11 156 Appendices 27-33: IR, MS and NMR spectra of PRAES-E19 159 Appendices 34-40: IR, MS and NMR spectra of PRAES-C2 162 Appendices 41-44: NMR spectra of PRAES-T1 166 Appendices 45-49: MS and NMR spectra of PRAES-E1 168 Appendices 50-54: NMR spectra of PRAES-T2 170 Appendices 55-58: NMR spectra of PRAES-E11 173 Appendices 59-62: NMR spectra of PRAES-T4 175 Appendices 63-66: MS and NMR spectra of PRAES-T6 177 Appendices 67-70: NMR spectra of PRAES-E2 179 Appendices 71-78: IR, MS and NMR spectra of PRAES-C22 181 Appendices 79-86: IR, MS and NMR spectra of PRAES-C23 185 Appendices 87-94: IR, MS and NMR spectra of PRAES-C24 189 Appendices 95-97: MS and NMR spectra of PRAES-C25 193 Appendices 98-106: IR, MS and NMR spectra of PRAES-C25M 194 Appendices 107-114: IR, MS and NMR spectra of PRAES-C26 199 Appendices 115-119: NMR spectra of PRAES-T3 203 Appendices 120-124: NMR spectra of PRAES-C7 205 xvi Appendices 125-131: MS and NMR spectra of PRAES-E18 208 Appendices 132-136: MS and NMR spectra of PRAES-C14 211 Appendices 137-141: NMR spectra of PRAES-C12 214 Appendices 142-147: MS and NMR spectra of PRAES-C5 216 Appendices 148-155: IR, MS and NMR spectra of PRAES-C15 219 Appendices 156-163: IR, MS and NMR spectra of PRAES-C16 223 Appendices 164-172: IR, MS and NMR spectra of PRAES-C20 227 Appendices 173-180: IR, MS and NMR spectra of PRAES-C18 232 Appendices 181-186: MS and NMR spectra of PRAES-C3 236 Appendices 187-192: MS and NMR spectra of PRAES-C4 239 Appendices 193-200: IR, MS and NMR spectra of PRAES-C21 242 Appendices 201-204: NMR spectra of PRAES-E5 246 Appendices 205-207: NMR spectra of PRAES-E3 248 Appendices 208-213: MS and NMR spectra of PRAES-C8 249 Appendices 214-222: IR, MS and NMR spectra of PRAES-C27 252 Appendices 223-231: IR, MS and NMR spectra of PRAES-C28 256 Appendices 232-235: NMR spectra of PRAES-E17 261 Appendices 236-237: NMR spectra of PRAES-E6 263 Appendices 238-244: MS and NMR spectra of PRAES-E13 264 Appendices 245-259: MS and NMR spectra of PRAES-E15 268 INTRODUCTION Lichens are by definition symbiotic organisms composed of a fungal partner (mycobiont) and one or more photosynthetic partners (photobiont/s). The photobiont can be either a green alga or a cyanobacterium. Morphologically lichens can be classified into three major groups. They are foliose, fruticose and crustose. Growing rates of lichens are extremely slow. More than twenty thousand species of lichens have been found. They can tolerate very drastic weather conditions and are resistant to insects and other microbial attacks. Lichens produce a variety of secondary compounds. They play an important role in protection and maintenance of the symbiotic relationship [1]. Many lichen secondary metabolites exhibited antibiotic, antitumour, antimutagenic, allergenic, antifungal, antiviral, enzyme inhibitory and plant growth inhibitory properties [5, 12]. In 2007, Balaji. P. et al. [3] indicated that dichloromethane, ethyl acetate and acetone methanol extracts of Parmotrema praesorediosum showed antimicrobial activity against ten bacterial (Gram + and -) (Bacillus cereus, Corynebacterium diptheriae, Proteus mirabilis, Proteus vulgari, Pseudomonas aeruginosa, Salmonella typhi, Shigella flexnerii, Staphylococcus aureus, Streptococcus pyogenes and Vibrio cholera) and one fungal Candida albicans by using standard dics diffusion method. This lichen could therefore be a potential source in the search for pharmaceutical useful chemicals. The primary goal of the present work was to isolate secondary metabolites on the lichen Parmotrema praesorediosum (Nyl.) Hale. The chemical structure of isolated compounds was characterized by spectroscopic methods (1D-, 2D-NMR, HRMS, CD). Finally, the purified substances from this source were assayed for the cytotoxic activities against three cell lines: MCF-7 (breast cancer cell line), HeLa (cervical cancer cell line) and NCI-H460 (human lung cancer cell line) by 1 sulforhodamine B colorimetric assay method (SRB assay) [56] and the inhibition against acetylcholinesterase in vitro. Based on spectroscopic evidence and their physical properties, the chemical structures were attributed for be forty compounds, including six aliphatic acids, twelve mononuclear phenolic acids, three depsides, two depsidones, eight diphenyl ethers, three dibenzofurans, two xanthones, three triterpenoids and a macrocyclic compound. The latter twenty two compounds appeared to be new and among eighteen known compounds, twelve compounds were known for the first time from the genus Parmotrema. These results pointed out that the Vietnamese lichens could be new sources of bioactive compounds with novel skeletons 2 CHAPTER 1 LITERATURE REVIEW 1.1. GENERIC DESCRIPTION 1.1.1. The lichen Lichens are by definition symbiotic organisms, usually composed of a fungal which is most often either a green alga or cyanobacterium. The photobionts produce carbohydrates by photosynthesis for themselves and for their dominant fungal counterparts (mycobionts), which provide physical protection, water and mineral supply [73]. Overall the lichen symbiosis is a very successful one, as lichens are found in almost all terrestrial habitats from the tropics and deserts to polar regions. As the results of the relationship, both the fungus and algae/cyanobacterium partners, which mostly thrive in relatively moist and moderate environments in free living form, have expanded into many extreme terrestrial habitats, where they would separately be rare or non-existent [52]. On the basis of their forms and habitats, lichens are traditionally divided into three main morphological groups: crustose, foliose and fructicose (Figure 1.1) [42]. Crustose Foliose Figure 1.1. Types of the lichen 3 Fructicose The lichen symbiosis is different other than kinds of symbiosis because the lichen takes on a new body shape that neither the fungus nor the alga had independently [73]. About 17,000 different lichen taxa, including 16,750 lichenized Ascomycetes, 200 Deuteromycetes, and 50 Basidiomycetes have been described world-wide. A thallus consists of a cortex and a medulla, both made up of fungal tissue and a photobiont layer in which the alga and cyanobacterial cells are endeveloped by fungal hyphae. 1.1.2. Parmotrema praesorediosum (Nyl.) Hale The Parmeliaceae is a large and diverse family of Lecanoromycetes. With over 2000 species in roughly 87 genera, it is regarded as the largest family of lichen forming fungi [39]. The most speciose genera in the family are the well-known groups: Xanthoparmelia (800+ species), Usnea (500+ species), Parmotrema (350+ species), and Hypotrachyna (190+ species) [39]. Nearly all members of the family have a symbiotic association with a green alga (most often Trebouxia spp., but Asterochloris spp. are known to associate with some species) [73]. The majority of Parmeliaceae species have a foliose, fruticose, or subfruticose growth form. The family has a cosmopolitan distribution, and can be found in a wide range of habitats and climatic regions [73]. Members of the Parmeliaceae can be found in most terrestrial environments Parmotrema A. Massal. (previously known as Parmelia s.lat.) is one of the largest genera of parmelioid core in the family Parmeliaceae [39]. The Parmotrema genus is characterized by foliose thalli forming short and broad, rarely elongated, often ciliate lobes, a pored epicortex, cylindrical conidia and the intermediate type of lichenan between Cetraria-type lichenan and Xanthoparmelia-type lichenan. The lower surface of the thallus is white to black, usually sparingly rhizinate with a wide bare marginal zone, sometimes irregularly rhizinate or finely short-rhizinate with scattered much longer rhizines mixed without an erhizinate margin or with a very narrow one [72]. 4 The upper surface The lower surface Figure 1.2. Parmotrema praesorediosum (Nyl.) Hale (Parmeliaceae) Scientific name: Parmotrema praesorediosum (Nyl.) Hale Parmelia praesorediosa Nyl. Family: Parmeliaceae Morphography: Thallus foliose, adnate to the substratum, 3~10 cm across. Lobes round, 4~10 mm wide; margins entire or crenate, eciliate, sorediate. Upper surface pale grey to grey, smooth, dull, emaculate, weakly rugose, lacking isidia, sorediate. Soralia marginal, linear to crescent shaped, granular. Medulla white. Lower surface black, minutely rugose, with shiny, mottled, ivory or brown, erhizinate marginal zone. Rhizines sparse, simple, short. Apothecia and pycnidia is not seen [49]. Spotest: Cortex K+ (yellow), C−, KC−, P−; medulla K−, C−, KC−, P− TLC: atranorin, chloroatranorin, fatty acids (protopraesorediosic acid, praesorediosic acid). 5 1.2. CHEMICAL STUDIES ON THE LICHEN GENUS PARMOTREMA 1.2.1. Lichen secondary metabolites Primary metabolites of lichens, which are intracellular, are proteins, amino acids, polyols, carotenoids, polysaccharides and vitamins. Lichens produce a wide array of secondary metabolites (intracellular). There are over 700 lichen substances reported to date and many are restricted to the lichenised state. Broadly speaking, there are three types of lichen substances based on their biosynthetic origin [43] (Figure 1.2). The acetate-malonate pathway produces depsides, depsidones and dibenzofurans. The most important of these are the esters and the oxidative coupling products of simple phenolic units related to orcinol and 3-orcinol. Most depsides and depsidones are colorless compounds which occure in the medulla of the lichen. However, usnic acids, yellow cortical compounds formed by the oxidative coupling of methylphloroacetophenone units are found in the cortex of many lichen species. Anthraquinones, xanthones and chromones, are all pigmented compounds which occur in the cortex. They are also produced by the acetate-malonate pathway, but their biosynthesis results from intramolecular condensation of long, folded polyketide units rather than the coupling of phenolic units. The shikimic acid pathway produces two major groups of pigmented compounds, which occur in the cortex: pulvinic acid derivatives and terphenylquinones. Although most pulvinic acid derivatives lack nitrogen, they are biosynthesized through phenylalanine. Nitrogen is strongly limited to metabolic activities in most lichens, and nitrogen rich metabolites such as alkaloids are unknown among lichen substances. The mevalonic acid pathway produces terpenoids and steroids. These compounds are found in lichens and many of them occur in higher plants as well. 6 Alga Fungus glucose erythritol ribitol mannitol Usnic acids Anthraquinones Poly saccharides Sugars Methylphloroacetophenone/ acetylmethylphloroglucinol Pentose phosphate cycle Polyketide Malonyl-CoA Amino acids Mevalonic acid Shikimic acid -Orsellinic acid Depsones Squalenes Geranylgeranyl-p-p Triterpens Phenylalanine Terphenylquinones Diterpenes Pulvinic acid derivatives Secondary aliphatic acids, esters and related derivatives Glucolysis Acetyl CoA Phenylpyruvic acid Xanthones, Chromones Orsellinic acid and homologues para- meta-Depsides Benzyl esters Tridepsides Dibenzofuran Depsidones Diphenyl ethers Steroids Carotenoids Figure 1.3. Biosynthetic pathways of the major groups of lichen substances [43]. 7 1.2.2. Chemical studies on the lichen genus Parmotrema Parmotrema praesorediosum (+)-Praesorediosic acid (1), (+)-protopraesorediosic acid (2), atranorin (11) and chloroatranorin (12) were isolated by David F. et al. (1990) [20]. Lecanoric acid (14) and stictic acid (18) were isolated from Parmelia praesorediosa (Nyl.) by Ramesh P. et al. (1994) [62]. Parmotrema sancti-angelii Atranorin (11), lecanoric acid (14) and α-collatolic acid (25) were isolated by Neeraj V. et al. (2011) [55]. Parmotrema conformatum Protocetraric acid (21), malonprotocetraric acid (23) and (+)-usnic acid (40) were isolated by Keogh M. F. (1977) [44]. Parmotrema dilatum Depside atranorin (11), depsidones salazinic acid (16), norstictic acid (19), hypostictic acid (20) and protocetraric acid (21) were isolated from Parmotrema dilatum by Honda N. K. et al. (2010) [32]. Pamotrema lichexanthonicum Depside atranorin (11), depsidone salazinic acid (16) and xanthone lichexanthone (41) were isolated from the chloroform extract of Pamotrema lichexanthonicum by Ana C. M. et al. (2009) [3]. Parmotrema mellissii Methyl orsellinate (5), ethyl orsellinate (6), n-butyl orsellinate (7), methyl βorsellinate (8), methyl haematommate (9), ethyl chlorohaematommate (10), atranorin (11), chloroatranorin (12), α-alectoronic acid (24), α-collatolic acid (25), 2′′′-O-methyl-α-alectoronic acid (26), 2′′′-O-ethyl-α-alectoronic acid (27), dehydroalectoronic acid (28), dehydrocollatolic acid (29), parmosidone A (30), 8 parmosidone B (31), parmosidone C (32), isocoumarin A (33), isocoumarin B (34), β-alectoronic acid (36), β-collatolic acid (37), 2′′′-O-methyl-β-alectoronic acid (38), 2′′′-O-ethyl-β-alectoronic acid (39), (+)-usnic acid (40) and skyrin (42) were isolated from Parmotrema mellissii that was collected at Da Lat city, Vietnam by Lê Hoàng Duy et al. (2012) [52]. Parmotrema nilgherrense α-Alectoronic acid (24), α-collatolic acid (25) and dehydrocollatolic acid (29) were isolated by Kharel M. K. et al (2000) [45]. Depside atranorin (11) were isolated by Neeraj V. et al. (2011) [55]. Parmotrema planatilobatum Orcinol (3), orsellinic acid (4), methyl orsellinate (5), methyl β-orsellinate (8), methyl haematommate (9), atranorin (11), gyrophoric acid (13), lecanoric acid (14), protocetraric acid (21), 9-methylprotocetraric acid (22), methyl 2-[3-(2,6dihydroxy-4-methylbenzyl)-2,4-dihydroxy-6-methylphenoxy]-3-formyl-4-hydroxy6-methylbenzoate (35) and usnic acid (40), were isolated by Duong T. H. et al. (2011, 2012) [22, 23]. Parmotrema reticulatum Atranorin (11), chloroatranorin (12), salazinic acid (16) and consalazinic acid (17) were isolated from the acetone extract by Fazio A. T. et al. (2009) [25]. Parmotrema saccatilobum Atranorin (11) and chloroatranorin (12) were isolated from the hexane extract of Parmotrema saccatilobum by Bugni T. S. et al. (2009) [12]. Parmotrema stuppeum Orsellinic acid (4), methyl orsellinate (5), atranorin (11) and lecanoric acid (14) were isolated by Javaprakasha G. K. et al. (2000) [40]. 9 Parmotrema subisidiosum Depside atranorin (11) and two depsidones salazinic acid (16) and consalazinic acid (17) were isolated from the acetone extract by O‟Donovan D. G. et al. (1980) [57]. Parmotrema tinctorum Isolecanoric acid (15) was isolated by Sakurai A. et al. (1987) [63]. Ethyl orsellinate (6) was isolated by Santos L. C. et al. (2004) [64]. Atranorin (11) and lecanoric acid (14) were isolated by Honda N. K. et al. (2010) [32]. Chemical structure of the compounds isolated from different species of genus Parmotrema Aliphatic acids Mononuclear phenolic compounds 10 Depsides Depsidones 11 12 Diphenylethers 13 Quinone 1. 3. BIOLOGICAL ACTIVITIES 1.3.1. The biological significance of lichen metabolites Production of secondary metabolites is costly to the organisms in terms of nutrient and energy, therefore one would expect that the plethora of metabolites produced by lichens would have biological significance to the organisms. Recent field and laboratory studies have shown that many of these compounds are indeed involved in important ecological roles. Some of the possible biological functions of lichen metabolites, are summarized as below [43]: Antibiotic activities – provide protection against microorganisms. Photoprotective activities – aromatic substances absorb UV light to protect algae (photobionts) against intensive irradiation. 14 Promote symbiotic equilibrium by affecting the cell wall permeability of photobionts. Chelating agents – capture and supply important minerals from the substrate. Antifeedant/ antiherbivory activities – protect the lichens from insect and animal feedings. Hydrophobic properties – prevent saturation of the medulla with water and allow continuous gas exchange. Stress metabolites – metabolites secreted under extreme conditions. 1.3.2. The biological significance of the lichen genus Parmotrema 1.3.2.1. Antimicrobial activities The lichen Parmotrema species were observed a marked dose dependent inhibition of test bacteria by lichen extracts. It has been found that lichens of the genus Parmotrema are promising antimicrobial agents. Balaji P. et al. [41] reported marked antimicrobial efficacy of dichloromethane extract of P. praesorediosum collected from silicious rocks of Western Ghats of Tamil Nadu. Kumar et al. [50] showed the antibacterial activity of methanol extract of P. pseudotinctorum from the Western Ghats of Karnataka. Sinha and Biswas [69] reported the antibacterial efficacy of solvent extracts of P. reticulatum from Sikkim, India. Neeraj V. et al. [44] found antibacterial efficacy of solvent extracts of P. nilgherrensis and P. sancti-angelii collected from Karnataka, India. Chauhan and Abraham [14] showed the inhibitory effect of methanol extract of Parmotrema sp. collected from Kodaikanal forest, India against clinical isolates of bacteria. Javeria et al. [3] showed the inhibitory efficacy of solvent extracts of P. nilgherrense collected from Nainital, India against drug resistant bacteria. 1.3.2.2. Antioxidant activities Lichens have been shown promising as they possess various bioactivities including antioxidant activity. The DPPH free radical scavenging assay is one of the most widely used assays to evaluate the antioxidant activity of several kinds of 15 samples including lichen extracts. The method is simple, rapid, sensitive and requires small amount of samples. It has been found that Parmotrema species possess radical scavenging activity. Kekuda et al. [50] observed dose dependent DPPH radical scavenging activity in the lichen P. pseudotinctorum. Though the scavenging of free radicals by lichen extracts was lesser than ascorbic acid, it is evident that the extracts showed hydrogen donating ability and therefore the extracts could serve as free radical scavengers, acting possibly as primary antioxidants. Extract of P. grayanum showed high scavenging activity followed by P. praesorediosum and P. tinctorum as indicated by lower IC50 value [76]. Methanol and ethanol extract of P. reticulatum have shown DPPH radical scavenging activity [68] (Table 1.1). 1.3.2.3. Antitumor activities The action of lichen-derived compounds on tumor cells has been a focus of evaluations for some decades. Lichexanthone and protocetraric acid isolated from the lichens Parmotrema dilatatum (Vain.) Hale and Parmotrema lichexanthonicum Eliasaro & Adler were evaluated against UACC-62 and B16-F10 melanoma cells and 3T3 normal cells by Sulforhodamine B assay [7]. A cytotoxicity assay was carried out in vitro with sulforhodamine B (SRB) using HEp-2 larynx carcinoma, MCF-7 breast carcinoma, 786-0 kidney carcinoma, and B16-F10 murine melanoma cell lines, in addition to a normal (Vero) cell line in order to calculate the selectivity index of the compounds from the lichen Parmotrema tinctorum [8]. The relationship between O-alkyl salazinic acids from Parmotrema lichexantonicum Eliasaro and Alder and potentially cytotoxic against human colon carcinoma (HCT8), melanoma (MDA-MB-435), and brain (SF-295) tumor cell was investigated by Micheletti A. C. et al. [54]. 16 Table 1.1. In vitro biological activities of the lichen genus Parmotrema. Activity Content Source Refferences Against ten bacterial (Gram + and -) (Bacillus cereus, The dichloromethane, ethyl Balaji. P. et Corynebacterium diptheriae, Proteus mirabilis, Proteus vulgari, acetate, acetone and methanol al. [3] Pseudomonas aeruginosa, Salmonella typhi, Shigella flexnerii, extracts of P.praesorediosum Staphylococcus aureus, Streptococcus pyogenes and Vibrio cholera) and one fungal Candida albicans Against eight bacterial (Gram + and -) Staphylococcus aureus, S. The methanol extracts of P. Vivek M. N. epidermidis, Bacillus cereus, Klebsiella pneumoniae, Enterobacter tinctorum, P. grayanum and et al. [76] aerogenes, Shigella flexneri, Salmonella typhi and Escherichia coli P. praesorediosum. by Agar well diffusion assay. Antimicrobial Antibacterial Antifungal Against Bacillus subtilis, Erwinia chrysanthemi, Escherichia coli, The methanol, ethanol, Sati S. C. et Agrobacterium tumefaciens and Xanthomonas phaseoli chloroform extract of the al [65] lichen P. nilgherrense Against Pseudomonas aeruginosa, P. fluorescens, Proteus vulgaris, The acetone, methanol, ethyl Javeria S. et Shegilla flexneri, Klebsiella pneumoniae and Salmonella typhi. acetate and benzene extract al. [41] of the lichen P. nilgherrense Against Staphylococcus aureus, Clostridium perfringens, Escherichia The methanol extract of P. coli and Pseudomonas aeruginosa by Agar well diffusion method pseudotinctorum Against Staphylococcus aureus and Pseudomonas aeruginosa by The methanol extract Agar well diffusion method Parmotrema sp. Againts the bacterial strains Bacillus cereus, Bacillus subtilis, Escherichia coli, Klebsiella pneumonia, Micrococcus luteus, Proteus vulgaris, Staphylococcus aureus, Streptococcus faecalis, Sarcina lutea and yeast strains Candida albicans, Cryptococcus var. diffluens. 17 Kumar S. V. P et al. [50] of Chauhan R. et al. [14] The ethyl acetate extract of Neeraj V. et Parmotrema nilgherrensis al. [44] and Parmotrema sanctiangelii Against Staphylococcus aureus and Escherichia coli Parmotrema lichexantonicum Micheletti A. C. [54] Against five bacterial strains viz. Staphylococcus aureus, Escherichia The acetone and methanol Sinha S. N. coli, Vibrio cholerae, Shigella dysenteriae. Shigella flexneri extracts of Parmotrema et al. [69] reticulatum DPPH radical scavenging activity The benzene and acetone Javaprakash extracts of Parmotrema a G. K. et al. stuppeum [33] The methanol extract exhibited marked antioxidant activity by The methanol extract of P. scavenging DPPH* (free radical) and converting into DPPHH. pseudotinctorum Antioxidant Kumar S.V.P et al. [50] P. grayanum (IC50148.39μg/ml) showed higher scavenging potential The methanol extracts of P. Vivek M. N. followed by P. praesorediosum (IC50 179.81μg/ml) and P. tinctorum tinctorum, P. grayanum and et al. [76] (IC50 439.06μg/ml) by scavenging of DPPH radicals. P.praesorediosum. Determined by Malondialdehyde (MDA) assay and ABTS radical Parmotrema austrosinese and Vattem D. quenching assay Parmotrema perforatum A. et al. [75] DPPH radical scavenging activity. The ethanol and methanol Sharma B. extracts of the lichen C. et al. [68] Parmotrema reticulatum Active in superoxide radical (SOR), DPPH, and nitric oxid Parmotrema grayana Hue scavenging activity. Active in hydroxyl and hypochlorous radical scavenging, DPPH, superoxide, singlet oxygen, nitric oxide and peroxynitrite scavenging activity. Yousuf S. et al. [77] The methanol extract of the Ghate N. B. lichen Parmotrema et al. [29] reticulatum Antioxidant activities by using DPPH, ABTS, superoxide, and The ethyl acetate extract of Raj P. S. et hydroxyl radical scavenging assay. Parmotrema tinctorum al [61] 18 Activity Content Source Refferences Antitumor activity against malignant cell lines of erythro leukemia. Parmotrema dilatatum Yousuf S. et (Vain.) Hale and Parmotrema al. [77] Antiproliferative against capan-1 and -2, PANC-1 (parcrease), NCIH1415 (lung cell), PC-3 (prostate), T47-D (breast), AGS (stomach), tinctorum (Nyl.) Hale NTH: OVCAR-3 (ovaries) and JURKAT (acute promyelocytic, Tcell and erythrocell leukemina cell lines). Toxicity test of against Artemia salina with BSLT method Cytotoxicity Anticancer Antitumor The dichloromethane extract and phenolic compounds of the lichen P. tinctorum Kusumaning rum I. K.. et al. [51] Gomes A. T. et al. [30] Cytotoxic against MCF-7 cells with an IC50 value 130.03±3.11 g/ml The methanol extracts of the Ghate N. B. lichen Parmotrema et al. [29] reticulatum Against human colon carcinoma (HCT-8), melanoma (MDA-MB435), and brain (SF-295) tumor cell Parmotrema Micheletti lichexantonicum Eliasaro and A. C. [54] Alder Cytotoxic against on B16-F10 murine melanoma, UACC-62 human melanoma cells and NIH/3T3fibroblasts by sulforhodamine B (SRB) assay Parmotrema dilatatum Brandão L. (Vain.) Hale and Parmotrema F. G. et al. lichexantonicum Eliasaro and [7] Alder In vitro with sulforhodamine B (SRB) using HEp-2 larynx arcinoma, Parmotrema tinctorum (Nyl.) Bogo D. et MCF7 breast carcinoma, 786-0 kidney carcinoma, and B16-F10 urine Hale al. [8] melanoma cell lines 19 CHAPTER 2 EXPERIMENTAL 2.1. MATERIALS AND ANALYSIS METHODS TLC was carried out on precoated silica gel 60 F254 (Merck) and precoated Kieselgel 60F254 plates (Merck). Gravity column chromatography was performed with silica gel 60 (Merck) and silica gel 60 (0.040 – 0.063 mm, Himedia). TLC spots were detected under ultraviolet (UV254) irradiation or visualized by spraying with a solution of 5% vanillin in ethanol, followed by heating at 100 oC. Solvents: Hexane, diethyl ether, petroleum ether (60-90 o C), toluene, chloroform, ethyl acetate, acetone, methanol, acetic acid. Melting points were determined on Maquenne block(a). The NMR experiments using residual solvent signal as internal reference: chloroform-d H 7.24, C 77.23 and acetone-d6 H 2.09, C 206.31, 30.6 were performed with: Bruker Avance 500III (500 MHz for 1H and 125 MHz for 13C-NMR(a, b). Varian VXR-500 spectrometers, with tetramethylsilane as internal standard(c). The HR–ESI–MS were recorded on HR–ESI–MS MicroOTOF–Q mass spectrometer(a). Hitachi M-4100 mass spectrometer(c). 20 The IR spectra were obtained with Bruker Vector 22 infrared spectrophotometer(a). Shimadzu FTIR-8200 infrared spectrophotometer(c). Optical rotations were measured on Kruss (German) digital polarimeter(a). Jasco DIP-370 digital polarimeter(c). Absorption and CD spectra were measured on Jasco V-570 spectrophotometer(d). Jasco J-820E spectropolarimeter(d). TD-DFT calculations of the CD spectra were optimized at the level of B3LYP/6-311++G** in vacuo and in CPCM solvent model of methanol. The populations of the two stable conformers were calculated based on the relative energies with the Boltzmann distribution at 300 K. The optimization under the CPCM solvent model of methanol did not change significantly these geometries or populations. The electronic CD spectra of the stable conformers were calculated at the TD-DFT theory with the same basis sets as the optimizations by using Gaussian09 program, fitted by Gaussian curves with 0.30 eV line width, and then weighted-averaged based on the Boltzamann population. (a) The Center Analysis of the University of Science, National University- Ho Chi Minh City, Vietnam. (b) The Institute of Chemistry, Vietnam Academy of Science and Technology, Hanoi, Vietnam. (c) Life Science Center, Kobe Pharmaceutical University, Japan. (d) Osaka University, Japan. 21 2.2. LICHEN MATERIALS The lichen Parmotrema praesorediosum (Nyl.) Hale was collected at Nam Cat Tien National Forest Reserve and Intermediate Zones, Nam Cat Tien Village, Tan Phu District, Dong Nai Province, Vietnam in January-July 2009. The scientific name of the lichen was determined by MSc. Vo Thi Phi Giao, Faculty of Biology, University of Science, National University – Ho Chi Minh city. A voucher specimen (No US-B020) was deposited in the Herbarium of The Department of Organic Chemistry, Faculty of Chemistry, University of Science, National University - Ho Chi Minh City-Vietnam. 2.3. EXTRACTION AND ISOLATION PROCEDURES The fresh lichen thalli (5.0 kg) were cleaned under running tap water and airdried. The ground powder sample (3.0 kg) was extracted with methanol at room temperature by method of maceration. After filtration, the solvent was evaporated at the reduced pressure. While the methanolic solution was evaporated, a precipitate occurred and was filtered off, then the solution was continued evaporated to dryness. The resulting was the precipitate (9.0 g) and the crude methanolic residue (450.0 g). The methanolic residue (450.0 g) was subjected to silica gel solid phase extraction and eluted consecutively with petroleum ether, chloroform, ethyl acetate, acetone and methanol in turn at room temperature to afford petroleum ether E1 extract (25.0 g), petroleum ether E2 extract (15.0 g), chloroform extract (105.0 g), ethyl acetate extract (50.0 g), acetone extract (45.0 g) and methanol extract (37.0 g) (Figure 2.1). 2.3.1. Isolating compounds from the methanol precipitate (Figure 2.1) The precipitate (9.0 g) was silica gel chromatographed, eluted with petroleum ether–chloroform to give 5 fractions (symboled as fraction T1 to fraction T5). 22 Fraction T2 (1.0 g) was silica gel rechromatographed and eluted with hexane–chloroform (8:2) to give five compounds: PRAES-T1 (9.0 mg), PRAES-T2 (7.0 mg), PRAES-T3 (5.0 mg), PRAES-T4 (45.0 mg) and PRAES-T6 (40.0 mg). 2.3.2. Isolating compounds from the petroleum ether E1 extract (Figure 2.1) The petroleum ether E1 (25.0 g) was applied to silica gel column chromatography, eluted with petroleum etherethyl acetate (10:0-5:5) to give 8 fractions (symboled as fraction E1.1 to fraction E1.8) Fraction E1.3 (4.5 g) was separated by silica gel column chromatography, eluted with petroleum ether–ethyl acetate (98:2) to give compound PRAESE2 (5.0 mg). Fraction E1.4 (3.7 g) was silica gel rechromatographed, eluted with petroleum ether–ethyl acetate (98:2) to give two compounds, coded PRAESE1 (200.0 mg) and PREAS-E6 (5.0 mg). Fraction E1.5 (2.5 g) was separated by silica gel column chromatography, eluted with petroleum ether–ethyl acetate (95:5) to give PRAES-E3 (4.0 mg). Fraction E1.6 (4.7 g) was separated by silica gel column chromatography, eluted with petroleum ether–ethyl acetate (95:5) to give PREAS-E5 (1.0 g). 2.3.3. Isolating compounds from the petroleum ether E2 extract (Figure 2.1) The petroleum ether E2 (15.0 g) was applied to silica gel column chromatography, eluted with petroleum ether–ethyl acetate (9:1-5:5) to give 9 fractions (symboled as fraction E2.1 to fraction E2.9). Fraction E2.4 (2.8 g) was silica gel rechromatographed, eluted with petroleum ether–ethyl acetate (95:5) to give compound PRAES-E11 (about 1.5 g). 23 Fraction E2.5 (4.5 g) was silica gel rechromatographed and eluted with petroleum ether–ethyl acetate (9:1) to give two compounds PRAES-E13 (5.0 mg) and PRAES-E14 (25.0 mg). The same manner was applied on fraction E2.6 (3.7 g) eluted with petroleum ether–ethyl acetate (9:1) to afford two compounds, coded PRAES-E15 (30.0 mg) and PRAES-E17 (50.0 mg) and on fraction E2.7 (2.5 g) eluted with petroleum ether–ethyl acetate (9:1) to afford two compounds PRAES-E18 (15.0 mg) and PRAES-E19 (250.0 mg). 2.3.4. Isolating compounds from the chloroform extract The chloroform extract (105.0 g) was subjected to silica gel column chromatography and eluted by the solvent system of petroleum ether–ethyl acetate with increasing ethyl acetate ratios to obtain twenty three fractions from C1 to C23 (Figure 2.2). Fraction C13 (5.7 g) was silica gel rechromatographed, eluted with petroleum ether–chloroform (8:2) to give three compounds: PRAES-C2 (about 1 g), PRAES-C4 (50.0 mg) and PRAES-C5 (5.0 mg). Fraction C15 (3.4 g) was silica gel rechromatographed, eluted with petroleum ether–chloroform (8:2) to give two compounds: PRAES-C1 (200.0 mg) and PRAES-C3 (5.0 mg). Fraction C16 (4.2 g) was silica gel rechromatographed, eluted with petroleum ether–chloroform (5:5) to give three compounds: PRAES-C7 (7.0 mg), PRAES-C8 (15.0 mg) and PRAES-C11 (295.0 mg). Fraction C17 (6.1 g) was silica gel rechromatographed, eluted with chloroform–methanol (95:5) to give three compounds: PRAES-C10 (15.0 mg), PRAES-C12 (15.0 mg) and PRAES-C14 (5.0 mg). 24 Fraction C19 (6.1 g) was applied on silica gel column and eluted with a gradient solvent system of chloroform–acetone (95:5) to give three fractions (C19a, C19b and C19c). Fraction C19a (1.0 g) was silica gel rechromatographed, eluted with chloroform–acetone (98:2) and subjected to pre TLC using chloroform– methanol (9:1 and 95:5) as eluent to afford PRAES-C15 (5.0 mg). Fraction C19b (3.2 g) was silica gel rechromatographed, eluted with chloroform–acetone (98:2) to give six fractions (C19ba to C19bf). Fraction C19ba (169.6 mg) was subjected to pre TLC (chloroform– methanol, 95:5, 9:1 and n-hexane–diethyl ether, 5:5) to afford three compounds PRAES-C18 (7.0 mg), PRAES-C20 (10.5 mg) and PRAESC21 (18.7 mg). Fraction C19bc (454.3 mg) was subjected to pre TLC (chloroform–methanol, 95:5) to afford PRAES-C16 (28.1 mg). Fractions C20 (23.9 g) was repeatedly subjected to silica gel column chromatography, eluted with chloroform–methanol (10:0-9:1) to obtain eight fractions (from C20a to C20h). The fraction C20c (5.8 g) was subjected to silica gel chromatography with solvent of chloroform–methanol to get six fractions (from C20ca to C20cf) (Figure 2.2). Fractions C20cb (979.3 mg) was silica gel rechromatographed, eluted with n-hexane–diethyl ether and continuously subjected to pre TLC (n-hexane–diethyl ether (2:8) and chloroform–methanol (98:2) to afford five compound PRAES-C22 (8.0 mg), PRAES-C23 (71.7 mg), PRAESC24 (6.2 mg), PRAES-C25 (15.7 mg) and PRAES-C26 (6.3 mg). Fraction C20ce (839.5 mg) was silica gel rechromatographed, eluted with chloroform–methanol and subjected to pre TLC with different kinds of solvents (chloroform–methanol, 98:2 and toluene–acetone, 8:2) to afford two compounds PRAES-C27 (61.9 mg) and PRAES-C28 (21.4 mg). 25 Fresh lichen (5.0 kg) 0) - Cleaned and dried, ground. Air-dried lichen powder (3.0 kg) - Macerated with methanol, room temp. - Solvent was partly evaporated. - Evaporated to dryness. Precipitate (9.0 g) Crude methanolic residue (450.0 g) - Solid phase extraction. - Eluted with solvents of different polarities. Petroleum ether E1 (25.0 g) Petroleum ether E2 (15.0 g) - CC with P:EA (10:0-5:5). E1.3 (4.5 g) E1.4 (3.7 g) P:EA (98:2) PRAES-E2 (5.0 mg) PRAES-E10)(200.0 mg) (98:2) 0) (5.0 mg) PRAES-E6 0) P:EA (95:5) E1.6 (4.7 g) Ethyl acetate (50.0 g) - CC with P:EA (9:1-5:5). P:EA 0) P:EA (95:5) E1.5 (2.5 g) 0) Chloroform (105.0 g) 0) (4.0 mg) PRAES-E3 E2.4 (2.8 g) E2.5 (4.5 g) P:EA (95:5) P:EA (9:1) 0) E2.6 (3.7 g) P:EA (9:1) 0) 0) (1.0 g) PRAES-E5 0) Acetone (45.0 g) E2.7 (2.5 g) Figure 2.1. Isolation of compounds from the precipitate and 0) petroleum ether extracts of Parmotrema praesorediosum (Nyl.) Hale 26 - CC with P:C (9:1-0:10). Methanol (37.0 g) PRAES-E11 (1.5 g) Fraction T2 (1.0 g) - CC. - Eluted with H:C (8:2). 0) (5.0 mg) PRAES-E13 PRAES-T1 (9.0 mg) 0) (25.0 mg) PRAES-E14 0) (7.0 mg) PRAES-T2 0) (30.0 mg) PRAES-E15 0) (50.0 g) PRAES-E17 P:EA 0) (15.0 mg) PRAES-E18 (9:1) 0)(250.0 mg) PRAES-E19 0) 0) (5.0 mg) PRAES-T3 0)(45.0 mg) PRAES-T4 0)(40.0 mg) PRAES-T6 0) Chloroform extract (105.0 g) CC with P:EA (10:0-0:10). C13 (5.7 g) C15 (3.4 g) C16 (4.2 g) P:C (8:2) P:C (8:2) PRAES-C2 (1.0 g) PRAES-C1 (200.0 mg) PRAES-C4 (50.0 mg) 0) PRAES-C3 (5.0 mg) 0) PRAES-C5 (5.0 mg) 0) PRAES-C7 (7.0 mg) 0) 0) PRAES-C8 (15.0 mg) 0) PRAES-C11 (295.0 mg) P:C (5:5) PRAES-C10 (15.0 mg) C17 (6.1 g) C19 (6.1 g) C:M (95:5) C:Ac 10:0-0:10 0) PRAES-C12 (15.0 mg) PRAES-C15 (5.0 mg) 0) PRAES-C14 (5.0 mg) 0) PRAES-C16 (28.1 mg) 0) 0) PRAES-C18 (7.0 mg) C19a (1.0 g) C19b (3.2 g) C:Ac (98:2) C:Ac (98:2) 0) PRAES-C20 (10.5 mg) PRAES-C21 (18.7 mg) PRAES-C22 (8.0 mg) PRAES-C23 (71.7 mg) C20 (23.9 g) C:M 10:0-9:1 C20c (5.8 g) C:M (95:5) 0) PRAES-C24 (6.2 mg) 0) PRAES-C25 (15.7 mg) 0) PRAES-C26 (6.3 mg) 0) PRAES-C27 (61.9 mg) PRAES-C28 (21.4 mg) Figure 2.2. Isolation of compounds from the chloroform extract of Parmotrema praesorediosum (Nyl.) Hale 27 2.4. PREPARATION OF SOME DERIVATIVES 2.4.1. Esterification of PRAES-C2 The esterification of PRAES-C2 with methanol, ethanol, n-propanol, nbutanol and isopentanol in the presence of concentrated H2SO4 as a catalyst was prepared by using the following procedure: Praes-C2 (x mg) was completely dissolved in the chosen alcohol (ml) which was acidified with concentrated H2SO4 for pH control of 0-1. The reaction mixture was stirred and refluxed. The progress of the reaction was monitored by thin layer chromatography. The resulting mixture was concentrated in vacuo to give the crude product, which was then purified by preparative silica gel TLC. Methylation of PRAES-C2: PRAES-C2 (20 mg) in 10 ml methanol was acidified with H2SO4 98% to get pH = 0-1. This solution was stirred for 8 hours at a temperature of 80 oC. The reaction mixture was concentrated at the reduced pressure and the residue was purified by preparative TLC (petroleum ether– chloroform, 5 : 5) to yield PRAES-C2Me (4 mg). Ethylation of PRAES-C2: PRAES-C2 (20 mg) in 10 ml ethanol was acidified with H2SO4 98% to get pH = 0-1. This solution was stirred for 8 hours at a temperature of 80 oC. The reaction mixture was concentrated under vacuum condition and the residue was purified by preparative TLC (petroleum ether– chloroform, 5 : 5) to yield PRAES-C2Et (6.0 mg). n-Propylation of PRAES-C2: PRAES-C2 (20 mg) in 10 ml n-propanol which was acidified with H2SO4 98% to get pH = 0-1. The solution was stirred for 9 hours at a temperature of 80 oC. The reaction mixture was concentrated under the reduced pressure and the residue was purified by preparative TLC (petroleum ether–chloroform, 5 : 5) to yield PRAES-C2Pro (8.2 mg). 28 2.4.2. Methylation of PRAES-C25 The methylation of PRAES-C25 with TMS-CH2N2 was prepared as the following procedure: To a solution of PRAES-C25 (12.0 mg) in Et2O (1 ml) and MeOH (0.5 ml), TMS-CH2N2 in n-hexane were added. The solution was stirred at room temperature for 1 hour and 15 mins. After termination by diluted acetic acid in MeOH, the reaction mixture was concentrated in vacuo and the residue was purified by preparative TLC (n-Hexane-Et2O, 2:8) to yield PRAES-C25M (4.1 mg). 2.5. BIOLOGICAL ASSAYS 2.5.1. Cytotoxicity Determination of cytotoxic activities against the HeLa (human epithelial carcinoma), MCF–7 (human breast cancer) and NCI-H460 (human lung cancer) cell lines of tested samples was performed at the concentration of 100 g/mL using the Sulforhodamine B (SRB) assay with camptothecin as the positive control [71]. Samples were sent to be in vitro tested at the Faculty of Biology, University of Science, Vietnam National University- Ho Chi Minh City, 227 Nguyen Van Cu Street, District 5, 784355 Ho Chi Minh City, Vietnam. The person in charge of the unit: Assoc. Prof. Ho Huynh Thuy Duong. All cells were cultured in E‟MEM medium (Eagle‟s Minimal Essential Medium) supplemented with 10% foetal bovine serum (FBS), 1% of 2 mM Lglutamine, 50 IU/mL penicillin, 50 μg/mL streptomycin and maintained at 37 °C in a 5% CO2 atmosphere with 95% humidity. Viable cells were counted and inoculated in 96-well plate with density of 104 cells/100 μL/well. After 24 h the cells were treated with pure compound while the control wells were added only by 100 μL medium. All experiments were performed in triplicate. The plates were incubated in an atmosphere of 5% CO2, 95% humidity at 37°C for 48 h. Adherent cell cultures were fixed by adding 50 μL of cold 50% (w/v) trichloroacetic acid per well and incubated 29 at 4°C for 1 h. The plates were washed five times with distilled water and air dried. Then a solution of 50 μL of SRB (0.4% w/v in 1% acetic acid) was added to each well and allow staining at room temperature for 30 mins. The SRB solution was removed out of plates by rinsing 4 times with a 1% glacial acetic acid solution (200 μL/well). The plates were air-dried for 12–24 h. The bound SRB was dissolved to each well by adding 100 μL of 10 mM Tris Base (pH 10.5). The plates were shaken gently for 20 mins and the optical density of each well was read using a scanning multiwall spectrophotometer at a test wavelength of 492 nm and a reference wavelength of 620 nm. The optical density (OD) of SRB in each well is directly proportional to the cell number. Cell survival was measured as the percentage absorbance compared to the control (non-treated cells). Evaluation of the result based on the I% (at the concentration of 100 g/mL): 0–49% (inactive), 50–70% (active), 70–90% (strong), 90–100% (very strong) [78]. % Inhibitive activity With: OD ODc ODs x100 ODc = OD‟ tested sample – OD‟ blanck OD‟ = OD492 – OD620 ODc = OD of 0.25% DMSO ODs = OD tested sample 2.5.2. In vitro acetylcholinesterase (AChE) inhibition assay The isolated compounds from Parmotrema praesorediosum (Nyl.) Hale were screened for their acetylcholinesterase inhibitory activity at the concentration of 100 µg/ml through Ellman‟s colorimetric method [28]. All the experiments were done in Department of Pharmacology, Ho Chi Minh City Medicine and Pharmacy University, 41 Dinh Tien Hoang Str., Dist. 1, Ho Chi Minh City, Vietnam. The person in charge of the unit: Assoc. Prof. Vo Phung Nguyen. 30 The principle of the method is the enzyme acetylcholinesterase (AchE) hydrolyzes the substrate (Acetylthiocholine is used as the substrate) to give a compound. This compound will further react with Ellman reagent (5,5‟-dithio-bis2-nitrobenzoate ion or DTNB) to give 2-nitrobenzoate-5-mecaptothiocholine and 5thio-2-nitrobenzoate. The later possesses a yellow color and therefore, the rate of color production is measured at 412 nm by a spectrophotometer. The reaction with the thiol has been shown to be sufficiently rapid so as not to be rate limiting in the measurement of the enzyme, and the used concentrations do not inhibit the enzymic hydrolysis. By recording the output of the photometer continuously, records of the complete assay can be obtained. All samples were tested in triplicate. Absorbance was measured at 412 nm, and the percent inhibitive activity was determined by comparison with the negative control as the following formula: % Inhibitive activity With: A N AT x100 % AN AN = OD412 of negative control AT = OD412 of tested sample Evaluation of the result based on the I% (at the concentration of 1.0 mg/ml): 0–30% (very weak), 30–50% (weak), 50–70% (average), 70–90% (strong), 90– 100% (very strong). 31 CHAPTER 3 RESULTS AND DISSCUSSION 3.1. CHEMICAL STRUCTURE ELUCIDATION From the lichen Parmotrema praesorediosum (Nyl.) Hale, 40 lichen substances were isolated including 22 new compounds along with 18 known ones. The structure of all compounds was elucidated on the basis of NMR and MS spectroscopies. All new compounds were checked by Scifinder in Kobe Pharmaceutical University, Japan in March 2012. In order to well interpretation, they were divided into nine groups as listed in Table 3.1. Table 3.1. Isolated compounds from Parmotrema praesorediosum Group Type of compound Total New Known compounds compounds 1 Aliphatic acids 6 5 1 2 Mononuclear phenolic compounds 12 5 7 3 Depsides 3 0 4 4 Depsidones 2 0 2 5 Diphenyl ethers 8 7 1 6 Dibenzofurans 3 1 2 7 Xanthones 2 2 0 8 Triterpenoids 3 1 2 9 Macrocyclic compound 1 1 0 32 3.1.1. Chemical structure elucidation of aliphatic acids 3.1.1.1. Structure elucidation of compound PRAES-C1 White needles (acetone). Melting point: 104–105 C. D + 518 (c= 0.006, EtOH). 23 IR spectrum (Appendix 1): IR (KBr) max cm-1: 3444 (OH), 1740 (C=O lactone), 1706 (C=O carboxyl), 1217 (CO). CD spectrum (Figure 3.6). Mass spectrum (Appendix 2): HR-ESI-MS m/z 395.2781 [M+H]+ (calcd. for C23H38O5 + H, 395.2797) 1H NMR spectrum (CDCl3) (Appendix 3): see Table 3.2. 13 C NMR and DEPT spectra (CDCl3) (Appendix 4, 5): see Table 3.3. HSQC and HMBC spectra (CDCl3) (Appendix 6, 7). Compound PRAES-C1 was obtained as white needles. The HR-ESI-MS showed the pseudomolecular ion peak at m/z 395.2781 [M+H]+ corresponding to the molecular formula C23H38O5 which implied five degrees of unsaturation. Its IR spectrum displayed two intense absorptions at 1740 cm-1 and 1706 cm-1 that were assigned to the lactone and the conjugated carboxyl functional group. The NMR spectra (Tables 3.2 and 3.3) exhibited signals attributable to an methyl-,-unsaturated––lactone moiety [H 2.23 (3H, d, J=2.0 Hz, H-5), 5.12 (1H, m, H-4); C 11.1 (C-5), 81.6 (C-4), 139.3 (C-2), 147.2 (C-3), 172.9 (C-1)] and an aliphatic side chain [H 1.25–1.28 (m, -CH2-), 1.58 (m, H-7), 2.11 (m, H-7), 2.15 (s, terminal -CH3), 2.43 (t, J=7.5 Hz, H-21); C 24.0, 24.8, 29.3–29.9, 32.9, 43.9 (-CH2-), 30.0 (terminal -CH3)]. 33 Despite the absence of the signal at C 210.6 in the 13 C NMR spectrum of compound PRAES-C1, the HMBC correlations from H-21 (H 2.43) and H-23 (H 2.15) to a carbon signal at C 210.6 confirmed the presence of a ketone group at C22 of the aliphatic side chain of PRAES-C1. Complete analysis of the HSQC and HMBC data as well as combining the HR-ESI-MS for PRAES-C1 resulted in its planar structure as 4-methyl-5-oxo-2-(16-oxoheptadecyl)-2,5-dihydrofuran-3- carboxylic acid. The absolute stereochemistry of the sole stereogenic centre C-4 in PRAES-C1 was determined to be R by comparison of its ultraviolet CD spectral data (Figure 3.6) with that reported for isomuronic acid isolated from Neuropogon trachycarpus [7]. PRAES-C1 was dextrorotatory therefore it was a homologous compound of isomuronic acid with the side chain containing two more methylene units. Therefore, the structure of PRAES-C1 was determined as (+)-4-methyl-5oxo-2-(16-oxoheptadecyl)-2,5-dihydrofuran-3-carboxylic acid or (+)- vinapraesorediosic acid A. 3.1.1.2. Structure elucidation of compound PRAES-E14 White needles (acetone). Melting point: 89–90 C. D + 837 (c= 0.006, EtOH). 23 IR spectrum (Appendix 8): IR (KBr) max cm-1: 3440 (OH), 1767 (C=O lactone), 1706 (C=O carboxyl), 1232 (CO). 34 CD spectrum (Figure 3.6). Mass spectrum (Appendix 9): HR-ESI-MS m/z 409.2988 [M+H]+ (calcd. for C24H40O5 + H, 409.2954). 1H NMR spectrum (CDCl3) (Appendix 10): see Table 3.2. 13 C NMR and DEPT spectra (CDCl3) (Appendix 11, 12): see Table 3.3. COSY, HSQC and HMBC spectra (CDCl3) (Appendix 13, 14, 15). Compound PRAES-E14 was isolated as white needles and its molecular formula was determined as C24H40O5 through its pseudomolecular ion peak at m/z 409.2988 [M+H]+ in the HR-ESI-MS spectrum. The comparison of spectral data, i.e. NMR, IR, CD of PRAES-C1 and PRAES-E14 showed the similarity (Table 3.2 and 3.3), except for the presence of an additional methoxy group in PRAES-E14. The 1H and 13 C NMR spectra of PRAES-E14 showed signals at H 3.89 (3H, s, OCH3) and C 52.3 (OCH3), characteristics of a methyl ester. In the HMBC spectrum of PRAES-E14, signal of this methoxy group (H 3.89) gave cross peak to C-6 (C 162.7) indicating that the methoxy group was at C-6. The 2D NMR experiments proved the proposed structure to be correct and allowed the completed characterization of compound PRAES-E14 as (+)-methyl 4methyl-5-oxo-2-(16-oxoheptadecyl)-2,5-dihydrofuran-3-carboxylate methyl vinapraesorediosate A. 35 or (+)-6- 3.1.1.3. Structure elucidation of compound PRAES-C10 White needles (acetone). Melting point: 124–125 C. D + 22 (c= 0.0013, CHCl3). 23 CD spectrum (Figure 3.6). Mass spectrum (Appendix 16): HR-ESI-MS m/z 419.2754 [M+Na]+ (calcd. for C23H40O5 + Na, 419.2775). 1H NMR spectrum (Acetone-d6) (Appendix 17): see Table 3.2. 13 C and DEPT NMR spectra (Acetone-d6) (Appendix 18, 19): see Table 3.3. HSQC and HMBC spectra (Acetone-d6) (Appendix 20, 21). The 1H and 13 C NMR spectra as well as CD spectrum of PRAES-C10 were similar to those of PRAES-C1, including signals of the α-methyl-α,β-unsaturated-lactone and the aliphatic side chain which were presented in Tables 3.2 and 3.3. However, some chemical shift differences were observed due to a modification 36 of the terminal side chain. A sharp singlet (3H, H-23) at H 2.15 as well as a triplet (2H, J = 7.5 Hz, H-21) at H 2.43 corresponding to the terminal 2oxopropyl group of the aliphatic side chain of compound PRAES-C1 were replaced by signals at H 1.10 (3H, d, J = 6.5 Hz), 3.70 (1H, sext, J = 6.5 Hz) and 2.05 (2H, m) for a terminal 2-hydroxypropyl group of the side chain of compound PRAES-C10. As expected, the signal at C 210.6 (C-22) of the carbonyl carbon in compound PRAES-C1 was replaced by the signal at C 68.0 (C-22) for a hydroxylated secondary carbon in compound PRAES-C10. This point was further corroborated by the HR-ESI-MS of PRAES-C10 which showed a typical quasi– molecular ion peak at m/z 419.2754 [M+Na]+ (calcd. for C23H40O5Na, 419.2775). On the basis of these observations, (+)-2-(16-hydroxyheptadecyl)-4-methyl-5-oxo2,5-dihydrofuran-3-carboxylic acid or vinapraesorediosic acid B proved to be a new natural compound. 37 Table 3.2.1H NMR of aliphatic compounds No PRAES-C1(a) PRAES-E14(a) PRAES-C10(b) H, J (Hz) H, J (Hz) H, J (Hz) No PRAES-C11(b) PRAES-E19(a) PRAES-C2(a) H, J (Hz) H, J (Hz) H, J (Hz) 4 5.12 m 5.09 m 5.14 m 4 5.14 m 5.09 m 5.12 m 5 2.23 d (2.0) 2.18 d (2.0) 2.12 d (2.0) 5 2.12 d (2.0) 2.18 d (2.5) 2.24 d (2.0) 3.89 s 3.88 s 1.56 m 1.39 m 1.55 m 1.60 m 2.07 m 1.62 m 2.05 m 2.14 m br s 1.29 br s (-CH2-)n br s 1.25 br s t (7.5) 2.05 m 19 1.60 m 1.64 m 2.32 t (7.5) 3.70 sext (6.5) 20 2.27 t (7.5) 2.34 t (7.5) 1.10 d (6.5) 20-OCH3 6-OCH3 7 (-CH2-)n – 1.58 m 2.11 m 1.25–1.28 21 2.43 22 – 23 2.15 br s t (7.5) 1.25–1.27 2.41 – s 2.13 s – 6-OCH3 7 a) Measured in chloroform-d. b) Measured in acetone-d6. 38 – 1.35 m 2.05 m 1.29–1.38 – br s 1.23–1.30 – – – 3.68 s Table 3.3.13C NMR of aliphatic compounds No PRAESC1(a) PRAESE14(a) PRAESC10(b) C C C No PRAESC11(b) PRAESE19(a) PRAESC2(a) C C C 1 172.9 172.9 173.8 1 173.4 173.1 172.9 2 139.3 137.5 137.5 2 137.3 137.6 139.6 3 147.2 147.6 150.0 3 149.4 147.8 147.3 4 81.6 81.4 82.4 4 81.8 81.6 81.5 5 11.1 10.8 11.2 5 10.8 11.0 11.1 6 164.9 162.7 164.4 6 163.9 162.8 165.9 7 32.9 32.8 33.8 7 33.4 33.0 32.9 8 24.8 24.7 27.1 8 25.5 24.8 25.1 29.3–29.9 29.2–29.6 29.4–30.4 29.2–29.7 29.3–29.7 20 24.0 23.9 25.9 18 21 43.9 43.8 40.7 19 25.7 24.9 34.3 22 210.6 209.3 68.0 20 34.3 34.1 175.0 30.0 – 29.8 52.3 174.7 – 179.5 52.5 – – 9–19 23 6-OCH3 29.9–30.8 9–17 24.4 21 – 6-OCH3 24.9 20-OCH3 51.7 a) Measured in chloroform-d. b) Measured in acetone-d6. 3.1.1.4. Structure elucidation of compound PRAES-C11 White needles (acetone). Melting point: 139–140 C. D + 513 (c= 0.001, MeOH). 23 CD spectrum (Figure 3.6). Mass spectrum (Appendix 22): HR-ESI-MS m/z 405.2238 [M+Na]+ (calcd. for C21H34O6 + Na, 405.2253). 1H NMR spectrum (Acetone-d6) (Appendix 23): see Table 3.2. 13 C NMR spectra (Acetone-d6) (Appendix 24): see Table 3.3. HSQC and HMBC spectra (Acetone-d6) (Appendix 25, 26). 39 Examination of NMR, IR, MS, and physical data of compound PRAES-C11 showed that they were in good agreement with those reported for (+)-praesorediosic acid, isolated by David et al. from this lichen [20]. Detailed 2D-NMR analysis and comparison with the reported data [22] led us to determine the structure of compound PRAES-C11 as (+)-2-(14-carboxyltetradecyl)-4-methyl-5-oxo-2,5- dihydrofuran-3-carboxylic acid or (+)-praesorediosic acid. 3.1.1.5. Structure elucidation of compound PRAES-E19 White needles (acetone). Melting point: 102–103 C. 23 D + 450 (c= 0.001, EtOH). IR spectrum (Appendix 27): IR (KBr) max cm-1: 3144 (OH), 1735 (C=O lactone), 1724 (C=O carboxyl), 1246 (CO). CD spectrum (Figure 3.6). Mass spectrum (Appendix 28): HR-ESI-MS m/z 397.2596 [M+H]+ (calcd. for C22H36O6 + H, 397.2590). 1H NMR spectrum (CDCl3) (Appendix 29): see Table 3.2. 13 C and DEPT NMR spectra (CDCl3) (Appendix 30, 31): see Table 3.3. HSQC and HMBC spectra (CDCl3) (Appendix 32, 33). 40 The NMR spectra of PRAES-E19 were similar to those of PRAES-C11, except for the presence of an additional methoxy group in PRAES-E19. The HMBC correlations between the methoxy group at H 3.88 (s) to signal at C 162.8 (C-6) in compound PRAES-E19 indicated the location of a methoxy group at C-6. These spectral features were identical with those of (+)-methyl 2-(14-carboxyltetradecyl)4-methyl-5-oxo-2,5-dihydrofuran-3-carboxylate or 6-methyl praesorediosate. This assignment was supported by the detailed IR, MS, 2D NMR studies as shown. 3.1.1.6. Structure elucidation of compound PRAES-C2 White needles (acetone). Melting point: 132–133 C. D + 130 (c= 0.001, EtOH). 23 IR spectrum (Appendix 34): IR (KBr) max cm-1: 3423 (OH), 1739 (C=O lactone), 1700 (C=O carboxyl), 1217 (CO). 41 CD spectrum (Figure 3.6). Mass spectrum (Appendix 35): HR-ESI-MS m/z 405.2200 [M+Na]+ (calcd. for C21H34O6 + Na, 405.2254). 1H NMR spectrum (CDCl3) (Appendix 36): see Table 3.2. 13 C NMR and DEPT spectra (CDCl3) (Appendix 37, 38): see Table 3.3. HSQC and HMBC spectra (CDCl3) (Appendix 39, 40). Compound PRAES-C2 was isolated as white needles and its high resolution mass spectrum showed a quasi–molecular ion peak at m/z 405.2200 [M+Na]+ corresponding to the molecular formula of C21H34O6 which was identical to PRAES-C11. The 1H and 13C NMR spectra of PRAES-C2 were also similar to those of PRAES-C11, including signals of the α,β-unsaturated--lactone and the aliphatic side chain which were presented in Table 3.2 and 3.3. However, compound PRAES-C2 differed from PRAES-C11 in the aliphatic side chain. The terminal carboxyl group in the side chain of PRAES-C11 was replaced by a methoxycarbonyl group and the length of the chain of PRAES-C2 is less one methylene group comparing to PRAES-C11. This was proved by the presence of an additional singlet signal at H 3.68 (3H, OCH3) in the 1H spectrum as well as a further signal at C 51.7 in the 13C spectrum of PRAES-C2. This methoxy group was at C-20 by the HMBC correlations between signal at H 3.68 to the carboxyl carbon at C 175.0 (C-20). The HMBC experiments confirmed the presence of a carboxyl group at C-3 of the lactone ring as normal by correlations of 42 the methyl signal at H 2.24 (H-5) to signals at C 165.9 (carboxyl carbon), 172.9 (C-1), 139.6 (C-2) and 147.3 (C-3). Compound PRAES-C2 was esterified with methanol, ethanol and n-propanol to give PRAES-C2Me, PRAES-C2Et, PRAES-C2Pro, respectively, proved the proposed structure of PRAES-C2 to be correct. This showed that under the acidic condition, the lactone ring in PRAES-C2 could not be opened, therefore, the obtained product possessed two ester functional groups. These data identified compound PRAES-C2 as (+)-4-methyl-2-(13-methoxycarbonyltridecyl)-5-oxo-2,5dihydrofuran-3-carboxylic acid or (+)-vinapraesorediosic acid C. Determining the absolute configuration at the C-4 position of aliphatic compounds (Figure 3.5 and 3.6) The depicted relative stereochemistry of the dihydrofuranone ring was established on the basic of the CD spectrum. PRAES-C2 showed a negative Cotton effect at ~225 nm associated to the n transition of lactone chromophore. In view of the more intense CD, the assignment of the absolute configuration of the methylated derivative PRAES-C2-Me was confirmed by circular dichroism calculations between the experimental spectrum and the theoretical calculation the assignment of the absolute configuration. Theoretical calculations of the CD spectrum of a model molecule of PRAES-C2-Me were executed with timedependent density functional theory (TD-DFT) of the B3LYP functional and the 643 311++G** basis set. The simulated spectrum under vacuum (Figure 3.5, center) well reproduced the experimental / CD couplet at 225/260 nm by the simulated couplet at 240/270 nm. The similar result was obtained by the calculation under a CPCM solvent model of methanol (Figure 3.5, center). The CPCM solvent model increased the absorption and CD intensities, but the ratio (/) of the couplet was similar to that in vacuo. The agreements between the experiment and the calculations indicated that PRAES-C2-Me possessed the R chirality at the C-4 position. The absolute configuration at the C-4 position in the dihydrofuranone ring of compounds PRAES-C1, PRAES-C10, PRAES-C11, PRAES-E19, PRAES-C2, PRAES-C2Et and PRAES-C2Pro was suggested to be R by comparison of their CD spectra with that of compound PRAES-C2Me (Figure 3.6) as well as with data in the literature [7]. As the biosynthetic aspect, the assignment of the chiral carbon C-4 of PRAES-E14, a methyl ester derivative of PRAES-C1, was also proposed to be R, as they were isolated from the same material and possessing similar positive optical rotation. Figure 3.5. Comparison of experimental CD spectrum of PRAES-C2Me in methanol (left), theoretical CD spectra (center) calculated in vacuo (dotted line) and in CPCM solvent model of methanol (solid), and two stable conformers (S1 and S2) of a model molecule of PRAES-C2Me with 4R configuration with simulated populations at 300 K. The calculation conditions: TD-DFT/B3LYP/6-311++G** and /CPCM(MeOH). The calculated spectra were weighted-averages of calculated spectra of S1 and S2. 44 Figure 3.6. CD spectra of isolating aliphatic compounds 3.1.2. Monoaromatic compounds 3.1.2.1. Structure elucidation of compound PRAES-T1 Colorless needles (Methanol) Melting point: 145-146 C. 1H and 13C NMR spectra (CDCl3) (Appendix 41, 42): see Table 3.4. HSQC and HMBC spectra (CDCl3) (Appendix 43, 44). Compound PRAES-T1 was obtained as colorless needles. The 1H NMR spectrum displayed signals for a methoxy group at H 3.96 (3H, s), a formyl group at H 10.34 (H-8), a methyl group at H 2.53 (3H, s), an aromatic methine proton at H 6.29 (s, H-5), and two chelated hydroxyl protons (H 12.86 and 12.40). The 13C, DEPT NMR spectra showed the resonances of 10 carbons including one aromatic methyl (C 25.2), a methyl ester group [C 172.0 (C-7), 52.3 (C-10)], one formyl 45 group (C 193.9) and six substituted aromatic carbons, two of which were oxygenated. The exact location of the aromatic protons and the substituted functional groups was established based on 2D NMR (HSQC and HMBC). In the HMBC spectrum, the aldehydic proton H-8 (H 10.34) showed correlations with C3 (C 108.5) and the oxygenated carbon C-4 (C 166.7). The methoxy proton (H 3.96) showed correlations with carboxyl carbon (C 172.0). Two chelated hydroxyl protons (H 12.86 and 12.40) jointed to C-2 and C-4, based on their HMBC correlations with carbon signals at C 168.3 and 166.7, respectively. Similarly, the aromatic methine proton at H 6.29 (H-5) showed HMBC correlations with C-3 (C 108.5) and C-4 (C 166.7). These spectroscopic data were suitable with the published data [74], therefore compound PRAES-T1 was methyl haematommate. 3.1.2.2. Structure elucidation of compound PRAES-E1 Yellow needles (Ethanol). Melting point: 179-180 C. Mass spectrum (Appendix 45): HR-ESI-MS m/z 266.9874 [M+Na]+ (calcd. for C10H9O5Cl+Na, 267.0036). 1H and 13C NMR spectra (CDCl3) (Appendix 46, 47): see Table 3.4. HSQC and HMBC spectra (CDCl3) (Appendix 48, 49). Compound PRAES-E1 was isolated as yellow needles. The spectral data of PRAES-E1 and PRAES-T1 were similar, with a remark that PRAES-E1 lacked the aromatic proton signal. The HR-ESI-MS (positive mode) displayed the 46 pseudomolecular ion peak at m/z = 266.9874 (calcd. 267.0036 for C10H9O5ClNa), corresponding to the molecular formula of C10H9O5Cl. Moreover, the HR-ESI-MS (positive mode) showed two ion peaks at m/z 266.9874 and 268.9839. These two peaks separated by 2 mass atomic units and with a ratio of 3 : 1 in their peak heights, confirming that the molecule contained one chlorine atom. This observation, together with the presence of chlorine in the molecule, suggested that compound PRAES-E1 was methyl chlorohaematommate [38]. Table 3.4. NMR data of PRAES-T1, PRAES-E1, PRAES-T2 (CDCl3) No PRAES-T1 H, J (Hz) PRAES-E1 C H, J (Hz) PRAES-T2 C H, J (Hz) C 1 103.9 105.2 104.0 2 3 168.3 108.5 165.4 108.5 168.4 108.5 4 166.7 162.4 166.6 112.1 152.3 114.9 148.8 172.0 171.4 5 6 6.29 s 7 6.28 s 112.1 152.3 171.7 8 10.34 s 193.9 10.31 s 193.6 10.34 s 193.9 9 2.53 s 25.2 2.66 s 20.7 2.54 s 25.2 10 3.96 s 52.3 3.99 s 52.7 4.38 t (6.5) 65.8 11 1.78 dt (7.5, 7.0) 30.5 12 1.49 sext (7.5) 19.4 13 0.99 t (7.5) 13.6 2-OH 12.86 s 12.61 s 12.98 s 4-OH 12.40 s 13.07 s 12.39 s 47 3.1.2.3. Structure elucidation of compound PRAES-T2 White paraffin oil. 1H, 13 C and DEPT NMR spectra (CDCl3) (Appendix 50, 51, 52): see Table 3.4. HSQC and HMBC spectra (CDCl3) (Appendix 53, 54). Compound PRAES-T2 was obtained as white paraffin oil. The spectral data of compounds PRAES-T1 and PRAES-T2 were similar. The 1H NMR spectrum displayed signals for a butyl group [H 4.38 (2H, t, J=6.5 Hz), 1.78 (2H, dt, J=7.5 Hz, 7.0 Hz), 1.49 (2H, sext, J=7.5 Hz), 0.99 (3H, t, J=7.5 Hz)]. The 13 C NMR of compound PRAES-T2 also showed signals for a butyl group (C 65.8, 30.5, 19.4, 13.6). The exact location of the aromatic proton and the substituted functional group were established based on 2D NMR (Figure 3.7). These spectroscopic data proposed that compound PRAES-T2 was n-butyl haematommate. 48 3.1.2.4. Structure elucidation of compound PRAES-E11 Yellow needles (Methanol). Melting point: 143–144 C. 1H and 13C NMR spectra (Acetone-d6) (Appendix 55, 56): see Table 3.5. HSQC and HMBC spectra (Acetone-d6) (Appendix 57, 58). Compound PRAES-E11 was obtained as yellow needles. The 1H NMR spectrum displayed signals for a methoxy group at H 3.91 (3H, s), methyl group at H 2.45 (3H, s), two aromatic methine protons [H 6.23 (d, J=2.0 Hz, H-3) and 6.27 (d, J =2.0 Hz, H-5)], and two hydroxyl protons at H 11.58, 9.26. The 13 C, DEPT NMR spectra showed the resonances of 9 carbons including one aromatic methyl (C 24.2), a methyl ester [C 172.9 (C=O), 52.1 (OCH3)], and six substituted aromatic carbons, two of which were oxygenated. In the HMBC spectrum, the methoxy protons (H 3.91) showed the correlation with the carbonyl carbon (C 172.9). Two hydroxyl protons (H 11.58 and 9.26) jointed to C-2 and C-4, based on their HMBC correlations with carbon signals at C 166.3 and 163.4, respectively (Figure 3.8). Similarly, the C-3 aromatic methine proton (H 6.23) showed HMBC correlation with C-2 (C 166.3) and C-4 (C 163.4). The methyl group (H 2.53) jointed to C-6 on the basis of its HMBC correlation with carbon signal at C 144.3 and C-5 (C 112.3). These spectroscopic data were suitable with the published one [6], compound PRAES-E11 was methyl orsellinate. 49 3.1.2.5. Structure elucidation of compound PRAES-T4 Colorless scale. 1H and 13C NMR spectra (CDCl3) (Appendix 59, 60): see Table 3.5. HSQC and HMBC spectra (CDCl3) (Appendix 61, 62). The NMR spectral features of PRAES-T4 were similar to those of PRAESE11 except for the presence of an additional methyl group (δH 2.10, δC 7.6) and the absence of an aromatic proton. Moreover, the HMBC correlation from the methyl group (δH 2.10) to C-2, C-3 and C-4 suggested the structure of PRAES-T4 to be methyl β-orsellinate (Figure 3.8) [38]. 3.1.2.6. Structure elucidation of compound PRAES-T6 Yellow needles. Melting point: 123–124 C. Mass spectrum (Appendix 63): HR-ESI-MS (positive mode) m/z 153.0516 [M+H]+ (calcd. for C8H8O3+H, 153.0552). 1H and 13C NMR spectra (Acetone-d6) (Appendix 64, 65): see Table 3.5. HMBC spectra (Acetone-d6) (Appendix 66). The molecular formula of PRAES-T6 was established as C8H8O3 by HRESI-MS. The 1H NMR spectrum of PRAES-T6 showed six singlets for two chelated hydroxyl groups at δH 10.67, a formyl proton at δH 10.26, two aromatic protons at δH 6.25 and a methyl group at δH 2.23. Its 50 13 C NMR spectrum showed 8 carbon signals including a methyl group, two aromatic methines, a formyl group, and four quaternary aromatic carbon signals. The exact location of the aromatic protons and the substituted functional groups was established based on 2D NMR (HSQC and HMBC). These spectroscopic data were suitable with the published atranol [38]. Therefore, PRAES-T6 was identified as atranol. 3.1.2.7. Structure elucidation of compound PRAES-E2 Colorless oil. 1H and 13C NMR spectra (CDCl3) (Appendix 67, 68): see Table 3.5. HSQC and HMBC spectra (CDCl3) (Appendix 69, 70). The NMR spectral features of compound PRAES-E2 resembled those of PRAES-E11. The differences were the presence of a n-propyl group [-CH2: δH 2.83 (quint, J=6.5, 1.5 Hz), δC 38.9; -CH2: δH 1.55 (sext, J= 8.0, 7.5, 5.0 Hz), δC 24.9 and -CH3: δH 0.95 (t, J=7.5 Hz), δC 14.2] instead of a methyl group as in PRAES-E11 and the addition of a methoxy group. The substitution pattern was confirmed by HMBC correlations (Figure 3.8). Accordingly, the structure of PRAES-E2 was established as methyl divaricatinate [38]. 51 Table 3.5. NMR data of PRAES-E11, PRAES-T4, PRAES-T6 and PRAES-E2 No PRAES-E11(a) H, J (Hz) PRAES-T4(b) C H, J (Hz) PRAES-T6(a) C H, J (Hz) 1 105.3 105.3 2 166.3 3 6.23 d (2.0) 4 5 6.27 d (2.0) H, J (Hz) C 104.7 163.1 163.1 165.6 101.6 108.6 109.3 163.4 158.1 163.1 6.20 s 110.6 6 144.3 140.2 7 172.9 172.6 3-CH3 2.10 s 6.25 s C 108.5 112.3 6.25 PRAES-E2(b) s 108.5 6.34 d (2.5) 98.9 164.0 6.29 d (2.5) 151.5 110.7 147.7 172.0 7.6 3-CHO 10.26 s 194.2 4-OCH3 3.80 s 55.3 3.92 s 51.8 2.83 quint (6.5, 1.5) 38.9 2 1.55 sext (8.0, 7.5, 5.0) 24.9 3 0.95 t (7.5) 14.2 7-OCH3 3.91 s 52.1 3.92 s 51.8 1 2.45 s 24.2 2.45 s 24.0 2.23 s 2-OH 11.58 s 12.02 s 10.67 s 4-OH 9.26 s 5.22 s 10.67 s 22.4 a) Measured in acetone-d6. b) Measured in chloroform-d. 52 11.68 s 3.1.2.8. Structure elucidation of compound PRAES-C22 White amorphous solid. IR spectrum (Appendix 71): IR (KBr) max cm-1: 3243 (OH), 1785 (C=O lactone), 1630 (C=C), 1363 (CO). Mass spectrum (Appendix 72): HR-ESI-MS (positive mode) m/z: 255.0862 [M+H]+ (calcd. for C12H14O6+H, 255.0869). 1H, 13C and DEPT NMR spectra (CDCl3) (Appendix 73, 74, 75): Table 3.6. HSQC, HMBC and NOESY spectra (CDCl3) (Appendix 76, 77, 78). Compound PRAES-C22 was obtained as a white amorphous solid. The molecular formula C12H14O6 was deduced from a pseudomolecular ion [M+H]+ at m/z 255.0862 in the HR-ESI-MS. The IR spectrum showed characteristic absorptions for a hydroxyl group (3243 cm−1) and a lactone group (1785 cm−1). The 1H NMR spectrum displayed signals for three methoxy groups at H 3.53, 3.62 and 3.86 (each 3H, s), two methylene protons at H 4.84 and 4.88 (each 1H, d, J = 14.0 Hz), an aromatic proton at H 6.88 (s), an acetalic methine proton at H 6.33 (s) and a hydroxyl phenolic proton at H 9.08 (s). The 13C NMR spectrum showed the signals for three methoxy groups (C 56.1, 56.3 and 59.3), a sp3 methylene (C 70.0), an aromatic methine (C 97.6), an acetalic methine carbon (C 102.2), a carboxyl group (C 168.8) and one penta-substituted benzene ring (Table 3.6). The IR, 1H NMR and 13 C NMR data indicated the presence of an α,- unsaturared--lactone. The position of functional groups of PRAES-C22 was determined by analysis of 2D NMR spectra (NOESY, HSQC and HMBC). The HMBC correlation from methoxy groups at H 3.62 (H3-1), 3.53 (H3-1), 3.86 (H3-9) to an acetalic methine at C 102.2 (C-3), to the oxygenated methylene carbon at C 70.0 (C-8) and 53 to an oxygenated carbon at C 159.7 (C-6) suggested that three methoxy groups were at C-3, C-6 and C-8, respectively. This was confirmed by the NOESY experiment which showed the correlations between the methoxy group at H 3.53 (H3-1) and methylene protons at H 4.84 and 4.88 (H2-8), between the methoxy group at H 3.62 (H3-1) with the acetalic methine proton at H 6.33 (H-3), and between the methoxy group at H 3.86 (H3-9) with the aromatic proton at H 6.88 (H-7), respectively. The HMBC correlations from signal of an aromatic proton at H 6.88 (H-7) to carboxyl carbon at C 168.8 (C-1). The NOESY cross peaks between hydroxyl phenolic group at H 9.08 and methoxy protons at H 3.62 (H3-1') indicated that the hydroxyl group located at C-4 (Figure 3.9). Accordingly, the structure of PRAES-C22 was determined as praesalide A. The stereochemistry of the sole chiral center C-3 was not determined. 54 3.1.2.9. Structure elucidation of compound PRAES-C23 White amorphous solid. IR spectrum (Appendix 79): IR (KBr) max cm-1: 3240 (OH), 1769 (C=O lactone), 1625 (C=C), 1341 (CO). Mass spectrum (Appendix 80): HR-ESI-MS (positive mode) m/z: 269.1018 [M+H]+ (calcd. for C13H16O6+H, 269.1026). 1H, 13 C and DEPT NMR spectra (CDCl3) (Appendix 81, 82, 83): see Table 3.6. HSQC, HMBC and NOESY spectra (CDCl3) (Appendix 84, 85, 86). Compound PRAES-C23 was obtained as a white amorphous solid and the molecular formula was established as C13H16O6 by HR-ESI-MS, with 14 mass atomic units more than that of PRAES-C22. The IR, 1 H and 13 C NMR spectra of PRAES-C23 revealed a close relationship to those of PRAES-C22, except for the presence of an ethoxy group at C-3 instead of the methoxy group as in PRAES-C22. The HMBC correlations from an acetalic methine at H 6.40 (H-3) to the oxygenated methylene carbon at δC 65.3 (C-1) and from methylene protons at H 3.86 and 3.94 (H2-1) to the acetalic carbon at δC 101.5 (C-3) indicated that this ethoxy group located at C-3. This was confirmed by the NOESY cross peaks which showed the proximity in space between oxygenated methylene protons at H 3.86 and 3.94 (H2-1) with methyl protons at H 1.33 (H3-2) and with the acetalic methine at H 6.40 (H-3). The substitution pattern was confirmed by HSQC, HMBC and NOESY correlations (Figure 3.10). 55 These results revealed the structure of PRAES-C23 as 3-ethoxy-4-hydroxy6-methoxy-5-methoxymethylphthalide or praesalide B. The absolute configuration of C-3 was not established. Praesalide B was identified as a new structure isolated from natural lichen. 3.1.2.10. Structure elucidation of compound PRAES-C24 White amorphous solid. IR spectrum (Appendix 87): IR (KBr) max cm-1: 3235 (OH), 1766 (C=O lactone), 1624 (C=C), 1339 (CO). Mass spectrum (Appendix 88): HR-ESI-MS (positive mode) m/z: 283.1174 [M+H]+ (calcd. for C14H18O6+H, 283.1182). 56 1H, 13C and DEPT NMR spectra (CDCl3) (Appendix 89, 90, 91): see Table 3.6. HSQC, HMBC and NOESY spectra (CDCl3) (Appendix 92, 93, 94). The HR-ESI-MS of PRAES-C24 indicated the molecular formula of C14H18O6. The IR and NMR spectral features of PRAES-C24 were similar to those of PRAES-C23 but PRAES-C24 showed signals of an ethoxy group at C-8 instead of the methoxy group as seen in PRAES-C23 (Table 3.6). The HMBC correlations from methylene protons at H 3.70 (H2-1) to the oxygenated methylene carbon at δC 68.1 (C-8) and methylene protons at H 4.86 and 4.92 (H2-8) to the carbon at δC 67.6 (C-1) indicated that this ethoxy group located at C-8. This was supported by the NOESY cross peaks between H2-1 at H 3.70 and H2-8 at H 4.86 and 4.92 (Figure 3.11). The 2D NMR experiments proved the proposed structure to be correct and allowed the completed characterization of compound PRAES-C23 as 3-ethoxy-4hydroxy-6-methoxy-5-ethoxymethylphthalide, although the absolute configuration of the sole carbon at C-3 was not established. 57 Compound 3-ethoxy-4-hydroxy-6-methoxy-5-ethoxymethylphthalide or praesalide C was identified as a new structure isolated from natural lichen. Table 3.6. NMR data of PRAES-C22, PRAES-C23 and PRAES-C24 (CDCl3) No. PRAES-C22 δH J (Hz) 1 3 PRAES-C23 δC δH J (Hz) 168.8 6.33 s 102.2 PRAES-C24 δC δH J (Hz) 169.0 6.40 s 101.5 δC 169.0 6.40 s 101.5 3a 124.5 124.9 124.8 4 153.3 153.2 153.3 5 116.1 116.0 116.2 6 159.7 159.6 159.5 7 6.88 s 7a 8 97.6 6.87 s 97.5 128.6 4.84 d (14.0) 70.0 4.88 d (14.0) 6.86 s 128.6 4.83 d (14.0) 70.0 4.88 d (14.0) 97.4 128.5 4.86 d (14.0) 68.1 4.92 d (14.0) 9 3.86 s 56.1 3.85 s 56.1 3.85 s 56.1 1' 3.62 s 56.3 3.86 dq (9.5, 7.0) 65.3 3.86 dq (9.5, 7.0) 65.3 3.94 dq (9.5, 7.0) 2' 1'' 3.53 s 59.3 1.33 t (7.0) 15.1 1.33 t (7.0) 15.1 3.53 s 59.3 3.70 q (7.0) 67.6 1.32 t (7.0) 15.0 2'' 4-OH 9.08 s 3.94 dq (9.5, 7.0) 9.03 br s 58 9.33 s 3.1.2.11. Structure elucidation of compound PRAES-C25 Yellow solid. Mass spectrum (Appendix 95): HR-ESI-MS (positive mode) m/z: 263.0523 [M+Na]+ (calcd. for C11H12O6+Na, 263.0532). 1H NMR spectra (DMSO-d6) (Appendix 96): see Table 3.7. HMBC spectra (DMSO-d6) (Appendix 97). Structure elucidation of compound PRAES-C25M Yellow solid. IR spectrum (Appendix 98): IR (KBr) max cm-1: 3477 (OH), 1725 (C=O carboxyl), 1626 (C=C), 1238 (CO). Mass spectrum (Appendix 99): HR-ESI-MS (positive mode) m/z: 269.1022 [M+H]+ (calcd. for C13H16O6+H, 269.1026). 1H, 13 C and DEPT NMR spectra (CDCl3) (Appendix 100, 101, 102): see Table 3.7. COSY, HSQC, HMBC and NOESY spectra (CDCl3) (Appendix 103, 104, 105, 106). The 1H NMR spectrum of PRAES-C25 showed signals for two methoxy groups at H 3.21 and 3.87 (each 3H, s), a methylene group at H 4.40 (s), an aromatic proton at H 6.86 (s), an aldehydic proton at H 10.42 (br s) and a chelated hydroxyl group at H 12.47 (br s). However, the 13 C NMR spectrum only displayed signals for two methoxy groups (C 56.0 and 57.3), a methylene group (C 61.1) and two carboxyl carbons (C 162.9 and 168.4). The chemical structure of PRAES-C25 could not be 59 determined by the spectral data, therefore, compound PRAES-C25 was methylated with an excess of TMS-CH2N2 to yield the PRAES-C25M derivative. The HR-ESI-MS of PRAES-C25M established the molecular formula of C13H16O6. Its 1H NMR spectrum exhibited signals for three methoxy groups at H 3.37, 3.87 and 3.90 (each 3H, s), two methylene groups [H 3.37 (1H, m) and 3.57 (1H, dd, J = 18.0, 6.5 Hz)] and [H 4.52 and 4.56 (1H each, d, J = 10.5 Hz)], a hemiacetalic proton at H 6.15 (1H, dd, J = 6.5, 2.5 Hz) and an aromatic proton at H 7.09 (1H, s). The 13C NMR revealed the resonances for 13 carbons which were assigned for three methoxy groups (C 52.1, 56.2 and 58.2), two methylene groups (C 38.9 and 63.1), a hemiacetalic carbon (C 101.8), a carboxyl carbon (C 166.6) and six aromatic carbons. The hemiacetalic proton H-11 of PRAES-C25M resonated at H 6.15 as doublet of doublets (J = 6.5, 2.5 Hz) due to the coupling to the vicinal methylene protons H2-12 (H 3.37 and 3.57). The HMBC correlations from this proton at H 6.15 (H-11) to two aromatic carbons at C 120.4 (C-2) and C 158.5 (C-3) and the COSY spectrum showed the sequence from the methylene (H2-12) to the oxygenated methine (H-11) suggested the appearance of a benzofuran skeleton. The position of the oxygenated methylene group (C-8) was determined by the HMBC correlations from signal at H 4.52 and 4.56 (H2-8) to signals of two oxygenated carbons at C 158.5 (C-3) and 158.8 (C-5). The HMBC correlations between the aromatic proton at H 7.09 (H-6) with signals of the carboxyl carbon at C 166.6 (C-7), with four aromatic carbons at C 158.5 (C-5), 126.5 (C-1), 120.4 (C-2), 113.1 (C-4) as well as the correlations of the two methoxy signals at H 3.90 (H3-13), 3.87 (H3-9) with signals at C 158.5 (C-5), 166.6 (C-7) indicated that the ester group located at C-1 (C 166.6). The NOESY interaction from H-6 to the methoxy group H 3.87 helped to support the 60 position of these substituents. The substitution pattern was confirmed by HSQC, HMBC and NOESY correlations (Figure 3.12). Consequently, the structure of PRAES-C25M was elucidated as methyl 2hydroxy-6-methoxy-7-methoxymethyl-2,3-dihydrobenzofuran-4-carboxylate or praesalide D. The stereochemistry of the sole chiral center C-2 was not determined. Prolonged treatment of PRAES-C25 with an excess of diazomethane in methanol proceeded with the methylation of the carboxyl group and cyclization to form benzofuranol skeleton (Figure 3.13). This specific mechanism is supported by several observations. The first was the reaction of aldehyde PRAES-C25 with 61 diazomethane to form homoligated aldehyde in a modification of the Buchner– Curtius–Schlotterbeck reaction [10, 58, 66]. The reaction has since been extended to form hemiacetal by acid-initiated nucleophilic addition of aldehyde with alcohol. This result with benzofuranol cyclization had been reported by Franko-Filipasic B. R. et al [26, 70]. Compound PRAES-C25 was isolated as a yellow solid and showed a pseudomolecular ion peak at m/z 263.0523 in its ESI-MS spectrum indicative the molecular formula of C11H12O6Na. Further analysis of HMBC spectra for PRAESC25 revealed that H-6 (δH 6.86) correlated with a carbon signal at δC 113.3 and the methoxy group H3-9 (δH 3.87) as well as the methylene protons H2-8 (δH 4.40) correlated with a oxygenated carbon signal at δC 162.9, confirming the presence of aromatic carbon C-4 (δC 113.3) and C-5 (δC 162.9) (Figure 3.14). 62 Complete analysis of the HMBC data as well as combining the HR-MS for PRAES-C25 showed that it was 2-formyl-3-hydroxy-5-methoxy-4- (methoxymethyl)benzoic acid or praesalide E. Compound PRAES-C25 was a new structure isolated from natural lichen. 3.1.2.12. Structure elucidation of compound PRAES-C26 Yellow solid. IR spectrum (Appendix 107): IR (KBr) max cm-1: 3398 (OH), 1718 (C=O carboxyl), 1615 (C=C), 1286 (CO). 63 Mass spectrum (Appendix 108): HR-ESI-MS (positive mode) m/z: 307.0787 [M+Na]+ (calcd. for C13H16O7+Na, 307.0794). 1H, 13 C and DEPT NMR spectra (CDCl3) (Appendix 109, 110, 111): see Table 3.7. HSQC, HMBC and NOESY spectra (CDCl3) (Appendix 112, 113, 114). Compound PRAES-C26 was isolated as a yellow solid. The HR-ESI-MS (positive mode) displayed a pseudomolecular ion peak with m/z 307.0787 [M+Na]+, corresponding to the molecular formula of C13H16O7. The 1H NMR spectrum of PRAES-C26 showed signals of two methoxy groups at H 3.39 and 3.75 (each 3H, s), one methylene group at H 4.57 (s), a chelated hydroxyl group at H 10.20 (s), an ethoxy group at H 4.24 (d, J = 7.0 Hz) and 1.21 (t, J = 7.0 Hz) and an aromatic proton at H 6.62 (s). The 13 C NMR revealed the resonant signals for 13 carbons, including two methoxy groups (C 56.0 and 58.4), a methylene carbon (C 63.7), two carboxyl carbons (C 169.1 and 173.6), an ethoxy group (C 62.1 and 13.7) and six aromatic carbons. The substitution pattern of PRAES-C26 was confirmed by HMBC and NOESY correlations. The methylene protons at H 4.57 (H2-8) showed HMBC cross peaks with two oxygenated aromatic carbons C-3 (C 159.3) and C-5 (C 161.5). The presence of a carboxyl group at C-1 (C 106.5) was also inferred through HMBC correlations from the aromatic proton at H 6.62 (H-6) to the carboxyl carbon C-7 (C 173.6). The position of the methoxy group (C-9) was determined by the HMBC correlation from H3-11 (H 3.75) to the oxygenated aromatic carbon C 161.5 (C-5). This was supported by the NOESY cross peaks of the methoxy protons H3-9 at H 3.75 to the aromatic proton H-6 at H 6.62 and to the methylene protons H2-8 at H 4.57 (Figure 3.14). Consequently, the structure of PRAES-C26 was proposed to be 2-ethoxycarbonyl-3-hydroxy-5-methoxy-464 methoxymethylbenzoic acid. PRAES-C26 was a new compound isolated from natural lichen and was named as praesalide F Table 3.7. NMR of PRAES-C25, PRAES-C25M and PRAES-C26 No. 1 2 3 4 5 6 7 8 9 10 11 12 13 3-OH PRAES-C25(a) δH J (Hz) δC δH PRAES-C25M(b) J (Hz) 113.3 162.9 6.86 4.40 3.87 3.21 10.42 12.47 s s s s br s 168.4 61.1 56.0 57.3 7.09 s 4.56 4.52 3.87 3.37 6.15 3.37 3.57 3.90 d (10.5) d (10.5) s s dd (6.5, 2.5) m dd (18.0, 6.5) s δC 126.5 120.4 158.5 113.1 158.8 104.1 166.6 63.1 6.62 s 4.57 s 56.2 58.2 101.8 38.9 3.75 3.39 s s 4.24 d (7.0) 52.1 1.21 10.20 t (7.0) s s a) Measured in DMSO-d6 b) Measured in chloroform-d. 65 δH PRAES-C26(b) J (Hz) δC 106.5 113.9 159.3 113.9 161.5 102.6 173.6 63.7 56.0 58.4 169.1 62.1 13.7 3.1.3. Depsides 3.1.3.1. Structure elucidation of compound PRAES-T3 White powder. Melting point: 158-160 C. 1H, 13 C and DEPT NMR spectra (CDCl3) (Appendix 115, 116, 117): see Table 3.8. HSQC and HMBC spectra (CDCl3) (Appendix 118, 119). Compound PRAES-T3 was a depside. In the 1H NMR spectrum, all of the ten resonances are singlets. It displayed a methoxy group at H 3.98 (s), a formyl group at H 10.36 (s), three methyl groups at H 2.69 (s), 2.54 (s), 2.09 (s), two isolated aromatic methine protons at H 6.51 and 6.40 (1H each, s) and three chelated hydroxyl protons at H 12.52, 12.48 and 11.91 (1H each, s). The 13 C, DEPT-NMR spectra displayed two carboxyl groups (C 172.2 and 169.1), an aldehyde carbon (C 193.8), a methoxy group (C 52.3), three methyl groups (C 25.5, 23.9 and 9.3) and twelve aromatic carbons. These findings implied that compound PRAES-T3 was composed of two mono-aromatic units, haematommic acid and β-orsellinic acid. The substitution pattern was confirmed by HSQC and HMBC correlations. These spectroscopic data were suitable with the published one [38, 74]. All these properties suggested that compound PRAES-T3 was atranorin. 66 Table 3.8. NMR data of PRAES-T3, PRAES-C7 and PRAES-E18 No PRAES-T3(b) δH J (Hz) PRAES-C7(a) δC δH J (Hz) PRAES-E18(b) δC δH J (Hz) 1 2 102.9 169.1 103.9 161.5 3 4 5 6 7 8 9 10 11 2-OH 4-OH 108.6 167.5 112.8 152.4 169.7 193.8 25.5 109.5 164.3 111.8 140.8 171.1 7.8 24.3 6.40 s 10.36 s 2.69 s 6.48 s 2.08 s 2.60 s δC 104.6 164.4 6.38 s 6.38 s 2.98 1.74 0.94 3.83 m sext (7.5) t (7.5) s 98.9 165.5 110.9 148.8 168.9 38.8 24.8 14.3 55.4 12.48 s 12.52 s 1 110.3 115.3 104.5 2 162.9 163.7 156.9 3 116.8 115.3 124.9 4 152.0 151.0 156.0 5 6.51 s 116.0 6.41 s 114.5 6.43 s 106.2 6 139.8 140.5 146.8 7 172.2 174.8 175.5 8 2.09 s 9.3 2.00 s 9.4 2.98 m 39.0 9 2.54 s 23.9 2.62 s 23.4 1.66 sext (7.5) 25.2 10 3.98 s 52.3 1.00 t (7.5) 14.3 3.89 s 56.0 11 2-OH 11.91 s 4-OH a) Measured in acetone-d6. b) Measured in chloroform-d. 3.1.3.2. Structure elucidation of compound PRAES-C7 Colorless needles. Melting point: 176-177 C. 67 1H, 13C and DEPT NMR spectra (Acetone-d6) (Appendix 120, 121, 122): see Table 3.8. HSQC and HMBC spectra (Acetone-d6) (Appendix 123, 124). Compound PRAES-C7 was obtained as colorless needles. The 1H NMR spectrum showed singlets for four methyl groups at δH 2.00 (s), 2.08 (s), 2.60 (s) and 2.62 (s) and two aromatic protons at δH 6.41 (s) and 6.48 (s). The 13C and DEPT NMR exhibited 18 carbons corresponding to four methyl groups (C 24.3, 23.4, 9.4 and 7.8), two aromatic methines (C 111.8 and 114.5) and twelve quaternary carbons including two carboxyl carbons (C 171.1 and 174.8) and four oxygenated carbons (C 164.3, 163.7, 161.5 and 151.0). These spectral data indicated that PRAES-C7 consisted of two units of -orsellinic acid and HMBC spectra confirmed the proposed structure as shown in Figure 3.15. These spectroscopic data were suitable with the published data [31, 38]. Accordingly, the structure of PRAES-C7 was established as 4--demethylbarbatic acid. This compound was also found in Ramalina subdecipiens [38]. 68 3.1.3.3. Structure elucidation of compound PRAES-E18 Colorless needles. Melting point: 150-151 C. Mass spectrum (Appendix 125): HR-ESI-MS (positive mode) m/z: 419.1702 [M+H]+ (calcd. for C22H27O8, 419.1701). 1H, 13 C and DEPT NMR spectra (CDCl3) (Appendix 126, 127, 128): see Table 3.8. COSY, HSQC and HMBC spectra (CDCl3) (Appendix 129, 130, 131). Compound PRAES-E18 was a meta-depside and showed a pseudomolecular ion peak at m/z 419.1702 in its HR-ESI-MS spectrum indicative the molecular formula of C22H27O8. The 1H NMR and HSQC spectra of PRAES-E18 showed three aromatic protons at δH 6.43 (1H, s) and 6.38 (2H, s), two methoxy groups at δH 3.89 (s) and 3.83 (s), four methylene groups at δH 2.98 (4H, m), 1.74 (2H, sext, 7.5 Hz), 1.66 (2H, sext, 7.5 Hz) and two methyl groups at δH 1.00 (t, 7.5 Hz), 0.94 (t, 7.5 Hz). 69 The 13C NMR spectrum revealed twenty two carbons including two carboxyl groups (δC 175.5 and 168.9), two methoxy groups (δ 56.0 and 55.4), three aromatic methine carbons (δC 110.9, 106.2, 98.9) and two n-propyl groups (δC 38.8, 24.8, 14.3, 39.0, 25.2 and 14.3). In the COSY spectrum, there were correlations of H-8 and H-9, of H-9 and H-10, of H-8 and H-9, and of H-9 and H-10. Moreover, the DEPT spectrum showed the presence of four methylene carbons and two methyl carbons, therefore, compound PRAES-E18 possessed two n-propyl groups. The exact location of the aromatic protons and the substituted functional groups was established based on 2D NMR (Figure 3.16).Detailed 2D NMR analysis and comparison with the reported data led us to determine the structure of PRAESE18 was sekikaic acid, respectively [38]. This compound was also found in Ramalina boulhautiana [38]. 3.1.4. Depsidones 3.1.4.1. Structure elucidation of compound PRAES-C14 Colorless needles. Melting point: 244250 C. Mass spectrum (Appendix 132): (calcd. for C19H16O9+Na, 411.0692). 70 HR-ESI-MS m/z 411.0681 [M+Na]+, 1H and 13C NMR spectra (DMSO-d6) (Appendix 133, 134): see Table 3.9. HSQC and HMBC spectra (DMSO-d6) (Appendix 135, 136). Compound PRAES-C14 was isolated as colorless needles. The HR-ESI-MS (positive mode) displayed a pseudomolecular ion peak with m/z 411.0681 [M+Na]+, corresponding to the molecular formula of C19H16O9. The 1H NMR spectrum of PRAES-C14 was simple. Its 1 H NMR spectrum displayed six singlets corresponding to two methyl groups at H 2.64 (H-9, s) and 2.47 (H-9, s), an oxygenated methylene at H 4.58 (H-8, s), an aromatic proton at H 6.83 (H-5, s), an aldehyde proton at H 10.76 (H-8, s) and a methoxy group at H 3.31 (H-10, s). The 13C and DEPT NMR spectra indicated that the molecule of PRAES-C14 contained two methyl groups [δC 21.2 (C-9) and 15.4 (C-9)], one oxygenated methylene [δC 62.9 (C-8)], one aldehyde group [δC 193.4 (C-8)], an aromatic methine [δC 117.9 (C-5)], a methoxy group [δC 57.9 (C-10)], two carbonyl groups [δC 161.4 (C-7) and 172.9 (C-7)] and 11 quaternary carbons [δC 113.0 (C-1), 165.5 (C-2) , 112.0 (C-3), 165.3 (C-4), 153.4 (C-6), 113.1 (C-1), 159.0 (C-2), 116.7 (C-3), 147.5 (C-4), 143.0 (C-5) and 133.5 (C-6)]. The position of the methoxy group (C-10) was determined by the HMBC correlation from the methoxy protons at H 3.31 (H3-10) to the methylene carbon C-8 (C 62.9). Analysis of 1D, 2D-NMR data (Figure 3.17) and the comparison of these data with the ones in the literature [9] suggested that compound PRAES-C14 is 8-O-methylprotocetraric acid. 71 Table 3.9. NMR data of PRAES-C14, PRAES-C12 No PRAES-C14(b) δH J (Hz) δC PRAES-C12(a) δH J (Hz) δC PRAES-C12(a) No δH J (Hz) δC 1 113.0 114.6 1 106.4 2 165.5 164.7 2 162.8 3 112.0 111.8 3 110.2 4 165.3 164.7 4 161.4 117.8 5 119.8 5 6.83 s 117.9 6.71 s 6 153.4 153.7 6 137.9 7 161.4 160.8 7 173.6 8 10.73 s 193.4 10.76 s 194.6 8 2.69 s 19.9 9 2.47 s 21.2 2.32 s 21.2 9 1.99 s 8.9 10 3.90 s 52.0 4-OH 12.16 12.16 s 1 113.1 113.6 2 159.0 160.4 3 116.7 119.1 4 147.5 145.9 5 143.0 141.5 6 133.5 132.5 7 172.9 166.4 8 4.58 s 62.9 4.06 s 22.2 9 2.64 s 15.4 2.74 s 14.9 10 3.31 s 57.9 2-OH 11.19 s a) Measured in acetone-d6. b) Measured in Acetone-d6. and DMSO-d6. 72 3.1.4.2. Structure elucidation of compound PRAES-C12 Colorless needles. Melting point: 250254 C. 1H, 13C and DEPT NMR spectra (Acetone-d6) (Appendix 137, 138, 139): see Table 3.9. HSQC and HMBC spectra (Acetone-d6) (Appendix 140, 141). The 1H and 13 C NMR spectra of PRAES-C12 revealed a close relationship with those of PRAES-C14. The 1H NMR spectrum of PRAES-C12 displayed singlet signals for four methyl groups at H 2.74 (s), 2.69 (s), 2.32 (s) and 1.99 (s), two chelated hydroxyl protons at H 12.16 (s) and 11.19 (s), a methylene group at H 4.06 (s), an aromatic proton at H 6.71 (s), an aldehyde proton at H 10.76 (s) and a methoxy group at H 3.90 (s). The 13C and DEPT NMR spectra showed resonances of 28 carbons including four methyl groups [δC 21.2 (C-9), 19.9 (C-9), 14.9 (C-9) and 8.9 (C-8)], three carboxyl carbons [δC 173.6 (C-7), 166.4 (C-7) and 160.8 (C-7)], one methylene carbon [δC 22.2 (C-8)], an aldehyde group [δC 194.6 (C-8)], a methoxy group [δC 52.0 (C-10)], an aromatic methine and 17 quaternary carbons. 73 These spectral data indicated that compound PRAES-C12 possessed one -orsellinic acid unit more than PRAES-C14. The -orsellinic acid unit was jointed to C-3 (δC 119.1) by a methylene group, on the base of HMBC correlations of these methylene protons δH 3.97 (H2-8) to aromatic carbons at δC 160.4 (C-2), 119.1 (C3), 145.9 (C-4), 161.4 (C-4), 119.8 (C-5), and 137.9 (C-6) (Figure 3.17). The exact location of the aromatic proton and the substituted functional groups was established based on 2D NMR (HSQC and HMBC). Accordingly, the structure of PRAES-C12 was determined to be furfuric acid. This compound was also found in Pseudevernia furfuracea (L.) Zopf [38]. 3.1.5. Diphenyl ethers 3.1.5.1. Structure elucidation of compound PRAES-C5 White amorphous solid. Mass spectrum (Appendix 142): HR-ESI-MS m/z 297.0752 ([M+Na]+, (calcd. for C15H14O5+Na, 297.0733). 1H, 13C and DEPT NMR spectra (Acetone-d6) (Appendix 143, 144, 145): see Table 3.10. HSQC and HMBC spectra (Acetone-d6) (Appendix 146, 147). 74 Compound PRAES-C5 was isolated as white amorphous solid. The HR-ESIMS (positive mode) displayed a pseudomolecular ion peak with m/z 297.0752 [M+Na]+, corresponding to the molecular formula of C15H14O5. The 1H NMR spectrum exhibited signals for five aromatic methine protons at H 6.29, 6.38, 6.58, 6.63 (5H, H-3, 5, 1‟, 3‟, 5‟) and these resonant signals concentrated in a narrow zone within 2.5 Hz, therefore these aromatic protons were meta coupled. The proton spectrum also showed signals corresponding to two methyl groups (H 2.29, 2.59). The 13C-NMR spectrum revealed the presence of 15 carbons including two methyl groups (C 21.4, 24.4), one carboxyl group (C 171.0) and 12 aromatic carbons including four oxygenated carbons (C 166.7, 164.1, 159.1 and 152.0). The NMR data suggested the presence of two aromatic rings. The first ring was similar to orsellinic acid. The second ring contained three meta protons at H 6.58 (H-3, H-5) and 6.63 (H-1) as well as a methyl group at H 2.29. The HMBC spectrum showed the correlations of the methyl group with C-6‟ (C 141.2) and the aromatic methine carbon C-5 (C 114.5). These findings implied that compound PRAES-C5 was composed of two mono-aromatic units, an orsellinic acid unit and an orcinol unit (Figure 3.18). Clear observation showed that PRAES-C5 did not contain a chelated hydroxyl group. Up to this point, the 1H NMR spectral features PRAES-C5 were somewhat different comparing to the corresponding ones of the depside lecanorol although these two compounds were measured in the same deuterated solvent 75 (acetone-d6) (Table 3.10). The chemical shift value (H 6.38, H-5, acetone-d6) of the aromatic proton in the 1H NMR spectrum of PRAES-C5 was somewhat at higher field than the similar proton (H 6.63, H-5, acetone-d6) in lecanorol [36]. This evidence suggested that PRAES-C5 was a tri-ortho-substituted diphenyl ether since these compounds are known to adopt an “H-inside conformation” in which the single ortho aromatic proton is shielded by the adjacent aromatic ring [15, 24]. Table 3.10. 1H NMR data of compound PRAES-C5 and Lecanorol No. Lecanorol[36] (Acetone-d6) PRAES-C5 (Acetone-d6) δH J (Hz) δH J (Hz) 3 6.29 d (2.5) 6.35 d (2.5) 5 6.38 dd (0.5, 2.5) 6.63 s 8 2.59 s 2.63 s 2-OH 11.33 s 4-OH 9.47 s 1 6.63 t (0.5, 1.0) 6.63 s 3 6.58 t (0.5, 1.0) 6.44 d (2.5) 5 6.58 t (0.5, 1.0) 6.67 d (2.5) 7 2.29 s 2.30 s 8.71 s 2-OH Therefore a proposed diphenyl ether structure as shown in Figure 3.18 could meet all the mentioned criteria. The structure of PRAES-C5 was elucidated as 4- 76 hydroxy-2-(3-hydroxy-5-methylphenoxy)-6-methylbenzoic acid or praesorether A. Praesorether A was identified as a new compound isolated from natural lichen. 3.1.5.2. Structure elucidation of compound PRAES-C15 Yellow solid. IR spectrum (Appendix 148): IR (KBr) max cm-1: 3383 (OH), 1730 (C=O carboxyl), 1645 (C=C), Mass spectrum (Appendix 149): HR-ESI-MS (positive mode) m/z 333.0970 [M+H]+, (calcd. for C17H16O7+H, 333.0975). 1H NMR spectrum (CDCl3) (Appendix 150): see Table 3.11. 13 C and DEPT NMR spectra (CDCl3) (Appendix 151, 152): see Table 3.12. HSQC, HMBC and NOESY spectra (CDCl3) (Appendix 153, 154, 155). Compound PRAES-C15 was obtained as a yellow solid and possessed a molecular formula of C17H16O7, as determined from HR-ESI-MS, with the a pseudomolecular ion peak at m/z 333.0970. The 1H NMR spectrum exhibited signals corresponding to two meta-coupled protons at H 6.32 (d, J = 2.5 Hz) and 6.17 (d, J = 2.5 Hz), and a singlet at H 6.55 due to one aromatic proton, a hydrogen-bonded hydroxyl group at H 12.06 (s), a formyl group at H 10.39 (s), a methoxy group at H 3.50 (s) and two methyl groups at H 2.22 (s) and 2.00 (d, J = 0.5 Hz). The 13 C-NMR spectrum showed the resonances of 17 carbons including two methyl groups (C 20.8 and 17.0), a methoxy groups (C 52.4), a carboxyl 77 carbon (C 167.0), a formyl group (C 193.7) and twelve substituted aromatic carbons, five of which were oxygenated. The HMBC spectrum of PRAES-C15 indicated that the first A ring contained a methyl group (H 2.22, C-9) and a chelated hydroxyl group (H 12.06), which correlated with a methine aromatic carbon at C 113.9 (C-5). Furthemore, this hydroxyl proton and the aldehyde proton correlated with the same carbon bearing an oxygen at C 164.0 (C-4) (Figure 3.19). The assignment of substituents on the first ring showed that PRAES-C15 possessed a methyl heamatommate unit (9), a monophenolic compound that was also isolated in this species. The B ring was substituted with two meta coupled proton at δH 6.32 (H-3) and 6.17 (H-1) as well as a methyl group at δH 2.00. In the HMBC spectrum, this methyl group showed correlations with the first methine aromatic carbon at δC 109.5 (C-1) and two carbons at δC 136.3 (C-5) and 131.1 (C-6). Therefore, the methyl group at δC 17.0 and the second methine aromatic carbon at δC 131.1 were in para positions together. The NOESY spectrum of compound PRAES-C15 showed the correlations between the formyl proton H-8 of A-ring and the methyl protons H3-7 at δH 2.00 of B-ring as well as the methoxy protons H3-10 at H 3.50 of A-ring and the aromatic proton H-3 at H 6.32 of B-ring. The proximity in space of these substituents implied that the two rings A and B are not co-planar. Via the ether bridge, the two rings are in two different planes that formed a certain angel, as proposed in Figure 3.19. 78 Accordingly, the structure of PRAES-C15 was elucidated as shown. Compound PRAES-C15 was designated as methyl methylphenoxy)-3-formyl-4-hydroxy-6-methylbenzoate. 2-(2,4-dihydroxy-6PRAES-C15 was identified as a new compound isolated from natural lichen and was named as praesorether B. 3.1.5.3. Structure elucidation of compound PRAES-C16 Yellow solid. IR spectrum (Appendix 156): IR (KBr) max cm-1: 3371 (OH), 1706 (C=O carboxyl), 1646 (C=C), 1263 (CO). Mass spectrum (Appendix 157): HR-ESI-MS (positive mode) m/z: 527.1544 [M+H]+ (calcd. for C27H26O11+H, 527.1554). 1H NMR spectrum (Acetone-d6) (Appendix 158): see Table 3.11. 13 C and DEPT NMR spectra (Acetone-d6) (Appendix 159, 160): see Table 3.12. HSQC, HMBC and ROESY spectra (Acetone-d6) (Appendix 161, 162, 163). Compound PRAES-C16 was isolated as a yellow solid. The HR-ESI-MS established a molecular formula of C27H26O11. The 1H NMR spectrum of PRAESC16 exhibited signals for three methyl groups at H 2.58, 2.15 and 1.99 (each 3H, 79 s), two methoxy groups at H 3.88 and 3.18 (each 3H, s), a methylene group at H 3.97 and 3.98 (each 1H, br s), three aromatic protons at H 6.52 (d, J = 0.5 Hz), 6.33 and 6.24 (each 1H, s), a formyl group at 10.44 (s) and two hydroxyl protons at H 12.00 (s) and 10.56 (s). The 13C NMR spectrum of compound PRAES-C16 revealed the presence of 27 carbons, including three methyl groups (C 20.5, 19.1 and 16.6), two methoxy groups (C 52.0 and 52.2), a formyl group (C 195.6), a methylene group (C 20.7), two carboxyl carbons (C 166.6 and 172.4) and three methine carbons (C 112.9, 108.9 and 101.5) and fifteen quaternary aromatic carbons. These spectroscopic data proposed that compound PRAES-C16 had three phenolic rings (A, B and C), each ring had one aromatic methine proton and one 80 methyl group. Analysis of 1D and 2D-NMR data indicated that compound PRAESC16 ressembled PRAES-C15 and it contained a further orsellinic acid unit. The orsellinic acid unit was jointed to B-ring at C-3 (δC 118.1) by a methylene carbon. This methylene carbon connected B and C rings on the base of HMBC correlations from this methylene protons δH 3.97 and 3.98 (H2-8) to aromatic carbons of B-ring at δC 153.3 (C-2), 113.1 (C-3), 149.2 (C-4), and to aromatic C-ring carbons at δC 160.0 (C-4), 119.5 (C-5) and 142.5 (C-6). This connection was confirmed by the NOESY cross peaks between methylene protons at δH 3.97 and 3.98 (H2-8) and methyl protons at δH 2.58 (H3-8) of C-ring (Figure 3.20). Therefore, the structure of PRAES-C16 was determined as shown. Compound PRAES-C16 was designated as methyl 2-[3-(4,6-dihydroxy-3methoxycarbonyl-2-methylbenzyl)-2,4-dihydroxy-6-methylphenoxy]-3-formyl-4hydroxy-6-methylbenzoate. Compound PRAES-C16 is a new one in the nature and was named praesorether C. 81 Table 3.11. 1H NMR data of PRAES-C15, PRAES-C16, PRAES-C20, PRAESC18, PRAES-C3 and PRAES-C4. No PRAES-C15(a) PRAES-C16(b) PRAES-C20(b) PRAESC18(a) PRAESC3(b) PRAESC4(a) H J (Hz) H J (Hz) H J (Hz) H J (Hz) H J (Hz) H J (Hz) 6.48 5 6.55 s 6.52 8 10.39 s 10.44 s 10.44 9 2.22 s 2.15 s 2.13 12.06 s 12.00 s 7-OCH3 3.50 s 3.18 s 3.17 s 1 6.17 d (2.5) 6.24 s 6.19 d (1.0) 3 6.32 d (2.5) 7 2.00 d (0.5) 1.99 s 1.98 s 5.20 3.97 br s 3.97 br s 3.98 br s 3.98 br s 4-OH 8 d (0.5) d (0.5) s d (0.5) 7-OCH3 6.71 s 6.46 s 6.54 s 10.12 s 10.42 s 10.32 s 2.31 s 2.07 s 2.21 s 11.92 s 12.03 s 12.05 s 3.23 s 2.94 s 3.28 s 6.27 s 6.31 s s 2.11 s 1.99 s 4.05 s 3.76 s 3.88 s 3.14 s 6.29 s 6.29 s 6.38 s 2.45 s 13.44 s 3.94 s 1 3 6.33 s 6.31 s 6.39 s 5 2.06 7 8 2.58 s 2.61 s 2.61 s 9 3.88 s 3.86 s 3.91 s 10.56 s 2-OH 7-OCH3 a) Measured in chloroform-d. b) Measured in acetone-d6 82 s Table 3.12. 13 C NMR data of PRAES-C15, PRAES-C16, PRAES-C20, PRAESC18, PRAES-C3 and PRAES-C4. No PRAESC15(a) PRAESC16(b) PRAESC20(b) PRAESC18(a) PRAESC3(b) PRAESC4(a) C C C C C C 1 114.9 115.5 115.7 116.5 116.1 115.3 2 158.1 158.9 159.2 156.4 159.4 158.3 3 110.6 111.0 111.0 111.8 111.5 110.9 4 164.0 164.3 164.2 163.6 164.3 164.1 5 113.9 112.9 112.7 116.2 112.8 114.0 6 147.7 148.2 148.1 148.1 148.1 147.6 7 167.0 166.6 166.8 165.8 167.0 167.5 52.4 52.0 52.0 52.2 51.9 52.3 8 193.7 195.6 195.6 193.7 195.6 193.8 9 1 20.8 109.5 20.5 108.9 20.5 108.5 21.2 103.4 20.6 109.6 20.9 111.1 2 153.3 153.3 153.9 153.1 152.5 152.3 3 102.1 113.1 113.7 117.6 114.1 112.2 4 148.8 149.2 149.8 151.7 148.4 145.5 5 136.3 135.8 135.7 134.2 138.3 136.3 6 131.1 129.9 129.6 129.2 136.4 129.5 7 17.0 16.6 16.7 101.6 16.6 16.8 20.7 21.1 20.0 18.2 17.3 7-OCH3 8 169.6 9 56.8 7-OCH3 1 109.4 107.1 107.5 109.6 105.0 2 161.5 162.3 162.4 131.4 160.0 3 101.5 102.0 102.0 111.2 111.0 4 160.0 163.5 159.5 155.7 111.0 5 119.5 120.9 117.1 109.6 113.4 6 142.5 142.1 142.6 136.4 142.0 7 172.4 172.9 172.0 21.3 173.1 7-OCH3 52.2 51.9 52.0 52.4 8 19.1 19.5 19.3 24.1 161.0 9 a) Measured in chloroform-d. b) Measured in acetone-d6. 83 3.1.5.4. Structure elucidation of compound PRAES-C20 Yellow solid. IR spectrum (Appendix 164): IR (KBr) max cm-1: 3394 (OH), 1708 (C=O carboxyl), 1647 (C=C), 1272 (CO). Mass spectrum (Appendix 165): HR-ESI-MS (positive mode) m/z: 525.1396 [M+H]+, (calcd. for C27H24O11+H, 525.1398). 1H NMR spectrum (Acetone-d6) (Appendix 166): see Table 3.11. 13 C and DEPT NMR spectra (Acetone-d6) (Appendix 167, 168): see Table 3.12. COSY, HSQC, HMBC and ROESY spectra (Acetone-d6) (Appendix 169, 170, 171, 172). Compound PRAES-C20 was obtained as a yellow solid. The IR, 1H, 13C and DEPT NMR spectral features of PRAES-C20 were closely similar to those of PRAES-C16, except for the lack of two chelated hydroxyl protons. The NMR spectra also revealed the signals of three methyl groups (H/C 2.13/20.5, 2.61/19.5 and 1.98/16.7), two methoxy groups (H/C 3.17/52.0 and 3.86/51.9), a formyl group (H/C 10.44/195.6), a methylene group (H/C 3.97 and 3.98/21.1), three aromatic methine carbons (H/C 6.48/112.7, 6.19/108.5 and 6.31/102.0) and two carboxyl carbons (C 166.8 and 172.9), and fifteen quaternary aromatic carbons. Analysis of 2D NMR spectra (COSY, HSQC, HMBC and ROESY) showed that the structure of PRAES-C20 was similar with that of praesorether C (PRAESC16) (Table 3.12). Moreover the ROESY spectrum of compound PRAES-C20 showed the correlations between the formyl proton H-8 at δH 10.44 of A-ring and the methyl protons H3-7 at δH 1.98 of B-ring, as well as the methylene protons H-8 and the methyl protons H3-8 of C-ring (Figure 3.21). 84 However, the HR-ESI-MS (positive mode) showed a pseudomolecular ion peak at m/z 525.1396 [M+H]+ (calcd. 525.1398), corresponding to the molecular formula of C27H24O11, two atomic mass units less than the one of PRAES-C16. The two compounds PRAES-C16 and PRAES-C20 were measured in the same deuterated solvent (acetone-d6), but the proton spectrum of PRAES-C16 showed two chelated hydroxyl protons at δH 12.00 (4-OH) and 10.56 (2-OH), but the proton spectrum of PRAES-C20 did not. Combination of the disappearance of the two chelated hydroxyl protons and the less of two atomic mass unit of PRAES-C20 comparing to the one of PRAESC16, revealed that there was a peroxy bridge between A-ring and C-ring, via the hydroxyl group at C-4 of A-ring and the hydroxyl group at C-2 of C-ring. 85 Therefore, the structure of PRAES-C20 was as shown. It is a new compound in the nature and was named praesorether D. 3.1.5.5. Structure elucidation of compound PRAES-C18 Yellow solid. IR spectrum (Appendix 173): IR (KBr) max cm-1: 3394 (OH), 1732 (C=O lactone), 1651 (C=C), 1276 (CO). Mass spectrum (Appendix 174): HR-ESI-MS (positive mode) m/z: 599.1396 [M+H]+ (calcd. for C29H26O14+H, 599.1402). 1H NMR spectrum (CDCl3) (Appendix 175): see Table 3.11. 13 C and DEPT NMR spectra (CDCl3) (Appendix 176, 177): see Table 3.12 HSQC, HMBC and ROESY spectra (CDCl3) (Appendix 178, 179, 180). Compound PRAES-C18 was isolated as a yellow solid, which was shown to have the molecular formula of C29H26O14 by the HR-ESI-MS. The 1H NMR spectrum of PRAES-C18 displayed signals for two methyl groups at H 2.61 and 2.31 (each 3H, s), three methoxy groups at H 3.91, 3.23 and 3.14 (each 3H, s), a methylene group at H 4.05 (s), an acetalic proton at H 5.20 (s), two aromatic 86 protons at H 6.71 and 6.39 (each 1H, s), a formyl group at H 10.12 (s) and a chelated hydroxyl proton at H 11.92 (s). The 13C NMR spectrum of compound PRAES-C18 revealed the presence of 29 carbons including two methyl groups (C 21.2 and 19.3), three methoxy groups (C 56.8, 52.2 and 52.0), a formyl group (C 193.7), a methylene group (C 20.0), an acetalic carbon (C 101.6), three carboxyl carbons (C 165.8, 169.6 and 172.0) and two methine carbons (C 116.2 and 102.0). The IR spectrum showed characteristic absorption for a hydroxyl group (3394 cm-1) and a lactone group (1732 cm-1). These spectral features were closely similar to those of PRAES-C16, except for the disappearance of one aromatic proton and one methyl group, and the appearance of an acetalic proton at H 5.20, one more methoxy group at H 3.14, an acetalic carbon at C 101.6 and a carboxyl carbon at C 169.6. This observation, together with analysis of HMBC spectrum, suggested the presence of a -lactone ring in PRAES-C18. The NOESY correlations between methoxy protons at H 3.14 (C7-OCH3) and the formyl proton at H 10.12 (H-8) 87 indicated that the -lactone ring jointed to the B-ring. This was confirmed by the comparison of the 1H NMR spectrum of PRAES-C18 and the one of a diphenyl ether in the literature that were measured in the same deuterated solvent (CDCl3-d) (Figure 3.22) [37]. The methylene group jointed B and C-rings at C 117.6 (C-3) and 117.1 (C5) which was deduced from HMBC correlations of H2-8 (H 4.05) to C-2 (C 153.1), C-4 (C 151.7), C-4 (C 159.5), C-5 (C 117.1) and C-6 (C 142.6). This was supported by NOESY cross peaks between methylene protons at H 4.05 (H28) and methyl proton at H 2.61 (H3-8) (Figure 3.23). 88 The 2D NMR experiments proved the proposed structure to be correct and allowed the completed structure of compound PRAES-C18 as show in Figure 3.23. PRAES-C18 was identified as a new compound isolated from the nature and was named as praesorether E. 1.5.6. Structure elucidation of compound PRAES-C3 Yellow solid. Mass spectrum (Appendix 181): HR-ESI-MS (positive mode) m/z: 491.1301 [M+Na]+ (calcd. for C25H24O9+Na, 491.1313) 1H NMR spectrum (Acetone-d6) (Appendix 182): see Table 3.11. 13 C and DEPT NMR spectra (Acetone-d6) (Appendix 183, 184): Table 3.12. HSQC and HMBC spectra (Acetone-d6) (Appendix 185, 186). The HR-ESI-MS of compound PRAES-C3 showed a pseudomolecular ion peak at m/z 491.1301 [M+Na]+ (calcd. 491.1313 for C25H24O9Na), corresponding to the molecular formula of C25H24O9. The 1H NMR spectrum of PRAES-C3 revealed the signals of three methyl groups at H 2.11, 2.07 and 2.06 (each 3H, s), one methoxy group at H 2.94 (s), a 89 methylene group at H 3.80 (2H, s), one chelated hydroxyl group at H 12.03 (s), one formyl group at H 10.42 (s), and four aromatic protons at H 6.49, 6.27 (each 1H, s) and 6.29 (2H, s). The 13 C NMR spectrum indicated 25 carbon signals due to three methyl carbons (C 21.3, 20.6 and 16.6), four aromatic methine carbons [C 116.1, 112.8 and 109.6 (two carbons)], one methoxy group (C 51.9), a methylene carbon (C 18.2), a formyl group (C 195.6), one carboxyl carbon (C 167.0) and 14 quaternary aromatic carbons. These findings, together with 2D NMR experiments implied that compound PRAES-C3 was composed of a PRAES-C15 unit and an orcinol unit. These two units were linked together via a methylene group. The methylene group jointed the orcinol unit C-ring to PRAES-C15 at its C-3. This was deduced from HMBC correlations of methylene protons H2-8 (H 3.80) to carbons of B-ring at C 114.1 (C-3), 148.4 (C-4), 152.5 (C-2), 111.2 (C-3) and to C-ring at C 155.7 (C-4) (Figure 3.24). The 2D NMR experiments and the comparison of these data with the ones in the literature proved the proposed structure to be correct [23]. All these findings allowed the completed characterization of compound PRAES-C3 depicted as 90 methyl 2-[3-(2,6-dihydroxy-4-methylbenzyl)-2,4-dihydroxy-6-methylphenoxy]-3- formyl-4-hydroxy-6-methylbenzoate or praesorether F. 3.1.5.7. Structure elucidation of compound PRAES-C4 Yellow solid. Mass spectrum (Appendix 187): HR-ESI-MS (positive mode) m/z: 577.1316 [M+Na]+, (calcd. for C28H26O12+Na, 577.1323). 1H NMR spectrum (CDCl3) (Appendix 188): see Table 3.11. 13 C and DEPT NMR spectra (CDCl3) (Appendix 189, 190): see Table 3.12. HSQC and HMBC spectra (CDCl3) (Appendix 191, 192). Compound PRAES-C4 was isolated as a yellow solid. The HR-ESI-MS of compound PRAES-C4 showed a pseudomolecular ion peak at 577.1316 [M+Na]+ (calcd. 577.1323), corresponding to the molecular formula of C28H26O12. Analysis of 1D and 2D NMR data for PRAES-C4 revealed a relationship to those of PRAES-C3 espescially the A and B-rings. The marked differences were at the C-ring with the presence of an additional methyl ester group [δC 173.1 (C-7), 52.4 (7-OCH3)] and a carboxyl group at δC 161.0 (C-9) in the 13C NMR spectrum and in the 1H NMR spectrum the appearance of a hydroxyl chelated proton at δH 91 13.44 (2-OH) and the lack of one aromatic proton comparing to the one of PRAES-C3. In the HMBC spectrum, the correlations of an aromatic proton δH 6.38 (H-5) to carbon signals at C-4 (δC 111.0), C-3 (δC 111.0), C-1 (δC 105.0), C-8 (δC 24.1) and C-9 (δC 161.0) indicated that the carboxyl group jointed to C-4. The location of the methoxycarbonyl group at C-1 was confirmed by HMBC cross peaks between the methyl protons at δH 2.45 (H3-8) to carbon signals at C-1 (δC 105.0), C-5 (δC 113.4) and C-6 (δC 142.0) (Figure 3.25). Consequently, the structure of PRAES-C4 was elucidated as show in. Compound PRAES-C4 was designated as methyl 2-[3-(2-carboxyl-6-hydroxy-5methoxycarbonyl-4-methylphenylmethyl)-2,4-dihydroxy-6-methylphenoxy]-3formyl-4-hydroxy-6-methylbenzoat. PRAES-C4 was identified as a new compound isolated from the nature and was named as praesorether G. 92 3.1.5.8. Structure elucidation of compound PRAES-C21 Yellow solid. IR spectrum (Appendix 193): IR (KBr) max cm-1: 3366 (OH), 1706 (C=O carboxyl), 1645 (C=C), 1268 (CO). Mass spectrum (Appendix 194): HR-ESI-MS (positive mode) m/z: 813.2394 [M+H]+, (calcd. for C43H40O16+H, 813.2396). 1H, 13C and DEPT NMR spectra (Acetone-d6) (Appendix 195, 196, 197): see Table 3.13. HSQC, HMBC and ROESY spectra (Acetone-d6) (Appendix 198, 199, 200). Compound PRAES-C21 was isolated as a yellow solid and the molecula of C43H40O16 which was confirmed by HR-ESI-MS with m/z 813.2394 ([M+H]+, calcd. 813.2400). The 1H NMR spectrum of PRAES-C21 revealed the signals of two methoxy groups at H 3.00 (s), five methyl groups at H 1.97, 2.08, 2.12, 2.13 and 2.38 (each 3H, s), two methylene groups at H 3.81 (2H, s), 3.88 and 3.89 (each 1H, s), two hydrogen-bonded hydroxyl groups at H 12.09 (s), two formyl groups at H 10.43 and 10.45 (each 1H, s), and five aromatic protons at H 6.16, 6.22, 6.24, 6.47 and 6.48 (each 1H, s). 93 The 13 C NMR spectrum indicated 43 carbon signals due to two methoxy groups (C 51.9 and 51.8), five methyl carbons (C 16.6, 16.7, 20.5, 20.5 and 20.8), five aromatic methine carbons (C 108.2, 108.2, 108.9, 112.4 and 112.7), two sp3 methylene (C 19.3 and 21.6), two carboxyl carbons (C 166.8 and 167.0), two aldehydic carbons (C 195.7 and 195.7) and 25 aromatic quaternary carbons. These findings, together with 2D NMR experiments and the HR-ESI-MS revealed that compound PRAES-C21 was composed of two PRAES-C15 units and an orcinol unit and this orcinol unit linked to two PRAES-C15 units via two methylene groups. The HMBC correlations of methylene protons H2-8b (H 3.88 and 3.89) to carbon signals at C 114.1 (C-3b), 150.0 (C-4b), 153.6 (C-2b) of the Bb-ring, 119.4 (C-4), 137.8 (C-5) and 156.5 (C-3) of the C-ring indicated that the methylene group C-8b (C 21.6) jointed the two Bb and C rings at their C-3b (C 114.1) and C-4 (C 119.4), respectively. This was comfirmed by NOESY cross peaks between H2-8b (H 3.88 and 3.89) and H3-7 (H 2.38) (Figure 3.27). The second methylene group H2-8a (H 3.81) jointed Ba and C-rings at their C-3a (C 114.9) and C-2 (C 112.5), respectively, on the base of HMBC correlations from the methylene protons H2-8a (H 3.81) to carbon signals at 94 C 114.9 (C-3a), 149.1 (C-4a), 152.7 (C-2a) of Ba-ring and to C 112.5 (C-2), and 152.9 (C-1) (Figure 3.26). Therefore, the structure of PRAES-C21 was determined as 2,6-bis-[3-(6formyl-5-hydroxy-2-methoxycarbonyl-3-methylphenoxy)-2,6-dihydroxy-4methylphenylmethyl]-1,3-dihydroxy-5-methylbenzene as shown in Figure 3.26. Compound PRAES-C21 was a new natural compound of lichens and was named as praesorether H. 95 Table 3.13. NMR data of compound PRAES-C21 (Acetone-d6) No. PRAES-C21 δH J (Hz) No. δC PRAES-C21 δH J (Hz) δC 1a 116.0 1b 115.6 2a 159.2 2b 159.6 3a 111.1 3b 111.0 4a 164.1 4b 164.2 112.4 5b 6a 148.0 6b 148.2 7a 167.0 7b 166.8 5a 6.48 s 6.47 s 112.7 8a 10.45 s 195.7 8b 10.43 s 195.7 9a 2.12 s 20.5 9b 2.13 s 20.5 7a-OCH3 3.00 s 51.9 7b-OCH3 3.00 s 51.8 4a-OH 1'a 12.09 s 6.22 s 4b-OH 12.09 s 108.9 1'b 6.16 s 108.2 2a 152.7 2b 153.6 3'a 114.9 3'b 114.1 4a 149.1 4b 150.0 5a 136.3 5b 135.8 6a 130.5 6b 129.4 7a 2.08 s 16.7 7b 1.97 s 16.7 8a 3.81 s 19.3 8b 3.88 s 21.6 3.89 s 1'' 152.9 2'' 112.5 3 156.5 4 119.4 5 137.8 6 6.24 s 108.2 7 2.38 s 20.8 96 3.1.6. Dibenzofurans 3.1.6.1. Structure elucidation of compound PRAES-E5 Yellow prisms (chloroform). Melting point: 203-205 C. D + 74 (c= 0.001, EtOH). 23 1H and 13C NMR spectra (CDCl3) (Appendix 201, 202): see Table 3.14. HSQC and HMBC spectra (CDCl3) (Appendix 203, 204). Compound PRAES-E5 was isolated as yellow prisms. The proton spectrum of compound PRAES-E5 was very simple in which all of the proton resonances were singlets and all of the hydroxyl protons were sharp singlets indicating that they formed H-bonds with the oxygen of neighbouring keto groups. The 1H NMR spectrum exhibited signals for two chelated hydroxyl groups at H 13.29 (s) and 11.01 (s), two methoxy groups at H 2.68 and 2.66, two methyl groups at H 2.11 and 1.76 and an aromatic methine proton at H 5.97. The 13 C, DEPT-NMR spectra showed signals for three carbonyl carbons [ C 201.7 (C-14), 200.3 (C-17) and 198.1 (C-1)], four methyl groups [C 32.1 (C-13), 31.2 (C-18), 27.8 (C-15) and 7.5 (C-16)]. 97 Table 3.14. NMR data of PRAES-E5 and PRAES-E3 (CDCl3) No PRAES-E5 δH J (Hz) Usnic acid[38] PRAES-E3 δC δH J (Hz) δC δH J (Hz) δC 1 198.1 198.7 198.1 2 105.3 105.4 105.3 3 191.7 191.8 191.8 4 5.97 s 98.3 5.95 s 98.1 5.92 s 98.4 5 179.4 179.9 179.4 6 155.2 159.2 155.2 7 101.6 101.9 101.6 8 163.9 166.5 163.9 9 109.4 107.8 109.4 10 157.5 154.7 157.6 11 103.9 102.2 104.0 12 59.1 59.7 59.1 13 1.76 s 14 32.1 1.76 s 201.7 31.8 1.75 s 201.8 32.2 201.8 15 2.66 s 27.8 2.66 s 28.0 2.66 s 27.9 16 2.11 s 7.5 2.12 s 7.6 2.10 s 7.6 18 2.68 s 2.77 s 2.67 s 8-OH 13.29 s 14.38 s 13.31 s 10-OH 11.01 s 11.30 s 11.02 s 18.84 s 17 200.3 31.2 204.6 3-OH 33.1 200.4 31.3 In the HMBC spectrum, the methyl protons at H 2.11 (H3-16) showed cross peaks with C-8 (C 163.9), C-9 (C 109.4) and C-10 (C 157.5), therefore this methyl group jointed to C-9 (C 109.4). The location of the two acetyl groups was confirmed by HMBC correlations from the methyl protons at H 2.66 (H3-15) to C-2 (C 105.3) and the methyl protons at H 2.68 (H3-18) to C-7 (C 101.6) (Figure 3.28). The comparison of these spectroscopic data of PRAES-E5 with those of usnic acid in the literature showed good compatibility [27, 38, 80]. Furthermore, compound PRAES-E5 was 98 dextrorotatory, D + 74 (c= 0.001, EtOH), therefore, PRAES-E5 was determined 23 to be (+)-(12R)-usnic acid. 3.1.6.2. Structure elucidation of compound PRAES-E3 Yellow prisms (chloroform). Melting point: 150-152 C. D + 80 (c= 0.001, EtOH). 23 1H and 13C NMR spectra (CDCl3) (Appendix 205, 206): see Table 3.14. HMBC spectrum (CDCl3) (Appendix 207). Compound PRAES-E3 was isolated as yellow prisms. The NMR spectra of compound PRAES-E3 were quite similar to those of compound PRAES-E5. The only difference was just observed in the HMBC spectrum of PRAES-E3. The HMBC spectrum exhibited cross peaks of the methyl protons at H 2.12 (H3-16) to carbon signals at C-8 (C 166.5), C-6 (C 159.2), C-7 (C 101.9) and of the methyl protons at H 2.77 (H3-18) to carbon signal at C-9 (C 107.8). 99 This result suggested that the methyl group jointed to C-7 (C 101.9) and the acetyl group located at C-9 (C 107.8) (Figure 3.29). Compound PRAES-C3 was also dextrorotatory, therefore the structure of compound PRAES-E3 was suggested to be (+)-(12R)-isousnic acid [27, 38]. This compound was also found in Cladonia mitis Sandst) [38]. 3.1.6.3. Structure elucidation of compound PRAES-C8 Yellow solid. 23 D + 852 (c= 0.001, MeOH). Mass spectrum (Appendix 208): HR-ESI-MS (positive mode) m/z: 366.0938 [M+Na]+, (calcd. for C18H17O6N+Na, 366.0954). 1H, 13 C and DEPT NMR spectra (CDCl3) (Appendix 209, 210, 211): see Table 3.15. HSQC and HMBC spectra (CDCl3) (Appendix 212, 213). Compound PRAES-C8 was obtained as a yellow solid. The HR-ESI-MS (positive mode) showed a pseudomolecular ion peak at m/z 366.0938 [M+Na]+ (calcd. 366.0954), corresponding to the molecular formula of C18H17O6N. Analysis of 1H and 13C NMR data, and comparison with those of PRAES-E5, enabled the identification of PRAES-C8 possessing the 9bH-dibenzofurandione moiety. The carbon numeration for PRAES-C8 was chosen as the one previously used for PRAES-E5. In the 13C NMR spectrum, there was no signal at 200-205 ppm for a ketone group, as in PRAES-E3 or PRAES-E5, but there appeared a new signal 100 at 180-175 ppm for a carboxyl group or an imino group. This observation, together with the presence of a nitrogen atom in the molecule, suggested the assignment of C-14 as the carbon of an imino group (C=N). This assignment was confirmed by the similarity of the remaining NMR data with those of Usimine A [67] (Figure 3.31 ). The 1H and 13C NMR assignments for this moiety of the molecule were confirmed by analysis of HMQC and HMBC data. The connection of the iminoethyl group to C-2 was approved by the HMBC correlations of H3-15 (δH 2.66) to signals at δC 175.5 (C-14) and 103.7 (C-2). The absolute configuration of the sole chiral center C-12 of PRAES-C8 was determined by comparison of its specific rotation value. In the biosynthetic aspect, the assignment of the chiral carbon C-12 of PRAES-C8 was also proposed to be R as in PRAES-E3 and PRAES-E5 because they were isolated from the same material 23 and possessing similar positive optical rotation, D + 852 (c= 0.001, MeOH). These data identified compound PRAES-C8 as show. PRAES-C8 was a new natural compound and was named as (+)-(12R)-praesousimine.. 101 Table 3.15. NMR data of PRAES-C8, PRAES-E5 and Usimine A No PRAES-C8(a) δH J (Hz) δC PRAES-E5(a) δH J (Hz) δC Usimine A(b)[67] δH J (Hz) δC 1 198.9 198.1 198.9 2 103.7 105.3 103.1 3 190.8 191.7 190.3 4 5.82 s 102.4 5.97 s 98.3 5.84 s 102.3 5 174.9 179.4 175.1 6 155.9 155.2 155.9 7 101.6 101.6 101.5 8 163.7 163.9 163.7 9 108.4 109.4 108.4 10 153.8 157.5 152.8 11 105.0 103.9 106.0 12 57.4 59.1 57.6 13 1.70 s 14 32.1 1.76 s 175.5 32.1 1.71 s 201.7 31.1 175.1 15 2.62 s 26.6 2.66 s 27.8 2.66 s 31.8 16 2.09 s 7.6 2.11 s 7.5 2.40 s 7.6 17 200.8 31.9 200.3 2.68 s 31.2 200.8 18 2.67 s 2.67 s 8-OH 13.35 s 13.29 s 13.33 s 10-OH 11.76 s 11.01 s 11.67 s a) Measured in chloroform-d. b) Measured in pyridine-d5. 102 31.4 3.1.7. Xanthones 3.1.7.1. Structure elucidation of compound PRAES-C27 Light yellow gum. 20 D + 1.07 (c= 2.152, CHCl3). IR spectrum (Appendix 214): IR (KBr) max cm-1: 3502 (OH), 1741 (C=O lactone), 1648 (C=C), 1270 (CO). Mass spectrum (Appendix 215): HR-ESI-MS (positive mode) m/z: 639.1710 [M+H]+ (calcd. for C32H30O14+H, 639.1715). 1H, 13 C and DEPT NMR spectra (CDCl3) (Appendix 216, 217, 218): see Table 3.16. COSY, HSQC, HMBC and ROESY spectra (CDCl3) (Appendix 219, 220, 221, 222). Compound PRAES-C27 was obtained as light yellow gum. The HR-ESI-MS (positive mode) m/z 639.1710 [M+H]+ (calcd. 639.1715, corresponding to the molecular formula of C32H30O14). Analysis of 1H, 13 C, DEPT and HSQC spectra revealed that PRAES-C27 possessed two methoxy groups (C 53.3 and 53.7), two methyl carbons (C 14.9 and 18.0), four sp3 methines (C 29.3, 33.5, 77.0 and 82.7), three sp3 methylenes (C 36.3, 36.7 and 39.8), five carbonyl carbons (C 169.1, 170.3, 174.9, 187.2 and 194.1), two oxygenated quaternary carbons and fourteen olefinic or aromatic carbons. A comparison of the 1H and 13 C NMR data of PRAES-C27 with those of blennolide G [67] (Table 3.16) revealed a good compatibility, except for the 1H and 13 C chemical shift values and the coupling constant of some carbons, such as at C-5 (C 77.0), C-6 (C 29.3), C-7 (C 36.3), C-9 (C 82.7), C-10 (C 33.5) and C-11 (C 36.7) in PRAES-C27. All proton and carbon signals were assigned by COSY and HMBC experiments to formulate the planar structure of PRAES-C27 103 (Figure 3.32). These findings implied that PRAES-C27 was a planar isomer of blennolide G. The stereochemistry of PRAES-C27 was proposed based on the ROESY experiments as well as the comparison of the H, C values and the coupling constants of some protons. In the F ring of PRAES-C27, the diaxial conformation between the carbinolic hydrogen H-5 (H 3.92) and the methine hydrogen H-6 (H 2.42) was confirmed by the large coupling constant of J5,6 11.0 Hz. This value was also observed in eumitrin A2 [80]. Figure 3.32. COSY, HMBC and ROESY correlations of PRAES-C27 (CDCl3) 104 The ROESY correlations of H-5/H3-11 also supported the anti arrangement of H-5 and H-6. Moreover, the comparison of the chemical shift values of the C-5 (C 77.0) with another xanthone such as blennolide B, possessing a β-hydroxyl group at C-5 (C 77.0) showed good compatibility (Table 3.16) [79]. These comparisons led to the establishment of the orientations of the hydroxyl group at C5 and the methyl connected to C-6 in an anti arrangement (Figure 3.32). In the C ring of PRAES-C27, the comparison of H, C values and the coupling constants of protons showed that the spatial structure of PRAES-C27 did not suit to the one of Blennolide G but well resembled the one of chromone lactone 44 (Table 3.16) (Figure 3.32) [60]. Furthermore, the ROESY correlations of H-9 and H-10 supported that H-9 and H3-13 were located in an anti arrangement (Figure 3.32). These findings suggested that the stereochemistry of this moiety of PRAES-C27 was similar to the one of chromone lactone 44. Consequently, the relative stereochemistry of PRAES-C27 was proposed as shown. Compound PRAES-C27 was proved to be a new natural compound. This 20 compound was dextrorotatory, D + 1.07 (c= 2.152, CHCl3), therefore it was named (+)-praesorexanthone A. 105 Table 3.16. NMR data for PRAES-C27, Blennolide G, Blennolide B and Chromone lactone 44 (all in CDCl3) No. δH 1 2 3 4 4a 5 6 7 J (Hz) 7.52 6.63 d (8.5) d (8.5) 3.92 2.42 2.32 dd (11.0, 2.0) m dd (19.0, 10.5) dd (19.0, 6.0) 2.74 8 8a 9 9a 10a 11 Blennolide G[79] PRAES-C27 1.17 d (6.5) δC 159.4 117.8 141.3 107.7 158.4 77.0 29.3 36.3 177.7 101.6 187.2 106.9 84.8 18.0 δH J (Hz) 7.43 6.57 d (8.5) d (8.5) 4.13 2.12 2.40 s m dd (19.0, 6.2) 2.53 dd (19.0, 11.3) 1.18 d (6.9) Blennolide B[79] δC 159.4 118.3 139.6 107.6 157.3 71.3 28.5 32.6 179.9 99.9 187.6 107.0 84.8 17.5 106 δH J (Hz) 6.53 7.36 6.55 dd (8.3, 8.0) t (8.3) dd (8.2, 8.0) 3.92 2.41 2.30 dd (11.2, 2.6) m dd (19.1, 10.6) 2.74 dd (19.1, 6.2) 1.17 d (6.5) Chromone lactone 44[60] δC 162.1 110.7 138.0 107.9 158.8 77.0 29.3 36.3 177.5 101.7 187.1 107.2 84.7 18.0 δH J (Hz) δC No. δH 12 13 1-OH 5-OH 8-OH 2' 3' 4' 4'a 5' 6' 7' 8' 8'a 9' 10' 11' 12' 13' 14' 15' 5'-OH Blennolide G[79] PRAES-C27 3.73 11.75 2.92 13.77 3.20 3.28 J (Hz) s s br s s d (17.5) d (17.5) 7.45 6.62 d (8.5) d (8.5) 4.82 2.98 2.71 2.48 d (6.5) m dd (17.0, 8.0) dd (17.0, 7.5) 1.34 3.77 11.93 d (7.5) s s δC 170.3 53.3 84.4 39.8 194.1 107.5 159.2 118.1 140.2 107.3 158.3 82.7 33.5 36.7 174.9 14.9 169.1 53.7 δH 3.72 11.84 2.52 13.94 3.05 3.21 J (Hz) s s s s d (17.0) d (17.0) 7.53 6.62 d (8.5) d (8.5) 4.45 2.85 2.91 2.23 d (3.9) m dd (17.5, 9.4) dd (17.5, 4.3) 1.29 3.76 11.87 d (6.8) s s Blennolide B[79] δC 171.2 53.5 84.2 39.7 194.1 107.5 159.2 118.1 141.3 107.3 158.6 87.6 30.0 36.1 175.0 20.8 168.8 53.6 107 δH J (Hz) 3.69 11.22 s s 13.80 s Chromone lactone 44[60] δC δH J (Hz) δC 170.3 53.1 3.18 3.25 d (17.3) d (17.3) 6.54 7.41 6.55 dd (8.2, 0.9) t (8.3) dd (8.3, 0.8) 4.79 2.96 2.69 2.46 d (6.8) m dd (17.3, 8.3) dd (17.3, 7.9) 1.32 3.73 11.44 d (7.2) s s 84.3 39.8 193.9 107.5 161.9 110.5 139.0 107.5 158.8 82.7 33.4 36.7 174.8 14.8 169.0 53.6 3.1.7.2. Structure elucidation of compound PRAES-C28 Yellow gum. 21 D -2.17 (c= 1.861, CHCl3). IR spectrum (Appendix 223): IR (KBr) max cm-1: 3410 (OH), 1744 (C=O lactone), 1624 (C=C), 1248 (CO). Mass spectrum (Appendix 224): HR-ESI-MS (positive mode) m/z: 655.1660 [M+H]+ (calcd. for C32H30O15+H, 655.1664). 1H, 13 C and DEPT NMR spectra (CDCl3) (Appendix 225, 226, 227): see Table 3.17. COSY, HSQC, HMBC and ROESY spectra (CDCl3) (Appendix 228, 229, 230, 231). Compound PRAES-C28 was obtained as light yellow gum. The HR-ESI-MS with a pseudomolecular ion peak at m/z 655.1660 [M+H]+ (calcd. 655.1664, corresponding to the molecular formula of C32H30O15), showed that it possessed 16 atomic mass units more than the one of PRAES-C27. The spectral features of PRAES-C28 resembled those of PRAES-C27, suggesting it possessed the same polycyclic skeleton. The differences were accounted for the presence of a carbonyl carbon (C 198.8) instead of an oxygenated carbon at C-8 and the lack of a chelated hydroxyl proton of C8-OH as in PRAES-C27. These findings suggested that PRAES-C28 was a derivative of PRAES-C27. The substitution pattern of PRAES-C28 was confirmed by HMBC and ROESY correlations (Figure 3.33 and 3.34). In the F ring of PRAES-C28, there were marked differences in the chemical shift values of C-5, C-6, C-7, C-8, C-8a and C-9 comparing to the corresponding ones of PRAES-C27. The carbon C-8 was a carbonyl carbon and C-8a was a quaternary oxygenated carbon. However, the large coupling constants J5,6 10.5 Hz and significant ROESY cross peaks between H-5/H3-11 suggested that H-5 and H-6 108 were located in an anti arrangement but the configurations of C-5 and C-6 were reversed comparing to the corresponding ones in PRAES-C27 (Figure 3.33). Figure 3.33. ROESY correlations of PRAES-C28 In the B moiety, the comparison of the C values of chiral centers at C-9 (C 82.8), C-10 (C 33.5) and C-11 (C 36.8) of PRAES-C28 with the one of PRAES-C27 showed good compatibility (Table 3.17). These findings suggested the stereochemistry of PRAES-C28 as shown in Figure 3.33. The absolute configuration of C-8a was not established. Based on the negative specific rotation and the 2D NMR data, the stereochemistry of PRAESC28 was proposed as shown. PRAES-C28 was a new natural compound and was named (-)-praesorexanthone B. 109 Table 3.17. NMR data for PRAES-C27, PRAES-C28 (CDCl3) No. 1 2 3 4 4a 5 6 7 8 8a 9 9a 10a 11 12 13 1-OH 5-OH 8-OH 8a-OH 2' 3' 4' 4'a 5' 6' 7' 8' 8'a 9' 10' 11' 12' 13' 14' 15' 5'-OH PRAES-C27 δH J (Hz) 7.52 d (8.5) 6.63 d (8.5) 3.92 2.42 2.32 2.74 dd (11.0, 2.0) m dd (19.0, 10.5) dd (19.0, 6.0) 1.17 d (6.5) 3.73 11.75 2.92 13.77 s s br s s 3.20 d (17.5) 3.28 d (17.5) 7.45 d (8.5) 6.62 d (8.5) 4.82 2.98 2.71 2.48 d (6.5) m dd (17.0, 8.0) dd (17.0, 7.5) 1.34 d (7.5) 3.77 s 11.93 s δC 159.4 117.8 141.3 107.7 158.4 77.0 29.3 36.3 177.7 101.6 187.2 106.9 84.8 18.0 170.3 53.3 84.4 39.8 194.1 107.5 159.2 118.1 140.2 107.3 158.3 82.7 33.5 36.7 174.9 14.9 169.1 53.7 110 PRAES-C28 δH J (Hz) 7.48 d (8.5) 6.67 d (8.5) 4.51 2.06 2.49 2.97 br d (10.5) m dd (15.0, 5.0) m 1.22 d (6.5) 3.67 s 11.68 s 2.80 br s 4.94 br s 3.19 d (17.0) 3.28 d (17.0) 7.54 d (8.5) 6.58 d (8.5) 4.82 2.97 2.72 2.48 d (7.0) m dd (17.0, 8.0) dd (17.0, 7.5) 1.32 d (7.5) 3.75 s 11.88 s δC 160.6 118.4 141.2 107.4 157.6 74.0 32.1 43.5 198.8 89.5 191.9 106.6 71.9 18.5 167.9 53.5 84.4 39.7 194.2 107.5 159.1 117.5 141.4 107.3 158.5 82.8 33.5 36.8 175.1 14.9 169.0 53.7 Figure 3.35. COSY and HMBC correlations of PRAES-C28 3.1.8. Triterpenoids 3.1.8.1. Structure elucidation of compound PRAES-E17 White powder. 1H and 13C NMR spectra (pyridine-d5) (Appendix 232, 233): see Table 3.18. HSQC and HMBC spectra (pyridine-d5) (Appendix 234, 235). Compound PRAES-E17 was a hopane skeleton triterpenoid. The 13C, DEPT NMR spectra permitted differentiating the 30 carbons of PRAES-E17 into eight methyls, ten methylenes, six methines and six quaternary carbons. Characteristic NMR data (Table 3.19) for eight tertiary methyls were [ H/C 0.91/16.4 (C-28), 0.93/17.5 (C-25), 1.00/17.3 (C-27), 1.09/18.5 (C-26), 1.29/22.6 111 (C-24), 1.35/29.8 (C-29), 1.39/31.4 (C-30), 1.56/37.3 (C-23)]. On the base of the HMBC and HSQC spectra, the proton signal at H 2.38 (H-21) showed cross-peaks with the signals at C 54.7 (C-17), 44.3 (C-18), 27.0 (C-20), and 72.5 (C-22). The exact location of all substituted groups were established based on 2D NMR (Figure 3.35). The comparison of these spectroscopic data of compound PRAES-E17 with those of zeorin in the literature [19] showed good compatibility. Therefore, PRAES-E17 was hopan-6,22-diol or zeorin. 3.1.8.2. Structure elucidation of compound PRAES-E6 White powder. 1H and 13C NMR spectra (CDCl3) (Appendix 236, 237): see Table 3.18. 112 The spectral data of compound PRAES-E17 and PRAES-E6 were similar, with a remark that PRAES-E6 lacked the hydroxyl group at C-6. Analysis of the 1D NMR spectral data and the comparison of these data with the ones in the literature suggested that compound PRAES-E6 was hopan-22-ol [33]. 3.1.8.3. Structure elucidation of compound PRAES-E13 White amorphous powder. Mass spectrum (Appendix 238): HR-ESI-MS (positive mode) m/z 581.3763 ([M+Na]+, (calcd. for C34H54O6+Na, 581.3813). 1H, 13 C and DEPT NMR spectra (CDCl3) (Appendix 239, 240, 241): see Table 3.18. COSY, HSQC and HMBC spectra (CDCl3) (Appendix 242, 243, 244). Compound PRAES-E13 was a white amophous powder. The HR-ESI-MS (positive mode) showed a molecular ion peak at m/z 581.3763 [M+Na]+ indicative of a molecular formula of C34H54O6. The comparison of NMR data of PRAES-E13 and PRAES-E6 showed good similarity suggesting that both compounds possessed the same triterpenoic framework. However, the comparison of the 13C NMR data of PRAES-E13 with the ones of PRAES-E6 showed that PRAES-E13 exhibited two further acetoxy groups at C 170.1 (C-1‟), 21.7 (C-2‟), 170.4 (C-1‟‟), 21.1 (C-2‟‟), one carboxyl group at C 182.1 but lacked a methyl group. This was supported by the HMBC experiments 113 with the correlations of the protons H-1 (H 4.67) to C-1‟ (C 170.1) and of H-3 (H 4.59) to C-1‟‟ (C 170.4). The HMBC spectrum also showed that the doublet methyl proton signal at H 1.14 (H-30) and the methine proton signal H 2.33 (H-22) correlated with the carboxyl carbon C-29 (C 182.1) and C-30 (C 17.7), respectively. The exact location of all substituted functional groups were established based on 2D NMR (Figure 3.36). In the 1H NMR spectrum, the large coupling constants of H-1 and H-3 as well as the comparison of 13 C spectral features for PRAES-E13 with the one of 1,3-diacetoxyhopan-22-ol in the literature [35] suggested that the two acetoxy groups at C-1 and C-3 were -orientated (Table 3.18). These spectroscopic data proposed that compound PRAES-E13 was 1,3-diacetoxyhopan-29-oic acid and was identified as a new natural compound from the lichens. 114 Table 3.18. NMR data of PRAES-E17, PRAES-E6, PRAES-E13 and 1,3-diacetoxyhopan-22-ol No . PRAES-E17(b) δH J (Hz) PRAES-E6(a) 1 δC 40.7 2 19.0 3 4 5 6 7 8 9 10 11 44.4 34.1 61.2 67.9 45.8 43.0 50.3 39.4 21.4 4.20 dt (4.5, 10.0) 1.80 m δH 1.64 0.96 1.66 1.47 1.30 J (Hz) m m m m m 0.78 bd(14.0) 1.38 m 1.42 m 1,57 m PRAES-E13(a) δC 41.4 δH J (Hz) 4.67 dd (11.0, 4.5) δC 80.3 1,3-diacetoxyhopan22-ol(a) δC 80.3 20.1 1.89 m 1.65 m 4.59 dd (12.5, 4.5) 30.0 30.0 76.4 37.8 52.8 17.8 33.0 42.2 50.7 42.2 22.9 76.4 37.8 52.8 17.7 32.9 42.3 50.7 42.2 23.0 45.4 32.7 56.3 18.9 33.4 42.1 51.6 38.0 24.3 115 0.77 m 1.49 m 12 13 14 15 16 17 18 19 24.4 49.8 42.2 34.7 22.3 54.7 44.3 41.7 20 21 22 23 24 25 26 27 28 29 30 1‟ 2‟ 1‟‟ 2‟‟ 27.0 51.6 72.5 37.3 22.6 17.5 18.5 17.3 16.4 29.8 31.4 2.38 q (11.0) 1.56 1.29 0.93 1.09 1.00 0.91 1.35 1.39 s s s s s s s s 1.40 m 1.49 m 1.45 m 1.93 bd(12.5) 1.47 m 1.64 0.96 1.77 2.22 m m m m 0.89 0.96 0.87 0.96 0.96 0.87 1.18 1.21 s s s s s s s s 24.6 50.5 42.1 34.6 22.1 54.1 44.3 41.5 26.7 51.3 74.1 33.6 22.1 16.4 17.1 17.1 16.4 31.2 28.9 1.32 m 1.25 m 1.91 2.37 2.33 0.84 0.84 1.00 0.95 0.91 0.79 m m m s s s s s s 1.14 d (6.0) 1.97 s 2.02 a) Measured in chloroform-d b) Measured in pyridine-d5 116 s 23.8 48.7 42.0 33.4 19.8 53.7 44.3 40.9 24.0 49.3 41.9 34.5 21.9 53.9 43.9 41.2 26.6 42.6 42.0 27.9 16.1 12.9 16.9 16.5 15.7 182.1 17.7 170.1 21.7 170.4 21.1 26.6 51.1 73.9 27.8 16.9 12.8 16.0 16.9 16.1 28.7 30.9 170.0 21.0 170.2 21.7 3.1.9. MACROCYCLIC COMPOUND 3.1.9.1. Structure elucidation of compound PRAES-E15 Colorless oil. Mass spectrum (Appendix 245): HR-ESI-MS (positive mode) m/z 695.3667 [M+Na]+ (calcd. for C34H56O13+Na, 695.3621). 1H, 13 C and DEPT NMR spectra (CDCl3) (Appendix 246, 247, 248): see Table 3.21. COSY, HSQC and HMBC spectra (CDCl3) (Appendix 249, 250, 251). Compound PRAES-E15 was isolated as a colorless oil. The HR-ESI-MS spectrum of compound PRAES-E15 showed a pseudomolecular ion peak at m/z 695.3667 [M+Na]+ (calcd. 695.3621), corresponding to the molecular formula of C34H56O13. The 1H NMR spectrum displayed signals for eight methyl doublets at H 0.73 (14-CH3), 0.85 (4-CH3), 0.87 (6-CH3), 0.92 (16-CH3), 1.01 (12-CH3), 1.04 (2-CH3), 1.20 (19-CH3) and 1.35 (9-CH3), four acetoxy groups at H 2.03, 2.04, 2.06 and 2.10 (3H each, s), six methylene protons H 0.96, 1.76 (m, H2-5), 0.98, 1.50 (m, H2-15) and 1.55, 1.62 (m, H2-17) and thirteen methine protons at H 1.55, 1.81, 1.88, 2.00, 2.59, 2.95, 3.78, 4.70, 4.86, 5.02, 5.09, 5.25, 5.34 (1H each) (Table 3.21). The 13C, DEPT NMR spectra showed the resonances of 34 carbons including eight methyl groups (C 13.5, 13.8, 14.0, 14.5, 15.2, 15.8, 17.7 and 20.7), four methyl ester groups [C 20.8, 170.7 (7-OCOCH3), 21.1, 170.5 (8-OCOCH3), 20.9, 170.1 (13-OCOCH3) and 20.8, 170.2 (18-OCOCH3)], two carboxyl carbons group (C 172.7 and 177.2), three methylene carbons (C 35.0, 36.8 and 40.5) and thirteen methine carbons, seven of which were oxygenated. Analysis of the COSY spectra (Figure 3.37) for PRAES-E15 revealed that H-2 (δH 2.59) correlated with H-3 (δH 3.78) as well as with the methyl group 2-CH3 117 (δH 1.04). The COSY data, in combination with HSQC data, also revealed correlations of 4-CH3 (δH 0.85) with H-4 (δH 1.81), H-4 with H-5 (δH 0.96 and 1.76), H-5 with H-6 (δH 2.00), H-6 with H-7 (δH 4.86) as well as with the methyl protons 6-CH3 (δH 0.87), H-7 with H-8 (δH 5.34), H-8 with H-9 (δH 5.25) and H-9 with 9CH3 (δH 1.35). The observation of the COSY spectrum also revealed the connectivity from 12-CH3 to 19-CH3. Briefly, the COSY spectrum revealed the correlations from 12CH3 (δH 1.01) with H-12 (δH 2.95), H-12 with H-13 (δH 4.70), H-13 with H-14 (δH 1.88), H-14 with H-15 (δH 0.98 and 1.50), H-15 with H-16 (δH 1.55), H-16 with H17 (δH 1.62), H-17 with H-18 (δH 5.09), H-18 with H-19 (δH 5.02) and H-19 with 19-CH3 (δH 1.20). These spectroscopy data (Table 3.19) as well as comparison of these data with those previously reported by Polborn et al. [59] proposed that compound PRAES-E15 was a macrocyclic bis-lactone. The position of functional groups of compound PRAES-E15 was determined by analysis of 2D NMR spectra (COSY, HSQC and HMBC) as shown in Figure 3.37. Figure 3.37. COSY and HMBC correlations of PRAES-E15 118 The HMBC spectrum for compound PRAES-E15 revealed correlations from methyl protons 7-OCOCH3 (δH 2.10) to carboxyl carbon at δC 170.7 (7-OCOCH3) and methine carbon C-7 (δC 77.0), from 8-OCOCH3 (δH 2.03) to carboxyl carbon at δC 170.5 (8-OCOCH3) and C-8 (δC 72.6), from 13-OCOCH3 (δH 2.04) to carboxyl carbon at δC 170.1 (13-OCOCH3) and C-13 (δC 80.0), and from 18-OCOCH3 (δH 2.06) to carboxyl carbon at δC 170.2 (18-OCOCH3) and C-18 (δC 73.5), indicated that four acetoxy groups located at C-7 (C 80.8), C-8 (C 72.6), C-13 (C 80.0) and C-18 (C 73.5). HMBC observations from H-9 (δH 5.25) to C-11 (δC 172.7) as well as from H-19 (δH 5.02) to C-1 (δC 177.2) suggested that the structure of compound PRAES-E15 was as shown. Consequently, the structure of compound PRAES-E15 was assigned to be 7,8,13,18-tetraacetoxy-3-hydroxy-2,4,6,9,12,14,16,19-octamethyl-10,20-dioxa1,11-dioxoycloicosane or praesbislactone. The absolute configuration of PRAESE15 has not yet been determined. 119 Table 3.19: NMR data of compound PREAS-E15 (CDCl3) PRAES-E15 No. δH J (Hz) 1 PRAES-E15 No. δC 177.2 11 δH J (Hz) δC 172.7 2 2.59 dq (10.0, 7.0) 44.0 12 2.95 qd (7.0, 2.5) 41.0 3 3.78 dd (10.0, 4.0) 73.1 13 4.70 brd (8.5) 80.0 4 1.81 m 30.6 14 1.88 m 32.0 5 0.96 m 36.8 15 0.98 m 40.5 1.76 m 1.50 m 6 2.00 m 31.1 16 1.55 m 25.7 7 4.86 dd (10.0, 3.0) 77.0 17 1.55 m 35.0 1.62 m 8 5.34 brs 72.6 18 5.09 td ( 9.0, 2.5) 73.5 9 5.25 qd (6.5, 2.0) 69.7 19 5.02 dq ( 9.0, 6.5) 70.9 9-CH3 1.35 d (6.5) 15.8 19-CH3 1.20 d (6.5) 17.7 2-CH3 1.04 d (7.0) 13.8 12-CH3 1.01 d (7.0) 14.0 4-CH3 0.85 d (6.5) 13.5 14-CH3 0.73 d (6.5) 14.5 6-CH3 0.87 d (6.5) 15.2 16-CH3 0.92 d (6.5) 20.7 7-OCOCH3 7-OCOCH3 2.10 s 8-OCOCH3 8-OCOCH3 2.03 s 170.7 13-OCOCH3 20.8 13-OCOCH3 170.5 18-OCOCH3 21.1 18-OCOCH3 170.1 2.04 s 20.9 170.2 2.06 s 20.8 3.2. BIOLOGICAL ASSAY 3.2.1. Cytotoxic activity against three cancer cell lines Samples of 12 new and 3 known compounds (at the concentration of 100 µg/mL) were tested the cytotoxic activity against three cell lines: MCF-7 (breast cancer cell line), HeLa (cervical cancer cell line) and NCI-H460 (human lung cancer cell line) by sulforhodamine B colorimetric assay method (SRB assay) [71]. 120 Every sample was tested three times. The cytotoxic activity of these compounds, expressed as a percentage of cell growth inhibition (I%), was presented in Table 3.22. In general, any tested compound with a percentage of inhibition higher than 50% may be potential anticarcinogen and was then be determined the IC50 value. The results showed that 4-O-demethylbarbatic acid (58), sekikaic acid (59) and praesorether G (67) performed good inhibitive activity on all three cell lines with %I about 7080%. The IC50 values on three cell lines of praesorether G (67) were smaller than the one of sekikaic acid (59) (Table 3.20 and 3.21). Especially, the IC50 value of praesorether G (67) against MCF-7 cells was 17.9 µg/mL (Table 3.23). It indicated that praesorether G (67) may be potential inhibitor against MCF-7, HeLa and NCI-H460 cell lines 3.2.2. Acetylcholinesterase inhibitory activity Anti–AChE activity of isolated compounds was determined by Ellman‟s method with galanthamine as the positive control [28]. The results were presented in Table 3.22. The tested results showed that all the extracts and isolated compounds from the lichen Parmotrema praesorediosum had no effect on acetylcholinesterase. 121 Table 3.20 : % Inhibition of cytotoxic activity against three cancer cell lines of isolated compounds Compounda) No. Inhibition of Cell Growth (I %) HeLa NCIH460 MCF-7 40.30.5b) 39.34.0 52.52.3 1 Vinapraesorediosic acid A (43) 2 6-Methyl vinapraesorediosate A (44) 13.56.7 22.02.4 25.310.9 3 Vinapraesorediosic acid B (45) 17.01.1 -4.11.3 26.84.9 4 Praesorediosic acid (1) 0.30.1 -1.90.9 -3.71.4 5 6-Methyl praesorediosate (46) 2.32.0 4.92.5 5.70.2 6 Vinapraesorediosic acid C (47) -6.41.8 -12.95.1 -3.33.7 7 -3.82.2 -5.54.9 9.73.9 8 1,3-Diacetoxyhopan-29-oic acid (75) Praesbislactone (76) -1.60.7 1.70.3 1.90.3 9 Praesalide B (53) 6.91.4 16.03.2 8.74.1 10 Praesoreusimine (70) 18.93.4 6.00.1 3.71.2 11 Praesorether A (62) 38.51.0 9.32.0 25.02.3 12 Praesorether F (35) 29.092.4 36.46.4 25.10.9 13 Praesorether G (67) 79.91.4 74.02.5 72.81.8 14 Sekikaic acid (59) 79.51.7 77.04.1 81.51.6 15 4-O-Demethylbarbatic acid (58) 88.53.3 79.11.1 81.51.4 58.23.3 77.60.6 41.22.4 Camptothecin (positive control) c) a) The compounds were tested at the concentration of 100 μg/mL. b) The presented data are means of three experiments ± S.D. c) Camptothecin was tested at the concentration of 0.01 μg/mL for MCF-7 and NCI-H 460 and of 1 μg/mL for HeLa. Table 3.21 : IC50 of cytotoxic activity against three cancer cell lines of Praesorether G (67) and Sekikaic acid (59) No. Compound IC50 (µg/mL) HeLa NCI-H460 MCF-7 1 Praesorether G (67) 22.54.7 21.42.1 17.90.8 2 Sekikaic acid (59) 53.44.1 48.85.4 44.15.4 122 Table 3.22. : Acetylcholinesterase inhibition of isolated compounds on acetylcholinesterase No. Compound Concentration (mg/mL) 1.0 0.5 0.25 1 Methyl haematommate (9) -7.5 -7.2 -5.3 2 Butyl haematommate (49) -7.9 -6.8 -5.7 3 Atranorin (11) -8.7 -7.9 -6.9 4 Methyl -orsellinate (8) -7.2 -7.0 -5.1 5 Atranol (50) -6.4 -6.6 -4.6 6 Methyl chlorohaematommate (48) -7.4 -6.5 -5.1 7 Methyl divaricatinate (51) -7.7 -6.6 -5.4 8 (+)-(12R)-Isousnic acid (69) -7.8 -7.7 -6.5 9 (+)-(12R)-Usnic acid (40) -8.3 -7.6 -6.2 10 Methyl orsellinate (8) -7.0 -6.4 -5.1 11 1,3-Diacetoxyhopan-29-oic acid (75) -7.9 -7.9 -7.4 12 6-Methyl vinapraesorediosate A (44) -8.5 -5.7 -5.7 13 Zeorin (Hopan-6α,22-diol) (74) -9.9 -8.8 -7.6 14 Praesorether A (62) -8.3 -6.7 -6.8 15 6-Methyl praesorediosate (46) -8.1 -5.9 -5.6 16 Vinapraesorediosate A (43) -8.6 -6.1 -5.5 17 Vinapraesorediosic acid C (47) -8.3 -5.9 -5.6 123 CHAPTER 4 CONCLUSION 4.1. CONSTITUENTS OF PARMOTREMA PRAESOREDIOSUM The chemical investigation of the lichen Parmotrema praesorediosum growing in Vietnam led to the isolation of forty compounds, including twenty two new compounds. Among eighteen known compounds, twelve compounds were known for the first time from the genus Parmotrema. The chemical structure of isolated compounds was determined by a combination of spectroscopic and chemical methods, as well as comparing with the ones in the literature. Aliphatic acids: Except for (+)-praesorediosic acid (1), the other five aliphatic acids (43-47) have not been reported. The five new aliphatic acids (43-47) possessed the same γ-lactone skeleton as (+)-praesorediosic acid (1). These compounds were obtained as major lichen substances from the thallis of Parmotrema praesorediosum. These results were suitable for previous phytochemical studies on this lichen by Krog H. [40]. Mononuclear phenolic compounds: Twelve compounds (5, 8-9, 48-55, 57) were isolated including seven known (5, 8-9, 48-51), three new phtalic acids (52-54) and two new mononuclear phenolic compounds (55, 57). The phtalic acids derived from polyketide pathway constituted a relatively rare group of lichen, only one product known prior to the present work. Depsides: Four known depsides were isolated (11, 15, 58, 59). They are the most typical aromatic polyketides. Depsidones: Two known compounds (60-61) was also isolated. Diphenyl ether: Although diphenyl ethers was a relatively rare group of lichens, the investigation of the chloroform extract of the lichen Parmotrema praesorediosum yielded eight compounds (35, 62-68) with only one known (35) and seven new compounds (62-68). With the single exception of 124 PRAES-C5 (62), the other diphenyl ethers (35, 63-68) possessed the same skeleton with the two isolated depsidones (60-61). These results suited to the biosynthesis pathway [13]. Huneck S. [27] revealed that the diphenyl ethers were sometimes referred as „pseudodepsidones‟ due to their apparent biosynthetic relationship therefore they could contain the same or similar monoaromatic units. Dibenzofurans: Dibenzofurans were the third most abundant group of coupled phenolics in lichens after depsides and depsidones. The chemistry and biosynthesis of usnic acid and its derivative have been well-studied due to their interesting structure, high yeild lichens and possessed various biological activities. Up to this point, this present work also obtained three compounds of dibenzofuran group (40, 69, 70), including two known (40, 69) and one new compound (70). Xanthones: From the chloroform extract of Parmotrema praesorediosum, two new xanthones (71-72) were isolated. Xanthones were the most typical compound in Usnea genus, but not from the lichen Parmotrema genus. Triterpenoids Three hopan skeleton triterpenoids (73-75), including one new (75) and two known compounds (73, 74) were isolated from this lichen. They are the first triterpenoids reported in Parmotrema genus. Macrocyclic compound: One new macrocyclic compound (75) was isolated from the petroleum ether extract of the thallis lichen Parmotrema praesorediosum. 125 Group 1: Aliphatic acids (six compounds, five new compounds and one known compound) 126 Group 2: Mononuclear phenolic compounds (twelve compounds, five new compounds and seven known compounds). 127 Group 3: Depsides (four known compounds). Group 4: Depsidones (two known compounds). Group 5: Diphenyl ether (eight compounds, seven new compounds and one known compound). 128 129 Group 6: Dibenzofurans (three compounds, one new compound and two known compounds). Group 7: Xanthones (two new compounds). 130 Group 8: Triterpenoids (three compounds, one new compound and two known compounds). Group 9: Macrocyclic compound (one new compound). 131 4.2. BIOLOGICAL ASSAY 4.2.1. Cytotoxicity Fifteen compounds isolated from Parmotrema praesorediosum were tested the cytotoxic activity against three cancer cell lines: MCF-7, HeLa and NCI-H460 by SRB assay method. The result showed that phenolic compounds exhibited antiproliferative effect against several lympho cell lines. Example for two depsides 4-O-demethylbarbatic acid (58), sekikaic acid (59) and one diphenyl ether praesorether G (67) performed strong inhibitive activities on all three cell lines. The other skeletons as aliphatic acids, macrocyclic compound or triterpenoids showed no cytotoxic activity against three surveyed cancer cell lines. This results has been previously reported that numerous lichens contain various phenolic components with anticancer activity including usnic acid, lecanoric acid, gyrophoric acid, salazinic acid, lobaric acid, evernic acid, and vulpinic acid [11, 13]. Further, it has also been suitable for phenolics arrest the cell cycle and activate apoptotic signal transduction pathways in cancerous cells [1]. 4.2.2. In vitro acetylcholinesterase inhibition activity Seventeen pure compounds isolated from Parmotrema praesorediosum were in vitro tested the inhibition against acetylcholinesterase. The results showed that all the tested samples had no effect on acetylcholinesterase 132 FUTURE OUTLOOK Studying the chemical constituents of the remaining extracts of Parmotrema praesorediosum, including ethyl acetate extract (50.0 g), acetone extract (45.0 g) and methanol extract (37.0 g) (Figure 4.1). Preparation of some derivatives from isolated aliphatic acids Testing the biological activity on other types of cancer cell lines and some other inhibitory activities of isolated compounds and derivatives. 133 LIST OF PUBLICATIONS 1. HUYNH BUI LINH CHI, DUONG THUC HUY, TAKAO TANAHASHI, NGUYEN KIM PHI PHUNG, Contribution to the study on chemical constituents of the lichen Parmotrema praesorediosum (Nyl.) Hale, Parmeliaceae, Vienam Journal of Chemistry, 48(4B), 332-337 (2010). 2. HUYNH BUI LINH CHI, DUONG THUC HUY, HA XUAN PHONG, TAKAO TANAHASHI, NGUYEN KIM PHI PHUNG, Two new compounds from the lichen Parmotrema praesorediosum (Nyl.) Hale, Parmeliaceae, Journal of Science and Technology. 49(5B), 430-435 (2011). 3. HUYNH BUI LINH CHI, DUONG THUC HUY, TUONG LAM TRUONG, HA XUAN PHONG, TAKAO TANAHASHI, NGUYEN KIM PHI PHUNG, A new diphenyl ether from the lichen Parmotrema praesorediosum (Nyl.) Hale, Parmeliaceae, Proceeding of the 3rd International Conference on Analytical Sciences and Life Science, 309 – 312 (2013). 4. HUYNH BUI LINH CHI, TUONG LAM TRUONG, TAKAO TANAHASHI, NGUYEN KIM PHI PHUNG, A new macrocylic compound from the lichen Parmotrema praesorediosum (Nyl.) Hale, Parmeliaceae, Journal of Science and Technology. 52(5A), 150-155 (2014). 134 REFERENCES [1] Agullo G., Gamet-Payrastre L., Manenti S., Viala C., Remesy C. (1997), “Relationship between flavonoid structure and inhibition of phosphatidylinositol-3-kinase and protein kinase C inhibition.”, Biochem Pharmalcol, 53, 1649-1657. [2] Ahmadjian V., Nilsson S. (1963), Swedish Lichens.Yb.Am.Swed.Hist.Fdn. [3] Ana C. M., Beatriz A., Lima E. P., Honda N. K. (2009), “Chemical constituents of Parmotrema lichexanthonicum Eliasaro & Adler – Isolation, structure modification and evaluation of antibiotic and cytotoxic activities”, Química Nova, 32, 12-20. [4] Balaji P., Hariharan G. N. (2007), “In vitro antimicrobial activity of Parmotrema praesorediosum thallus extracts”, Research Journal of Botany, 2, 54-59. [5] Barrington E. J. W., Willis A. J (1974), The biology of lichens: Contemporary biology, 2nd edition, Edward Arnold, London. [6] Behera B. C, Verma N., Sonone A., Markhija U. (2008), “Antioxidant and antibacterial properties of some cultured lichens”, Bioresource Technology, 99, 776-784. [7] Bodo D., Molho D. (1980), “Structure des acides isomuronique et neuropogolique, nouveaux acides aliphatiques du lichen Neuropogon trachycarpus”, Phytochemistry, 19, 1117–1120. [8] Bogo D., Fatima Cepa Matosa M., Honda N. K, Pontes E. C., Oguma P. M., Santos E. C. S, Carvalho J. E., Nomizoe A. (2010), “In vitro antitumour activity of Orsellinates”, Zeitschrift für Naturforschung C: A Journal of Chemical Sciences, 65, 43-48. 135 [9] Brandão L. F., Alcantara G. B., Matos Mde F., Bogo D., Freitas Ddos S., Oyama N. M., Honda N. K. (2013), “Cytotoxic evaluation of phenolic compounds from lichens against melanoma cells”, Chemical & Pharmaceutical Bulletin, 61, 176-183. [10] Bruchner E, Curtius T. (1885), "Synthese von ketonsäureäthern aus aldehyden und diazoessigäther". Berichte der Deutschen Chemischen Gesellschaft, 18, 2371–2377. [11] Bucar F., Schneider I., Ogmundsdottier H., Ingolfsdottir K. (2004), “Antiproliferative lichen compounds with inhibitory activity on 12(S)-HETE production in human platelets.”, Phytomedicine, 11, 602-606. [12] Bugni T. S., Andjelic C. D., Pole A. R., Rai P., Ireland C. M., Barrows L. R. (2009), “Biologically active components of a Papua New Guinea analgesic and anti-inflammatory lichen preparation”, Fitoterapia, 80, 270-273. [13] Burlando B., Ranzato E., Volante A., Apprendino G., Pollastro F. (2009), “Antiproliferative effects on tumour cells and promotion of keratinocyte wound healing by different lichen compounds”, Planta Medica, 75, 607-613. [14] Chauhan R., Abraham J. (2013), “In vitro antimicrobial potential of the lichen Parmotrema sp. extracts against various pathogens.”, Iranian Journal Basic Medicine Science, 16, 882-885. [15] Chester D. O., Elix J. A (1980), “A new dibenzofuran and diphenyl ether from the lichen Gymnoderma melacarplcm”, Australian Journal of Chemistry, 33, 1153-1156. [16] Choudhary M. I., Ali M., Wahab A. T., Khan A., Rasheed S., Shyaula S. L., Rahman A. U. (2011), “New antiglycation and enzyme inhibitors from Parmotrema cooperi”, Science China Chemistry, 54, 1926-1931. 136 [17] Choudhary M. I., Jalil A. S., Atta-ur-Rahman (2005), “Bioactive phenolic compounds from a medicinal lichen, Usnea longissima”, Phytochemistry, 66, 2346-2350. [18] Comber M. F, Sargent M. V., Skelton B. W., White A. H. (1989), “Depsidone synthesis. Part 24. The synthesis of epiphorellic acid 2. A pseudodepsidone and X-ray crystal structure of a grisadienedione epoxide”, Journal of the Chemical Society, Perkin Transactions, 1, 441-448. [19] Cuellar M., Cruslhot W., Rubio C. , Soto C., Espinoza L., Carrasco H.(2008), “Phenolics, depsides and tridepsides from the Chilean lichen Pseudocyphellaria nudata (Zahlbr.) D. J. Galloway”, Journal of the Chilean Chemical Society, 53, 1624-1625. [20] David F., Elix J. A., Binsamsudin M. W. (1990), “Two new aliphatic acids from the lichen Parmotrema praesorediosum (Nyl.) Hale”, Australian Journal of Chemistry, 43, 1297-1300. [21] Divakar P. K., Upreti D. K. (2005), Parmelioid lichens in India (A revisionary study), 295-397, Bishen Singh Mahendra Palsingh, India. [22] Duong T. H., Huynh B. L. C., Ha X. P., Ton T. Q., Nguyen K. P. P (2011), “Some phenolic compounds of lichen Parmotrema planatilobatum (Hale.) Hale, Parmeliaceae”, Vietnam Science and Technology Development Journal, 14 (6), 5-11. [23] Duong T. H., Huynh B. L. C., Ha X. P., Tuong L. T., Ton T. Q., Boustie J., Nguyen K. P. P (2012), “New diphenylether from lichen Parmotrema planatilobatum (Hale.) Hale, Parmeliaceae”, Vietnam Journal of Chemistry, 50 (4A), 199-202. [24] Elix J. A., Engkaninan U., Jones A. J., Raston C. L., Sargent M. V., White A. H. (1978), “Chemistry and crystal structure of Leprolomin, a novel diphenyl 137 Ether from the lichen Psoroma leprolomum”, Australian Journal of Chemistry, 31, 2057-2068. [25] Fazio A. T., Bertoni M. D., Adler M. T. (2009), “Culture studies on the mycobiont isolated from Parmotrema reticulatum (Taylor) Choisy: metabolite production under different conditions”, Mycological Progress, 8(4), 359-365. [26] Franko-Filipasic B. R., Township M., County B. (1967), “Synthesis of 2,2dimethyl-7-benzofuranol”, United State Patent Office, 436279, 1-3. [27] Gabriele M. K., Anthony D. W. (1999), “1H and 13 C-NMR and biological activity investigations of four lichen-derived compounds”, Phytochemical Analysis, 10, 279-284. [28] George L. E., Courtney D. K., Andres V. JR., Featherstone R. M. (1961), “A new and rapid colorimetric determination of acetylcholinesterase activity”, Biochemical Pharmacology, 7, 88-95. [29] Ghate N. B.., Chaudhuri D., Sarkar R., Sajem A. L., Panja S., Rout J., Mandal N. (2013), “An antioxidant extract of tropical lichen, Parmotrema reticulatum, induces cell cycle arrest and apoptosis in breast carcinoma cell line MCF-7”, Indian Institute of Toxicology Reserach, 8, 1-14. [30] Gomes A. T., Honda N. K., Roese F. M., Muzzi R. M., Sauer L. (2006), “Cytotoxic Activity of Orsellinates”, Zeitschrift für Naturforschung C: A Journal of Chemical Sciences, 61, 653-657. [31] Hamada N., Ueno T. (1987), “Depside from an isolated lichen mycobiont”, Agricultural and Biological Chemistry, 51, 1705-1706. [32] Honda N. K., Pavan F. R., Coelho R. G., AndradeLeite S. R., Micheletti A.C., Lopes T. I. B., Misutsu M. Y., Beatriz A., Brum R. L., Leite C. Q. F. (2010), “Anticobacterial activity of lichen substances”, Phytomedicine, 17, 328-332. 138 [33] Hoshino T., Nakano S., Kondo T., Sato T., Miyoshi A. (2004), “Squalenehopene cyclase: final deprotonation reaction, conformational analysis for the cyclization of (3R,S)-2,3-oxidosqualene and further evidence for the requirement of an isopropylidene moiety both for initiation of the polycyclization cascade and for the formation of the 5-membered E-ring”, Organic & Biomolecular Chemistry., 2, 1456-1470. [34] Huneck S. (2001), New Results on the Chemistry of Lichen Substances. Springer, New York. [35] Huneck S., Preiss A., Schmidt J., Mendez A. M. (1983), “3β-Acetoxyhopan1β, 22-diol, a triterpen from the lichen Pseudoparmelia texana”, Phytochemistry, 9, 2027-2030. [36] Huneck S., Schmidt J. (1989), “Thermal decomposition of lichen depsides”, Zeitschrift für Naturforschung B: A Journal of Chemical Sciences, 44b, 1283-1289. [37] Huneck, S., Tabacchi, R. (1987), “-Ester of depsidones with a lactole ring” Phytochemistry, 26, 1131-1138. [38] Huneck S., Yoshimura I. (1996), Identification of lichen substances, Springer, Berlin, Heidelberg, New York. [39] Jayalal U., Divakar P. K., Joshi S., Oh S., Koh Y. K, Hur J. S. (2013), “The lichen genus Parmotrema in South Korea”, Mycobiology, 41(1), 25-36. [40] Javaprakasha G. K., Rao L. J. (2000), “Phenolic constituents from the lichen Parmotrema stuppeum (Nyl.) Hale and their antioxidant activity”, Zeitschrift für Naturforschung C: A Journal of Chemical Sciences, 55, 1018-1022. [41] Javeria S., Shahi S. K., Shahi M. P., Uperti D. K. (2013), “Parmotrema nilgherrense: potential antimicrobial activity against drug resistant pathogens”, International Journal of Microbial Resource Technology, 2, 3640. 139 [42] Karunaratne V. (1999), “Lichen substances: Biochemistry, ecological role and economic uses”, Ceylon Journal of Science: Physical Sciences, 6(1),1328. [43] Karunaratne V., Bombuwela K., Kathirgamanathar S., Thadhani V. M. (2005), “Lichen: A chemically important biota”, Journal of the National Science Foundation of Sri Lanka, 33(3), 169-186. [44] Keogh M. F. (1977), “Malonprotocetraric acid from Parmotrema conformatum”, Phytochemistry, 16(7), 1102. [45] Kharel M. K., Rai N. P., Manandhar M. D., Elix J. A., Wardlan J. H. (2000), “Dehydrocollatolic acid, a new depsidone from the lichen Parmotrema nilgherrense”, Australian Journal of Chemistry, 53, 891-892. [46] Kimura Y., Yoshinari T., Koshino H., Fujioka S., Okada K., Shimata A. (2007), “Rubralactone, rubralides A, B and C, and rubramine produced by Penicillium rubrum”, Bioscience, Biotechnology, and Biochemistry, 71, 1896-1901. [47] Koolen H. H. F, Menezes L. S, Souza M. P., Silva F. M. A., Almeida F. G. O, Souza A. Q. L., Nepel A., Barison A., Silva F. H., Evangelist D. E., Souza A. D. L. (2013), “ Talaroxanthone, a novel xanthone dimer from the endophytic Fungus Talaromyces sp. associated with Duguetia stelechantha (Diels) R. E. Fries”, Journal of the Brazilian Chemical Society, 24, 880883. [48] Krog H., Swinscow T. D. V. (1981), “Parmelia subgenus Amphigymnia (lichens) in East Africa”, Bulletin of the British Museum (Natural History), Botany, 9, 143-231. [49] Kukwa M., Bach K., Sipman H. J. M., Flakus A. (2012), “Thirty-six species of the lichen genus Parmotrema (Lecanorales, Ascomycota) new to Bolivia”, Polish Botanical Journal, 57(1), 243–257. 140 [50] Kumar S. V. P., Kekuda T. R. P., Vinayaka K. S., Sudharshan S. J., Mallikarjun N., Swathi D. (2010), “Studies on antibacterial, anthelmintic and antioxidant activities of a macrolichen Parmotrema pseudotinctorum (des. Abb.) Hale (Parmeliaceae) from Bhadra wildlife sanctuary, Karnataka”, International Journal of PharmTech Research, 2, 1207-1214. [51] Kusumaningrum I. K., Suwarso W. P., Cahyana A. H. (2011), “Screening for bioactive compound group in Parmotrema tinctorum‟s extract and bioactivity test of dichloromethane extract as anti-tuberculosis against mycobacterium tuberculosis H37RV and toxicity against Artemia salina.”, Science Journal Ubon Ratchathani University, 2, 53-59. [52] Le H. D. (2012), Chemical study of common lichens in the south of Vietnam, Doctoral Thesis, Kobe Pharmaceutical University, Japan. [53] Lopes T. I. B., Coelho R. G., Yoshida N. C., Honda N. K. (2008), “Radicalscavenging activity of orsellinates”, Chemical & Pharmaceutical Bulletin, 56, 1551-1554. [54] Micheletti A. C., Beatriz A., Lima D. P., Honda N. K. (2009), “Chemical constituents of Parmotrema lichexanthonicum Eliasaro and Alder: isolation, structure modification and evaluation of antibiotic and cytotoxic activities”, Quimica Nova, 32, 12-20. [55] Neeraj V., Behera B. C., Parizadeh H., Bo S. (2011), “Bactericidal activity of some lichen secondary compounds of Cladonia ochrochlora, Parmotrema nilgherrensis and Parmotrema sancti-angelii”, International Journal of Drug Development and Research, 3(3), 222-232. 141 [56] Nising, C. F., Ohnemuler, U. K., Brase, S. (2006), “The total synthesis of the fungal metabolited diversonol”, Angewandte Chemie International Edition, 45, 307-309. [57] O‟Donovan D. G., Robert G., Keogh M. F. (1980), “Structure of the βorcinol depsidones, connorstictic acid and consalazinic acid”, Phytochemistry, 19, 2497-2499. [58] Pechmann V., Hans (1895), "Ueber diazomethan", Berichte der deutschen chemischen Gesellschaft, 28, 855–861. [59] Polborn K., Steglich W. (1995), “Structure of macrocyclic bis-lactone Lepranthin from the lichen Arthonia impolita; an X-ray analysis”, The Zeitschrift für Naturforschung B: A Journal of Chemical Sciences, 50b, 1111-1114. [60] Qin T., Johnson R. P., Porco J. A. (2011), “Vinylogous addition of siloxyurans to benzopyryliums: A concise approach to the tetrahydroxanthone natural products”, Journal of the American Chemical Society, 133, 1714-1717. [61] Raj P. S., Prathapan A., Sebastian J., Antony A. K., Riya M. P., Rani M. R. P., Biju H., Priya S., Raghu K. G. (2014), “Parmotrema tinctorum exhibits antioxidant, antiglycation and inhibitory activities against aldose reductase and carbohydrate digestive enzymes: an in vitro study”, Natural Product Research, 28, 1480-1484. [62] Ramesh P., Shere E., Baig A. (1994), “Chemical investigation of South Indian lichen: Parmelia praesorediosa (Nyl.) and Parmelia reticulate (Tayl.)”, Indian Journal of Heterocyclic Chemistry, 3 (3), 211-212. [63] Sakurai A., Goto Y. (1987), “Chemical studies on the lichen. I. The structure of isolecanoric acid, a new ortho-depside isolated from Parmelia tinctorum Despr.”, Bulletin of the Chemical Society of Japan, 60, 1917-1918. 142 [64] Santos L. C., Honda N.K., Carlos I. Z., Vilegas W. (2004), “Intermediate reactive oxygen and nitrogen from macrophages induced by Brazilian lichens”, Fitoterapia, 75, 473-439. [65] Sati S. C., Joshi S. (2011), “Antibacterial activity of the Himalayan lichen Parmotrema nilgherrense extracts”, British Microbiology Research Journal, 1, 26-32. [66] Schlotterbeck, Fritz (1907), "Transformation of aldehydes into ketones by means of diazomethane", Berichte der Deutschen Chemischen Gesellschaft, 40, 479, 1826, 3000. [67] Seo C., Sohn J. H., Park S. M., Yim J. H., Lee H. K., Oh H. (2008), “Usimine A-C, bioactive usnic acid derivatives from the antartic lichen Stereocaulon alpinum”, Journal of Natural Product, 71, 710-712. [68] Sharma B. C., Kalikotay S. (2012), “Screening of antioxidant activity of lichens Parmotrema reticulatum and Usnea sp. from Darjeeling hills, India”, IOSR Journal of Pharmacy, 2, 54-60. [69] Sinha S. N, Biswas M. (2011), “Evaluation of antibacterial activity of some lichen from Ravangla, Sikkim, India”, International Journal of Pharma and Bio Sciences, 2, 23-28. [70] Skaletzky L. L, Kalamazoo, Mich (1968), “Process for 2-alkoxy-2,3dihydro-5-benzofuranols”, United State Patent Office, 399368, 1-8. [71] Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J. T., Bokesch H., Kenney S., Boyd S. R. (1990), “New colorimetric cytotoxicity assay for anticancer-drug screening”, The Journal of the National Cancer Institute, 82, 1107–1112. [72] Swinscow T. D. V., Krog H. (1988), Macrolichens of East Africa, Bristish Museum, London. 143 [73] Thomas H. Nask III (2008), Lichen Biology, 2nd edition, Cambridge University Press., Cambridge. [74] Toledo Marante F. J., García Castellano A., Estévez Rosas F., Quintana Aguiar J., Bermejo Barrera J. (2003), “Identification and quantitation of allelochemicals from the lichen Lethariella canariensis: Phytotoxicity and antioxidative activity”, Journal of Chemical Ecology, 29, 2049-2071. [75] Vattem D. A., Vaden M., Jamison B. Y., Maitin V. (2012), “Antioxidant and anti-adhesive activity of some common lichens”, Journal of Pharmacology and Toxicology, 7, 96-103. [76] Vivek M. N., Kambar Y., Manasa M., Kekuda T. R. P, Vinayaka K. S. (2014), “Radical scavenging and antibacterial activity of three Parmotrema species from Western Ghats of Karnataka, India”, Journal of Applied Pharmaceutical Science, 4, 86-91. [77] Yousuf S., Choudhary M. I., Atta-ur-Rahman (2014), “Lichens: Chemistry and biological activities”, P. E. In Studies in Natural Products Chemistry, Atta-ur-Rahman, editor, Elsevier BV, Amsterdam, 43, 223-256. [78] Yvonne P. K. (1991), “Comparison of the sulforhodamine B protein and tetrazolium (MTT) assay for in vitro chemosensitivity testing”, European Journal of Cancer, 27, 897–900. [79] Zhang, W., Krohn, K., Zia-Ullah, Florke, U., Pescitelli, G., Bari, L.D., Antus, S., Kurtan, T., Rheinheimer, J., Draeger, S., Schulz, B. (2008), “New mono- and dimeric members of the secalonic acid family: Blennolides A-G isolated from the fungus Blennoria sp.”, Chemistry: A European Journal, 14, 4913-4923. [80] Zhihui D., Jingkai D., Jiafeng L., Guang Z. (1990), “Chemical constituents from Parmelia tinctorum”, Acta Botanica Yunnanica, 12, 99-106. 144 APPENDICES 145 6 HOOC 5 CH3 3 H 23 H3C 22 C 21 H2C 20 H2C H2C 11 8 H2C O Appendix 1. IR spectrum for PRAES-C1 [M+Na]+ [M+H]+ Appendix 2. MS spectrum for PRAES-C1 146 7 H2C 2 4 1 O O 23 4 5 21 7 Appendix 3. 1H NMR spectrum for PRAES-C1 6 HOOC 5 CH3 3 H 23 H3C 22 C 21 H2C 20 H2C H2C 11 8 H2C 7 H2C 2 4 1 O O O 7 4 1 6 3 21 2 Appendix 4. 13C NMR spectrum for PRAES-C1 147 20 5 Appendix 5. DEPT spectrum for PRAES-C1 6 HOOC 5 CH3 3 H 23 H3C 22 C 21 H2C 20 H2C H2C 11 8 H2C 7 H2C 2 4 1 O O Appendix 6. HSQC spectrum for PRAES-C1 148 O 6 HOOC 5 CH3 3 H 23 H3C 22 C 21 H2C 20 H2C H2C 11 8 H2C 7 H2C 2 4 1 O O O Appendix 7. HMBC spectrum for PRAES-C1 6 H3COOC 5 CH3 3 H 23 H3C 22 C 21 H2C 20 H2C H2C 11 8 H2C 7 H2C 2 4 1 O O O Appendix 8. IR spectrum for PRAES-E14 149 [M+H]+ 6 H3COOC 5 CH3 3 H 23 H3C 22 C 21 H2C 20 H2C H2C 11 8 H2C 7 H2C 2 4 1 O O O Appendix 9. MS spectrum for PRAES-E14 6-OCH3 23 5 21 4 Appendix 10. 1H NMR spectrum for PRAES-E14 150 6 H3COOC 5 CH3 3 H 23 H3C 22 C 21 H2C 20 H2C H2C 11 8 H2C 7 H2C 2 4 1 O O O 21 4 7 6-OCH3 22 1 6 3 2 Appendix 11.13C NMR spectrum for PRAES-E14 Appendix 12. DEPT spectrum for PRAES-E14 151 20 5 6 H3COOC 5 CH3 3 H 23 H3C 22 C 21 H2C 20 H2C H2C 11 8 H2C 7 H2C O Appendix 13. COSY spectrum for PRAES-E14 Appendix 14. HSQC spectrum for PRAES-E14 152 2 4 1 O O 6 H3COOC 5 CH3 3 H 23 H3C 22 C 21 H2C 20 H2C H2C 11 8 H2C 7 H2C 2 4 1 O O Appendix 15. HMBC spectrum for PRAES-E14 [M+Na]+ Appendix 16. MS spectrum for PRAES-C10 153 O 23 5 22 4 21 Appendix 17. 1H NMR spectrum for PRAES-C10 21 7 20 8 4 22 1 6 3 2 Appendix 18. 13C NMR spectrum for PRAES-C10 154 5 Appendix 19. DEPT spectrum for PRAES-C10 Appendix 20. HSQC spectrum for PRAES-C10 155 Appendix 21. HMBC spectrum for PRAES-C10 6 HOOC 5 CH3 3 H HO 21 C 20 H2C 19 H2C 8 H2C H2C 7 H2C 10 O [M+Na]+ Appendix 22. MS spectrum for PRAES-C11 156 2 4 1 O O 6 HOOC 5 CH3 3 H 21 C HO 20 H2C 19 H2C 8 H2C H2C 7 H2C 2 4 1 O O 10 5 O 20 7 4 Appendix 23. 1H NMR spectrum for PRAES-C11 7 20 19 4 5 21 1 6 3 2 Appendix 24. 13C NMR spectrum for PRAES-C11 157 6 HOOC 5 CH3 3 H HO 21 C 20 H2C 19 H2C 7 H2C 8 H2C H2C 2 4 1 O O 10 O Appendix 25. HSQC spectrum for PRAES-C11 6 HOOC 5 CH3 3 H HO 21 C 20 H2C 19 H2C 8 H2C H2C 7 H2C 2 4 1 O O 10 O Appendix 26. HMBC spectrum for PRAES-C11 158 6 H3COOC 5 CH3 3 H HO 21 C 20 H2C 19 H2C 8 H2C H2C 7 H2C 2 4 1 O O 10 O C=O lactone Appendix 27. IR spectrum for PRAES-E19 [M+H]+ Appendix 28. MS spectrum for PRAES-E19 159 6 H3COOC 5 CH3 3 H 21 C HO 20 H2C 19 H2C 7 H2C 8 H2C H2C 2 4 1 O O 5 10 O 6-OCH3 20 7 4 Appendix 29. 1H NMR spectrum for PRAES-E19 6 H3COOC 5 CH3 3 H 21 C HO 20 H2C 19 H2C 8 H2C H2C 7 H2C 2 4 1 O O 10 7 O 19 4 6-OCH3 3 21 1 6 20 2 Appendix 30. 13C NMR spectrum for PRAES-E19 160 5 Appendix 31. DEPT spectrum for PRAES-E19 6 H3COOC 5 CH3 3 H HO 21 C 20 H2C 19 H2C 8 H2C H2C 7 H2C 2 4 1 O O 10 O Appendix 32. HSQC spectrum for PRAES-E19 161 6 H3COOC 5 CH3 3 H HO 21 C 20 H2C 19 H2C 8 H2C H2C 7 H2C 2 4 1 O O 10 O Appendix 33. HMBC spectrum for PRAES-E19 Appendix 34. IR spectrum for PRAES-C2 162 [M+Na]+ 6 HOOC 5 CH3 3 H 21 H3CO 20 C 19 H2C 18 H2C 8 H2C H2C 7 H2C 9 O Appendix 35. MS spectrum for PRAES-C2 6 HOOC 5 CH3 3 H 21 H3CO 20 C 19 H2C 18 H2C 7 H2C 8 H2C H2C 2 4 1 O 5 O 20-OCH3 9 O 19 4 7 Appendix 36. H1 NMR spectrum for PRAES-C2 163 2 4 1 O O 18 19 4 20 1 3 6 7 20-OCH3 2 Appendix 37. C13 NMR spectrum for PRAES-C2 6 HOOC 5 CH3 3 H 21 H3CO 20 C 19 H2C 18 H2C 8 H2C H2C 7 H2C 2 4 1 O O 9 O Appendix 38. DEPT spectrum for PRAES-C2 164 5 Appendix 39. HSQC spectrum for PRAES-C2 6 HOOC 5 CH3 3 H 21 H3CO 20 C 19 H2C 18 H2C H2C 9 8 H2C 7 H2C 2 4 1 O O O Appendix 40. HMBC spectrum for PRAES-C2 165 9 CH3 O 5 7 10 1 3 HO 8 OCH3 OH CHO Appendix 41. 1H NMR spectrum for PRAES-T1 9 CH3 O 5 7 10 1 3 HO 8 OCH3 OH CHO Appendix 42. 13C NMR spectrum for PRAES-T1 166 9 CH3 O 5 7 10 1 3 HO 8 OCH3 OH CHO Appendix 43. HSQC spectrum for PRAES-T1 Appendix 44. HMBC spectrum for PRAES-T1 167 [M+Na]+ Appendix 45. MS spectrum for PRAES-E1 Cl 9 CH3 O 5 7 10 1 3 HO 8 OCH3 OH CHO Appendix 46. 1H NMR spectrum for PRAES-E1 168 A Appendix 47. 13C NMR spectrum for PRAES-E1 Cl 9 CH3 O 5 7 10 1 3 HO 8 OCH3 OH CHO Appendix 48. HSQC spectrum for PRAES-E1 169 Cl 9 CH3 O 5 7 10 1 3 HO 8 OCH3 OH CHO Appendix 49. HMBC spectrum for PRAES-E1 9 CH3 O 5 7 10 1 3 HO 8 11 12 13 OCH2CH2CH2CH3 OH CHO Appendix 50. 1H NMR spectrum for PRAES-T2 170 9 CH3 O 5 7 10 1 3 HO 8 11 12 13 OCH2CH2CH2CH3 OH CHO Appendix 51. 13C NMR spectrum for PRAES-T2 Appendix 52. DEPT spectrum for PRAES-T2 171 9 CH3 O 10 5 1 3 HO 8 7 11 12 13 OCH2CH2CH2CH3 OH CHO Appendix 53. HSQC spectrum for PRAES-T2 Appendix 54. HMBC spectrum for PRAES-T2 172 1' CH3 O 5 1 3 HO 7 OCH3 OH Appendix 55. 1H NMR spectrum for PRAES-E11 1' CH3 O 5 HO 1 3 7 OCH3 OH Appendix 56. 13C NMR spectrum for PRAES-E11 173 1' CH3 O 5 HO 1 3 7 OCH3 OH Appendix 57. HSQC spectrum for PRAES-E11 Appendix 58. HMBC spectrum for PRAES-E11 174 1' CH3 O 5 HO 1 3 7 OCH3 OH CH3 Appendix 59. 1H NMR spectrum for PRAES-T4 Appendix 60. 13C NMR spectrum for PRAES-T4 175 1' CH3 O 5 7 1 3 HO OCH3 OH CH3 Appendix 61. HSQC spectrum for PRAES-T4 1' CH3 O 5 HO 1 3 7 OCH3 OH CH3 Appendix 62. HMBC spectrum for PRAES-T4 176 [M+H]+ Appendix 63. MS spectrum for PRAES-T6 1' CH3 5 HO 1 3 OH CHO Appendix 64. 1H NMR spectrum for PRAES-T6 177 Appendix 65. 13C NMR spectrum for PRAES-T6 1' CH3 5 HO 1 3 OH CHO Appendix 66. HMBC spectrum for PRAES-T6 178 3' CH3 2' 1' 5 H3CO 3 O 7 1 OCH3 OH Appendix 67. 1H NMR spectrum for PRAES-E2 3' CH3 2' 1' 5 H3CO 3 1 O 7 OCH3 OH Appendix 68. 13C NMR spectrum for PRAES-E2 179 3' CH3 2' 1' 5 3 H3CO O 7 1 OCH3 OH Appendix 69. HSQC spectrum for PRAES-E2 3' CH3 2' 1' 5 H3CO 3 1 O 7 OCH3 OH Appendix 70. HMBC spectrum for PRAES-E2 180 C=O (lactone) 1785 cm-1 Appendix 71. IR spectrum for PRAES-C22 [M+Na]+ [M+H]+ Appendix 72. MS spectrum for PRAES-C22 181 1 1 9 7 4-OH 3 8 Appendix 73. 1H NMR spectrum for PRAES-C22 3 7 8 9 1 1 6 4 7a 3a 5 1 Appendix 74. 13C NMR spectrum for PRAES-C22 182 Appendix 75. DEPT spectrum for PRAES-C22 Appendix 76. HSQC spectrum for PRAES-C22 183 9 4-OH 8 7 3 8 9 11 7 3 5 3a 7a 4 6 1 Appendix 77. HMBC spectrum for PRAES-C22 Appendix 78. NOESY spectrum for PRAES-C22 184 1 1 C=O (lactone) 1789 cm-1 Appendix 79. IR spectrum for PRAES-C23 [M+H]+ Appendix 80. MS spectrum for PRAES-C23 185 9 1 2 3 7 8 1 4-OH Appendix 81. 1H NMR spectrum for PRAES-C23 3 9 8 7 1 1 6 4 7a 3a 1 5 Appendix 82. 13C NMR spectrum for PRAES-C23 186 2 Appendix 83. DEPT spectrum for PRAES-C23 Appendix 84. HSQC spectrum for PRAES-C23 187 9 7 3 1 2 8 1 2 9 1 1 8 7 3 5 3a 7a 4 6 1 Appendix 85. HMBC spectrum for PRAES-C23 Appendix 86. NOESY spectrum for PRAES-C23 188 C=O (lactone) 1766 cm-1 Appendix 87. IR spectrum for PRAES-C24 [M+Na]+ [M+H]+ Appendix 88. MS spectrum for PRAES-C24 189 2, 2 9 4-OH 3 7 1 8 1 Appendix 89. 1H NMR spectrum for PRAES-C24 9 7 3 1 8 6 1 4 1 5 7a 3a 2, 2 Appendix 90. 13C NMR spectrum for PRAES-C24 190 Appendix 91. DEPT spectrum for PRAES-C24 Appendix 92. HSQC spectrum for PRAES-C24 191 9 4-OH 7 3 8 1 2, 2 1 2, 2 9 8 1 7 3 5 3a 7a 4 6 1 Appendix 93. HMBC spectrum for PRAES-C24 Appendix 94. NOESY spectrum for PRAES-C24 192 [M+Na]+ Appendix 95. MS spectrum for PRAES-C25 Appendix 96. 1H NMR spectrum for PRAES-C25 193 Appendix 97. HMBC spectrum for PRAES-C25 Appendix 98. IR spectrum for PRAES-C25M 194 [M+Na]+ [M+H]+ Appendix 99. MS spectrum for PRAES-C25M 13 10 9 6 8 11 Appendix 100. 1H NMR spectrum for PRAES-C25M 195 12 12 8 6 11 7 5, 3 1 2 10 9 13 4 Appendix 101. 13C NMR spectrum for PRAES-C25M Appendix 102. DEPT spectrum for PRAES-C25M 196 12 Appendix 103. COSY spectrum for PRAES-C25M Appendix 104. HSQC spectrum for PRAES-C25M 197 6 8 11 13 9 10 12 12 13 9 10 8 11 6 4 2 1 5, 3 7 Appendix 105. HMBC spectrum for PRAES-C25M Appendix 106. NOESY spectrum for PRAES-C25M 198 Appendix 107. IR spectrum for PRAES-C26 [M+Na]+ Appendix 108. MS spectrum for PRAES-C26 199 10 9 8 13 12 6 3-OH Appendix 109. `1H NMR spectrum for PRAES-C26 10 9 12 8 11 5 2, 4 3 7 6 1 Appendix 110. 13C NMR spectrum for PRAES-C26 200 13 Appendix 111. DEPT spectrum for PRAES-C26 Appendix 112. HSQC spectrum for PRAES-C26 201 10 8 6 12 9 13 9 10 12 8 6 1 2, 4 5 11 7 3 Appendix 113. HMBC spectrum for PRAES-C26 Appendix 114. NOESY spectrum for PRAES-C26 202 13 Appendix 115. 1H NMR spectrum for PRAES-T3 Appendix 116. 13C NMR spectrum for PRAES-T3 203 Appendix 117. DEPT spectrum for PRAES-T3 Appendix 118. HSQC spectrum for PRAES-T3 204 Appendix 119. HMBC spectrum for PRAES-T3 Appendix 120. 1H NMR spectrum for PRAES-C7 205 Appendix 121. 13C NMR spectrum for PRAES-C7 Appendix 122. DEPT spectrum for PRAES-C7 206 Appendix 123. HSQC spectrum for PRAES-C7 Appendix 124. HMBC spectrum for PRAES-C7 207 [M+H]+ Appendix 125. MS spectrum for PRAES-E18 Appendix 144. H1 NMR spectrum for PRAES-E18 Appendix 144. H1 NMR spectrum for PRAES-E18 Appendix 126. 1H NMR spectrum for PRAES-E18 208 Appendix 127. 13C NMR spectrum for PRAES-E18 Appendix 128. DEPT spectrum for PRAES-E18 209 Appendix 129. COSY spectrum for PRAES-E18 Appendix 130. HSQC spectrum for PRAES-E18 210 Appendix 131. HMBC spectrum for PRAES-E18 Appendix 132. MS spectrum for PRAES-C14 211 Appendix 133. 1H NMR spectrum for PRAES-C14 Appendix 134. 13C NMR spectrum for PRAES-C14 212 Appendix 135. HSQC spectrum for PRAES-C14 Appendix 136. HMBC spectrum for PRAES-C14 213 Appendix 137. 1H NMR spectrum for PRAES-C12 Appendix 138. 13C NMR spectrum for PRAES-C12 214 Appendix 139. DEPT spectrum for PRAES-C12 Appendix 140. HSQC spectrum for PRAES-C12 215 Appendix 141. HMBC spectrum for PRAES-C12 [M+Na]+ Appendix 142. MS spectrum for PRAES-C5 216 Appendix 143. 1H NMR spectrum for PRAES-C5 Appendix 144. 13C NMR spectrum for PRAES-C5 217 Appendix 145. DEPT spectrum for PRAES-C5 Appendix 146. HSQC spectrum for PRAES-C5 218 Appendix 147. HMBC spectrum for PRAES-C5 OH C=O C=C Appendix 148. IR spectrum for PRAES-C15 219 [M+H]+ Appendix 149. MS spectrum for PRAES-C15 A Appendix 150. 1H NMR spectrum for PRAES-C15 220 Appendix 151. 13C NMR spectrum for PRAES-C15 Appendix 152. DEPT spectrum for PRAES-C15 221 Appendix 153. HSQC spectrum for PRAES-C15 Appendix 154. HMBC spectrum for PRAES-C15 222 Appendix 155. NOESY spectrum for PRAES-C15 OH C=O C=C Appendix 156. IR spectrum for PRAES-C16 223 [M+H]+ [M+Na] Appendix 157. MS spectrum for PRAES-C16 Appendix 158. 1H NMR spectrum for PRAES-C16 224 + Appendix 159. 13C NMR spectrum for PRAES-C16 Appendix 160. DEPT spectrum for PRAES-C16 225 Appendix 161. HSQC spectrum for PRAES-C16 Appendix 162. HMBC spectrum for PRAES-C16 226 Appendix 163. ROESY spectrum for PRAES-C16 C=O OH C=C Appendix 164. IR spectrum for PRAES-C20 227 [M+Na]+ [M+H]+ Appendix 165. MS spectrum for PRAES-C20 Appendix 166. 1H NMR spectrum for PRAES-C20 228 Appendix 167. 13C NMR spectrum for PRAES-C20 Appendix 168. DEPT spectrum for PRAES-C20 229 Appendix 169. COSY spectrum for PRAES-C20 Appendix 170. HSQC spectrum for PRAES-C20 230 Appendix 171. HMBC spectrum for PRAES-C20 Appendix 172. ROESY spectrum for PRAES-C20 231 OH C=O C=C Appendix 173. IR spectrum for PRAES-C18 [M+Na]+ [M+H]+ Appendix 174. MS spectrum for PRAES-C18 232 Appendix 175. 1H NMR spectrum for PRAES-C18 Appendix 176. 13C NMR spectrum for PRAES-C18 233 Appendix 177. DEPT spectrum for PRAES-C18 Appendix 178. HSQC spectrum for PRAES-C18 234 Appendix 179. HMBC spectrum for PRAES-C18 Appendix 180. ROESY spectrum for PRAES-C18 235 [M+Na]+ Appendix 181. MS spectrum for PRAES-C3 Appendix 182. 1H NMR spectrum for PRAES-C3 236 Appendix 183. 13C NMR spectrum for PRAES-C3 Appendix 184. DEPT spectrum for PRAES-C3 237 Appendix 185. HSQC spectrum for PRAES-C3 Appendix 186. HMBC spectrum for PRAES-C3 238 [M+Na]+ Appendix 187. MS spectrum for PRAES-C4 Appendix 188. 1H NMR spectrum for PRAES-C4 239 Appendix 189. 13C NMR spectrum for PRAES-C4 Appendix 190. DEPT spectrum for PRAES-C4 240 Appendix 191. HSQC spectrum for PRAES-C4 Appendix 192. HMBC spectrum for PRAES-C4 241 C=O OH C=C Appendix 193. IR spectrum for PRAES-C21 [M+Na]+ [M+H]+ Appendix 194. MS spectrum for PRAES-C21 242 Appendix 195. 1H NMR spectrum for PRAES-C21 Appendix 196. 13C NMR spectrum for PRAES-C21 243 Appendix 197. DEPT spectrum for PRAES-C21 Appendix 198. HSQC spectrum for PRAES-C21 244 Appendix 199. HMBC spectrum for PRAES-C21 Appendix 199. NOESY spectrum for PRAES-C21 245 Appendix 201. 1H NMR spectrum for PRAES-E5 Appendix 202. 13C NMR spectrum for PRAES-E5 246 Appendix 203. HSQC spectrum for PRAES-E5 Appendix 204. HMBC spectrum for PRAES-E5 247 Appendix 205. 1H NMR spectrum for PRAES-E3 Appendix 206. 13C NMR spectrum for PRAES-E3 248 Appendix 207. HMBC spectrum for PRAES-E3 [M+Na]+ Appendix 208. MS spectrum for PRAES-C8 249 Appendix 209. 1H NMR spectrum for PRAES-C8 Appendix 210. 13C NMR spectrum for PRAES-C8 250 Appendix 211. DEPT spectrum for PRAES-C8 Appendix 212. HSQC spectrum for PRAES-C8 251 Appendix 213. HMBC spectrum for PRAES-C8 OH C=O C=C Appendix 214. IR spectrum for PRAES-C27 252 [M+H]+ Appendix 215. MS spectrum for PRAES-C27 Appendix 216. 1H NMR spectrum for PRAES-C27 253 Appendix 217. 13C NMR spectrum for PRAES-C27 Appendix 218. DEPT spectrum for PRAES-C27 254 Appendix 219. COSY spectrum for PRAES-C27 Appendix 220. HSQC spectrum for PRAES-C27 255 Appendix 221. HMBC spectrum for PRAES-C27 Appendix 222. ROESY spectrum for PRAES-C27 256 OH C=O C=C Appendix 223. IR spectrum for PRAES-C28 Appendix 224. MS spectrum for PRAES-C28 257 [M+H]+ Appendix 225. 1H NMR spectrum for PRAES-C28 Appendix 226. 13C NMR spectrum for PRAES-C28 258 Appendix 227. DEPT spectrum for PRAES-C28 Appendix 228. COSY spectrum for PRAES-C28 259 Appendix 229. HSQC spectrum for PRAES-C28 Appendix 230. HMBC spectrum for PRAES-C28 260 Appendix 231. ROESY spectrum for PRAES-C28 Appendix 232. 1H NMR spectrum for PRAES-E17 261 Appendix 233. 13C NMR spectrum for PRAES-E17 Appendix 234. HSQC spectrum for PRAES-E17 262 Appendix 235. HMBC spectrum for PRAES-E17 Appendix 236. 1H NMR spectrum for PRAES-E6 263 Appendix 237. 13C NMR spectrum for PRAES-E6 [M+Na]+ Appendix 238. MS spectrum for PRAES-E13 264 Appendix 239. 1H NMR spectrum for PRAES-E13 Appendix 240.13C NMR spectrum for PRAES-E13 265 Appendix 241. DEPT spectrum for PRAES-E13 Appendix 242. COSY spectrum for PRAES-E13 266 Appendix 243. HSQC spectrum for PRAES-E13 Appendix 244. HMBC spectrum for PRAES-E13 267 [M+Na]+ Appendix 245. MS spectrum for PRAES-E15 Appendix 246. 1H NMR spectrum for PRAES-E15 268 Appendix 247. 13C NMR spectrum for PRAES-E15 Appendix 248. DEPT spectrum for PRAES-E15 269 Appendix 249. COSY spectrum for PRAES-E15 Appendix 250. HSQC spectrum for PRAES-E15 270 Appendix 251. HMBC spectrum for PRAES-E15 Appendix 252. 1H NMR spectrum for PRAES-C2Me 271 Appendix 253. 13C NMR spectrum for PRAES-C2Me Appendix 254. 1H NMR spectrum for PRAES-C2Et 272 Appendix 255. 13C NMR spectrum for PRAES-C2Et Appendix 256. 1H NMR spectrum for PRAES-C2Pro 273 Appendix 257. 13C NMR spectrum for PRAES-C2Pro Appendix 258. HSQC spectrum for PRAES-C2Pro 274 Appendix 259. HMBC spectrum for PRAES-C2Pro 275